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Summary 
The correct regulation of gene expression in space and time is central to embryonic 
development and is mediated by transcription factors (TF). Transcription factors are DNA-
binding proteins that control the expression of distinct sets of target genes.  Mutations in TFs 
frequently underlie hereditary diseases, since the mutation not only affects the TF itself, but can 
also change the expression of the TF’s target genes. 
The genes of the HOXA and HOXD clusters are a group of evolutionary highly conserved TFs 
that control the formation of the anterior-posterior body axis as well as the patterning of the 
vertebrate limb. More than 20 distinct pathogenic mutations in HOXD13, the most posteriorly 
expressed gene of the HOXD-cluster, have been associated with a broad range of disease 
phenotypes, including synpolydactyly, clinodactyly, and different types of brachydactylies. 
However, a molecular basis providing a genotype-phenotype correlation for the diverse 
HOXD13-associated diseases remains elusive. 
To date, the experimental methods used to functionally characterize HOXD13 mutations have 
allowed only limited insights into the underlying molecular pathomechanisms. While ChIP-seq 
technology has proven to be a powerful new method to investigate control mechanisms of TFs 
on a genome-wide scale, a number of technical hurdles hinder the application of ChIP-seq for 
functional characterization of TFs mutations involved in hereditary diseases.  
The aim of this study was to overcome these limitations by establishing a new cell-culture based 
ChIP-seq approach that can be used to investigate a wide spectrum of TFs and TF mutations. 
The new method was applied to characterize two previously unknown missense mutations in 
HOXD13, p.Q317K and p.R298Q, which both alter the DNA-binding domain of HOXD13 but 
lead to very different disease phenotypes. 
Initial analysis of the HOXD13Q317K mutant indicated an alteration of the TFs recognition 
sequence, which resembled the recognition sequence of another TF, PITX1. Detailed analyses 
of ChIP-seq data revealed a genome-wide shift in binding of HOXD13Q317K towards a more 
PITX1-like binding pattern. Even further, expression analysis and viral overexpression in 
developing chicken limb buds confirmed that the mutation introduced a partial conversion of 
HOXD13Q317K into a TF with PITX1-like properties. Examination of the HOXD13R298Q mutant 
suggested a quantitative instead of qualitative modification of binding activity. Here, initial 
analysis of genomic binding was followed by detailed comparison between wildtype and mutant 
binding sites. In combination with the patient phenotype, these analyses point to a dominant-
negative effect of the HOXD13R298Q mutation, which might be caused by a more complex 
biochemical mechanism. 
In addition to functional characterization of the two HOXD13 missense mutations, analysis of 
genome-wide HOXD13 binding revealed a set of binding sites that suggest cooperative gene 
regulation by HOXD13 and other posterior HOX TFs. 
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Collectively, applying ChIP-seq to functionally characterize the pathophysiology of HOXD13 
mutations provides direct evidence for distinct molecular pathomechanisms underlying the 
HOXD13Q317K and HOXD13R298Q missense mutations and point to different aspects necessary 
for correct HOXD13 function. 
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Zusammenfassung 
Der Embryonalentwicklung liegt eine präzise räumliche und zeitliche Regulation der 
Genexpression zugrunde. Diese Regulation wird durch Transkriptionsfaktoren ermöglicht – 
DNA-bindende Proteine, von denen jedes ein bestimmtes Repertoire an sogenannten Zielgenen 
reguliert. Mutationen von Transkriptionsfaktoren führen häufig zu angeborenen Erbkrankheiten, 
da eine solche Mutation nicht nur den Transkriptionsfaktor betrifft, sondern auch die Expression 
seiner Zielgene.  
Die Gene der HOXA- und HOXD-Cluster gehören zu einer Gruppe von evolutionär 
hochkonservierten Transkriptionsfaktoren, welche in Wirbeltieren sowohl die Genexpression 
entlang der Längsachse des Körpers, als auch entlang der Extremitäten steuern. Über 20 
verschiedene Mutation in HOXD13, dem Gen des HOXD-Clusters welches das am stärksten 
posteriore Expressionsmuster aufweist, sind bisher in Zusammenhang mit humanen 
Erbkrankheiten entdeckt worden. Die HOXD13-Mutationen führen zu einer Reihe 
unterschiedlicher Dysplasien der Extremitäten, darunter Synpolydactylie, Clinodactylie und 
verschiedene Brachydactylien. Eine molekularbiologische Grundlage für die Vielgestaltigkeit 
der HOXD13-Mutationen ist bisher jedoch noch nicht beschrieben worden.  
Die experimentellen Methoden welche bisher zur funktionellen Charakterisierung von 
HOXD13-Mutationen verwendet wurden ermöglichten lediglich eine eingeschränkte 
Interpretation der zugrunde liegenden Pathomechanismen. Die im letzten Jahrzehnt entwickelte 
ChIP-seq Technologie zeigt sich als leistungsfähige neue Methode, welche es ermöglicht die 
Funktion eines Transkriptionsfaktors genomweit zu untersuchen. Um diese Technik jedoch zur 
funktionellen Charakterisierung von mutanten Transkriptionsfaktoren anzuwenden, gilt es 
einige technische Herausforderungen zu bewältigen. 
In dieser Arbeit wurde eine neue, Zellkultur-basierter Methode etabliert, welche genutzt werden 
kann um eine Vielzahl von Transkriptionsfaktoren und Transkriptionsfaktormutationen zu 
untersuchen. Die neue Methode wurde anschließend angewandt um zwei zuvor unbeschriebene 
Punktmutationen in dem Transkriptionsfaktor HOXD13, p.Q317K und p.R298Q, zu 
charakterisieren. Obwohl beide Mutationen die DNA-bindende Domäne von HOXD13 
verändern, verursachen sie in Patienten stark unterschiedliche Phänotypen. 
Eine erste Analyse der ChIP-seq Daten für die HOXD13Q317K Mutante zeigte eine Veränderung 
der Bindungssequenz, welche nun jener eines anderen Transkriptionsfaktors, PITX1, ähnelte. 
Weiterführende Analysen der genomweiten Bindung von HOXD13Q317K zeigten, dass die 
Mutation genomweit zu einem veränderten Bindungsprofil führte, welches eher dem 
Bindungsmuster von PITX1 entspricht. Darüber hinaus zeigten induzierte Genexpression sowie 
phänotypische Effekte nach viraler Überexpression in Hühnerextremitätenknospen, dass die 
HOXD13Q317K-Mutante PITX1-ähnliche Eigenschaften aufweist. Im Gegensatz zu dieser 
qualitativen Änderung der DNA-Bindung deutete die Analyse der HOXD13R298Q-Mutante 
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vielmehr auf eine quantitative Veränderung der DNA-Bindung hin. Der initialen Analyse der 
HOXD13R298Q-Bindestellen folgte ein detaillierter Vergleich zwischen HOXD13wt- und 
HOXD13R298Q-gebundenen Sequenzen. In Kombination mit dem humanen Phänotyp deutet bei 
dieser Mutante vieles auf einen dominant-negativen Pathomechanismus hin. Die Analyse zeigte 
des Weiteren, dass möglicherweise komplexe molekularbiologische Mechanismen diesem 
Effekt zugrunde liegen. 
Zusätzlich zur funktionellen Analyse der mutanten HOXD13 Proteine ergab das genomweite 
Bindeprofil von HOXD13 erste deutliche Hinweise auf ein kooperatives Binden von HOXD13 
mit anderen posterioren HOX-Transkriptionsfaktoren. 
Zusammengenommen ermöglichte die Verwendung von ChIP-seq für die funktionelle 
Charakterisierung von HOXD13 Mutationen zum ersten Mal die Erhebung von experimentellen 
Daten welche beweisen, dass klar unterscheidbare molekularbiologische Mechanismen den 
HOXD13Q317K- und HOXD13R298Q-Mutationen zugrunde liegen und diese wiederum auf 
unterschiedliche Aspekte der normalen HOXD13 Funktion hinweisen. 
 
 1 
 Introduction 1
In embryonic development, the body with its organ systems, organs, and appendages arises 
from a single cell in a stereotypic and highly coordinated way. In this process, cells differentiate 
into hundreds of different cell types, all carrying the same DNA. Consequently, cells do not 
differ in their genetic information but rather in the way they use it. Therefore, every cell is 
determined by the genes it expresses.  
The regulation of gene expression is mediated by transcription factors (TF). Each TF regulates 
the expression of a distinct set of target genes and each cell expresses a unique combination of 
TFs that is referred to as the cell’s regulatory state (Davidson 2006). Mutations in TFs not on ly 
affect the TF itself, but also the expression of its target genes. Misexpression of genes due to TF 
mutations severely affects the developing organism, since correct embryonic development 
results from a series of highly coordinated gene expression steps. Therefore, it is of little 
surprise that TF mutations are frequently underlying hereditary diseases of congenital 
malformations (Boyadjiev and Jabs 2000; Vaquerizas et al. 2009). 
 Transcription Factors  1.1
In the vertebrate genome, 6-10% of all protein-coding genes code for (sequence-specific) 
transcription factors (TF)1 (Maston et al. 2006). A unique combination of TFs orchestrates the 
gene expression in each individual cell. TFs control gene expression by regulating the activity 
of RNA-Polymerase at their target genes; however, a wide range of additional proteins 
contribute to this regulation (Figure 1.1). These so-called general transcription factors (GTF) 
form the pre-initiation complex, nucleosome remodeling enzymes make the DNA accessible, 
and histone modifying enzymes together with other non-DNA-binding proteins change the local 
chromatin state to increase or reduce the rate of transcription (Lee and Young 2000; Kadonaga 
2004; Maston et al. 2006; Spitz and Furlong 2012). Most of these factors are found at every 
expressed gene. However, the cell type specific set of genes to which this transcriptional 
machinery is recruited is directed by sequence-specific TFs, with each TF having a particular set 
of target genes. To regulate their target genes, TFs bind specific DNA-elements, so-called cis-
regulatory elements (CRE); which are DNA sequences of several hundred basepairs in length 
that contain binding sites for multiple TFs (Lelli et al. 2012; Spitz and Furlong 2012).  
CREs were initially considered to be located mainly in the vicinity of a gene’s transcription start 
site (TSS) (Lee and Young 2000; Lenhard et al. 2012). This assumption originated from studies 
in bacteria, where the regulatory information is located mainly in promoters directly adjacent to 
a gene (reviewed in Haugen et al. 2008). Similarly, in the eukaryotic yeast gene expression is 
1  The use of the term transcription factor (TF) varies in the literature. If not stated otherwise, I refer sequence specific transcription 
factors when using the term TF. 
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also mostly controlled at the gene promoter. These findings subsequently led to a large body of 
research investigating the interplay between TFs and promoters (e.g. Struhl 1981; Hill et al. 
1986). In parallel, individual CREs were discovered in the larger genomes of animals, 
frequently located in intergenic regions and often separated by thousands of basepairs from the 
genes they control. The widespread distribution of CREs raised the question how TF-binding in 
the genome is distributed and how TFs identify their target genes (Nobrega et al. 2003; Ruf et 
al. 2011)? Using the available methods at the time, only investigation with a single or a few 
CREs or DNA-sequences was feasible. Only in the last decade, major technological advances 
have enabled new experimental approaches and TF function is now increasingly investigated by 
profiling the genome-wide binding of TFs in various organisms and cell types (Johnson et al. 
2007). The insights gained through these studies radically changed the understanding of TF-
DNA interaction: TFs bind to thousands of sites in the genome and most TF binding sites are 
located in intergenic regions that can be hundreds of kilobases away from the nearest gene (He 
et al. 2011; Junion et al. 2012; Wang et al. 2012b).  
However, these findings created two unresolved questions addressing TF function. First, not 
each binding site will be of equal importance; therefore, how can functional binding sites be 
distinguished from non-functional binding sites? Second, if functional binding sites in distant 
CREs can be located far away from the target genes, how can a TF binding site be associated 
with the regulated gene?  
 
 
 
Figure 1.1 General and specific regulatory factors involved in the regulation of gene expression. 
Scheme of proteins involved in the control of gene expression. DNA-binding (dark blue) and non-DNA-binding (light 
blue) TFs, nucleosome remodeling, and histone modifying enzymes facilitate the pre-ininitiation-complex, consisting of 
RNA-Polymerase and general TFs (GTF) to assemble at a Transcription Start Site (TSS). The specificity in gene 
regulation is brought about by proximal and distal cis-regulatatory elements (CREs) to which TFs bind. 
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 Transcription Factor Target Recognition 1.1.1
TF proteins bind DNA via specialized DNA-binding domains. The DNA-binding domain 
usually recognizes a short (6-12bp), degenerate DNA sequence: its recognition sequence 
(reviewed in Luscombe et al. 2000). A common biochemical mechanism of DNA-binding 
domains is an alpha helix that anneals into the major grove of the DNA, which allows the 
amino-acid side chains to directly contact the DNA-base-pairs (Figure 1.2A). Thereby, 
depending on the amino-acid composition of the alpha helix, the protein can distinguish 
between different DNA sequences. Unlike restriction enzymes, the sequence-specificity of TFs 
is often variable and allows a number of similar sequences to be recognized. For example, the 
preferred binding site of a TF could be the sequence TATTAGC; but it might also bind to 
TAATAGC or TATTACC sequences, although with lower affinity. But if there are too many 
variations from the optimal sequence (for example TAATCGA) or when crucial residues in the 
recognition sequence are altered, the TF will not bind. To graphically represent this variability, 
sequence logos representing DNA-motifs where developed (Figure 1.2B) (Schneider and 
Stephens 1990). The size of each letter used in these models signifies the frequency with which 
each base occurs in a set of binding sites (D'Haeseleer 2006).  
Additionally, TFs can change their recognition sequence when binding together with other 
DNA-binding TFs (Figure 1.3). For instance, in the absence of cofactors the Drosophila PBX-
ortholog Extradenticle (Exd) binds TTTGACA and the HOX1-ortholog Labial (Lb) preferably 
binds the sequence TAATTA. However, the two proteins can form a heterodimer that binds a 
TGATTGATGG sequence, where Exd recognizes the TGAT bases and Lb the TGATGG of the 
composite recognition sequence (Joshi et al. 2007; Mann et al. 2009). 
 
Figure 1.2 Transcription factor DNA recognition.  
(A) A homeodomain (Drosophila Engrailed (Fraenkel et al. 1998)) annealed to DNA with the amino-acids conferring 
sequence-specificity highlighted. (B) Sequence logos of Extradenticle (Exd) and Labial (Lb) and a composite binding 
site of the dimer. 
 
 
1. Introduction 
 4 
Such a mechanism ensures that certain binding sites will only be recognized if both TFs are 
present and, with hundreds of TFs in the genome, allows DNA-binding of TFs to be both 
variable and highly specific.  
 Cofactors 1.1.2
Transcription factors control gene expression by recruiting the transcriptional machinery to their 
target genes. Although the specific biochemical mechanism is not fully understood, it is evident 
that TFs are incorporated in large multi-protein complexes that mediate this process (Lenhard et 
al. 2012). Generally speaking, the term “cofactor” can be applied to any protein in those 
complexes. More stringently a cofactor is a protein that directly interacts directly with the TF 
and, depending on type of protein, can lead to different effects on the DNA-binding TF (Figure 
1.3). TFs bind cofactors via protein-interaction domains that are separate from the DNA-binding 
domain. In other cases, such as for Lb and Exd, the DNA-binding domain also mediates the 
cofactor binding.  
Functionally, cofactors are thought to bring about versatility to TF through site-specific 
interactions. In fact, many TFs are described as activators for some target genes and repressors 
for other target genes, which could be due to a modulating effect of a cofactor. In contrast to the 
Lb-Exd interaction, cofactors can also be non-DNA-binding proteins that bind a TF at a subset 
of its binding sites. One such protein is Friend of GATA1 (FOG1), a cofactor of the TF GATA-
binding factor 1 (GATA1). FOG1 is essential for activation and repression of GATA1 target 
genes in megakaryocytes and erythrocytes (Tsang et al. 1997). Since FOG1 is a non-DNA-
binding protein, the interaction of FOG1-GATA1 at individual loci can be identified by the 
presence or absence of a GATA1 recognition sequences. In addition, comparison of all FOG1 
binding sites might reveal the recognition sequence of novel DNA-binding TF interacting with 
FOG1.  
 
Figure 1.3 Types of TF binding with different co-factors 
TFs bind to DNA either alone or in combination with other proteins. The different types of cofactors mediate TF effects 
e.g. altering the recognition site or changing the local chromatin 
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Another important group of cofactors are histone-modifying enzymes such as histone acetyl-
transferases (HAT) or histone deacetylases (HDAC). The acetylation of histones at a CRE or a 
promoter is needed for transcription, whereas deacetylation through HDACs causes 
transcriptional repression. In developing Drosophila embryos, the TF Dorsal activates its target 
genes by recruiting the HAT CBP/p300 to many of its binding sites. In absence of Dorsal, 
CBP/p300 binding at these loci, as well as transcription of the target genes is lost (Holmqvist et 
al. 2012) .  
Taken together, not only the TF binding sites are crucial to TF function, but also the 
combination of proteins that are cobinding at individual sites. Therefore, careful analysis of TF 
binding sites can shed light on possible cofactor interaction and thereby molecular mechanisms 
of TF function.  
 Homeodomain Transcription Factors 1.1.3
Homeodomain TFs are a group of evolutionary highly conserved TFs that share their DNA-
binding domain. The eponymous feature, the homeodomain, was named after the homeotic 
genes (HOX genes), a group of TFs that were discovered through their essential role in anterior-
posterior patterning of the Drosophila embryo (Lewis 1978). Strikingly, when the vertebrate 
orthologs were identified, the genes were also found to pattern the vertebrate embryo along the 
anterior-posterior axis (Akam 1989), indicating that patterning mechanism and gene function is 
conserved in all animals. Aside from the HOX genes, many other homeodomain TFs are pivotal 
in embryonic development. For example, homeodomain-TFs are required for the formation of 
the heart (NKX2-5 (Komuro and Izumo 1993)), the eye (PAX6 (Ton et al. 1991)), the kidney 
(PAX2, HOXA/D11 (Gong et al. 2007)), the limb (e.g. genes of the HOXA/HOXD cluster, 
MSX2, or PITX1 (Logan and Tabin 1999; Zakany and Duboule 2007)), and most other body 
parts.  
The DNA-binding homeodomain is a 60aa protein domain that contains three alpha helices 
separated by turns (Figure 1.2A and Figure 1.4). The first and second helices stabilize the 
domain structure, the third helix – the recognition helix – anneals into the major grove of the 
DNA and confers sequence specificity. The sequence specificity is mainly mediated by the 
amino acids at position 47, 50, 51 and 54 of the homeodomain, all located in the recognition 
helix (Gehring et al. 1994). Additional specificity is conferred by amino acids in the N-terminal 
arm that frequently contact residues in the minor grove (Berger et al. 2008). Compared to other 
TF classes, homeodomains have broad, usually AT-rich binding sites. HOX-gene 
homeodomains bind either to a [T/C]ATTA (HOX1-8) or to a TAAAA core sequence (HOX9-
13). The individual recognition sequence of a given HOX-TF then varies in the bases preceding 
the core sequence (Jolma et al. 2013).  
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 Transcription Factor Mutations 1.1.4
A mutation in a TF does not only affect the TF protein, but often also influences the expression 
of its target genes. Since correct gene regulation is of central importance in embryonic 
development, mutations in human TFs are more prone to cause hereditary diseases than 
mutations in many other genes (Boyadjiev and Jabs 2000; Vaquerizas et al. 2009). Mutations 
can cause complex phenotypes affecting seemingly unrelated organs, because many TFs are 
involved in the development of multiple organ systems and cell types (e.g. the Ulnar-Mammary-
Syndrome, which is caused by mutations in TBX3 (Bamshad et al. 1999)). 
Importantly, analysis of TF mutations must consider that each mutation could alter the TF in a 
specific way. TF mutations in a protein-binding domain may specifically disrupt the interaction 
with one or more cofactors without affecting the DNA-binding of the protein. Thereby only in a 
certain cell type, where the cofactor interaction is essential, might be affected, whereas in 
another cell type that does not required cofactor interaction the TF might function normally 
(Chlon et al. 2012). 
On the other hand, mutations in the DNA-binding domain affect TF function in different ways. 
A mutation can, for example, completely abolish the DNA-binding of the protein by disrupting 
the structure of the domain (Todeschini et al. 2011). In consequence, the mutant TF could either 
be non-functional and act like a complete loss of the protein or might only recognize targets that 
are bound indirectly via a cofactor (Stender et al. 2010). Furthermore, subtle mutations can lead 
to similarly drastic consequences. Missense mutations in homeodomain and zinc-finger TFs 
have been shown to specifically alter the recognition sequence of the TF (Percival-Smith et al. 
1990b; Bulyk et al. 2001; Caronia et al. 2003). Thereby, such a mutant TF will remain a fully 
functional DNA-binding protein, but likely loose many of its original binding sites. Moreover, it 
could gain new set of binding sites and potentially adapt and misregulate novel target genes. 
 
Figure 1.4 Structure of the DNA-binding homeodomain 
(A) The 60 amino acid homeodomain and position of the three alpha-helices. (B) Model of a homeodomain bound to 
DNA (Gehring et al. 1994). Helix III and IV are commonly referred to as helix III/recognition helix. 
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Therefore, the effects to DNA-binding and protein-binding functions of the mutant TFs need to 
be carefully examined. In return, these mutations can be instrumental in elucidating the 
molecular and regulatory function of the TF. 
However, the standard approaches currently used for characterization of TF mutations are of 
general nature and do not take all of these molecular mechanisms into account. In most cases, 
nuclear localization of the protein is tested in transient transfection assays, which is then 
supplemented with in vitro DNA-binding and/or luciferase assays using reporter constructs. 
Failure to bind the consensus motif or to activate the reporter results in the characterization of 
the mutation as a loss-of-function. These experiments mostly allow a simple yes-or-no answer 
and do not adequately address the complex effects of missense mutations; therefore novel 
experimental approaches are needed.  
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 ChIP-seq 1.2
For many years, in vivo studies of TF-DNA interaction were limited to single or a few loci using 
Chromatin Immunoprecipitation (ChIP). The development of massively parallel sequencing 
dramatically changed this, since, combined with new sequencing methods, the ChIP technique 
enables genome-wide identification of protein-DNA interactions (Johnson et al. 2007).  
In the ChIP-seq procedure (Figure 1.5), the chromatin is crosslinked in vivo through 
formaldehyde fixation. Following chromatin purification, protein-DNA complexes are 
fragmented into short stretches of 200 to 500bp of DNA with the bound proteins crosslinked to 
it. The fragmented chromatin is then subjected to immunoprecipitation using an antibody 
directed against the target protein (e.g. a TF). Through this step, the DNA fragments bound by 
the protein of interest are coenriched and after the immunoprecipitation step the coprecipitated 
DNA is isolated and sequenced. When mapped to a reference genome, the ChIP-seq method 
generates a coverage profile in which regions of high coverage (peaks) represent the location of 
protein-DNA interaction (Figure 1.5). ChIP-seq experiments for various TFs in dozens of cell 
types have shown that TFs typically bind to thousands of sites in the genome. While this poses 
enormous challenges to interpreting individual binding sites, it also allows for powerful analysis 
of TF binding in its in vivo environment.  
Bioinformatic research groups have developed a plethora of analysis tools that enable versatile 
evaluation of the enriched regions and address various aspects of TF function. For example, de 
novo motif analysis can identify a TF recognition sequence without prior information. Since 
TFs bind DNA in a sequence specific manner, the bound genomic sequences will contain the 
TFs recognition site. By comparing the sequences of all TF binding sites, the recognition 
sequence can be identified from the ChIP-seq dataset. Furthermore, this analysis can also 
identify possible cofactors since not only the TFs recognition sequence, but also the recognition 
sequences of DNA-binding cofactors will be present in the TF binding sites. Unknown cofactor 
interactions can be identified in ChIP-seq experiments by targeting a non-DNA-binding 
cofactor. Analysis of the detected binding sites will offer information about the DNA-binding 
partners of that factor.  
Other tools address the genomic location of TF binding sites and comparative analysis of 
different ChIP-seq datasets. Analysis of ChIP-seq datasets for multiple TFs with related 
biological function bind has successfully identified CREs by selecting those binding sites, 
where multiple TFs bind (Junion et al. 2012). Independently, ChIP-seq experiments profiling 
the genomic distribution of histone modifications achieved to identify CREs independent of TF 
binding (Heintzman et al. 2007; Ernst and Kellis 2012). Thus, ChIP-seq experiments generate 
valuable datasets that, when carefully analyzed, offer important insights into TF function and 
gene regulation. 
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To date, ChIP-seq has mainly been used to investigate the binding of wildtype TFs. Given the 
multitude of ways in which a mutation can affect TF function, ChIP-seq offers to be a promising 
technique for investigating mutant TFs. However, current ChIP-seq methodologies are not well 
suited to investigate the effects of mutations in TFs, in part because antibodies need to be of 
high quality and typically do not distinguish between wildtype and mutant proteins. 
Additionally, TFs often belong to gene families that consist of several close paralogs, which in 
many cases are coexpressed. A further hindrance is that TFs in developmental processes are 
active at specific developmental time points for which only very small amounts of tissue would 
be available in mouse models and which are difficult to recapitulate in cell culture systems. 
However, if these problems can be overcome, ChIP-seq can be a promising technique to 
investigate TF mutations. 
 
 
  
 
Figure 1.5 Scheme of the ChIP-seq procedure. 
Proteins and DNA of the chromatin are crosslinked in vivo and subsequently purified from the sample. The chromatin is 
then fragmented and used for immunoprecipitation with highly specific antibodies, which recognize e.g. TFs bound to 
DNA or of covalently modified histones. Subsequently, the DNA is purified from immunoprecipitated protein-DNA 
complexes and sequenced by massive parallel sequencing. When the sequence reads are mapped to a reference 
genome, protein-bound regions show high coverage with a characteristic, peak-like shape. 
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 Vertebrate Limb Development 1.3
The vertebrate limbs begin to emerge after the primary axis has formed and while axis 
elongation is still taking place. On each side of the embryo, mesenchymal cells of the lateral 
plate mesoderm accumulate beneath the overlying ectoderm to form a protrusion, the limb bud. 
Along the body axis, two pairs of limb buds form and develop into fore- and hindlimbs. The 
initial limb bud consists of mesodermal mesenchyme that is surrounded by an ectodermal 
epithelium. These mesenchymal cells will later give rise to the skeleton, connective tissue and 
tendons of the extremity, while the cells that will form all other organ systems in the limb 
(muscles, nerves, vascular system, etc.) will invade the growing limb bud at later stages (see 
review by Tickle 2005).  
The undifferentiated early limb bud is already patterned along the three main axes of the 
extremity, the proximo-distal (shoulder to digit), the dorso-ventral (back-of-the-hand to palm) 
and the anterior-posterior axis (thumb to pinkie) (Figure 1.6A). Coordinated growth along the 
three axes then forms the final limb with the stylo-, zeugo-, and autopod; upper extremity, 
middle extremity, and hands/feet, respectively. The main proliferation occurs in a group of 
rapidly dividing cells in the so-called progress zone of the distal limb bud (Summerbell 1974; 
Dudley et al. 2002). The cells of the progress zone receive the proliferative signal from the 
apical ectodermal ridge (AER), a thickening in the ectoderm along the dorso-ventral midline of 
the limb bud. In parallel, a region at the posterior end of the limb bud establishes the anterior-
posterior axis. This region, the zone of polarizing activity (ZPA), consists of a group of cells 
that secrete the signaling molecule Sonic hedgehog (SHH), which creates a SHH concentration 
gradient that determines digit number and identity (Saunders 1948; Riddle et al. 1993). Whereas 
the interplay between the two signaling centers (AER and ZPA) is well understood, it remains 
unclear how the signaling gradient is translated into the formation of skeletal elements along the 
developing limb. Genetic analyses of human mutations and mouse models point to the HOXA 
and HOXD TFs, that possibly integrate the anterior-posterior and proximo-distal signals 
originating from the AER and ZPA (Zakany et al. 2004; Zakany and Duboule 2007).  
 Transcription Factors in Limb Development 1.3.1
Although signaling molecules are the best-described factors governing limb patterning, a 
myriad of TFs are expressed in the limb bud and show distinctive expression patterns. In 
combination with the downstream effectors of signaling pathways, TFs pattern the limb bud by 
creating regionalized gene expression signatures that define the proximal and distal, digital and 
interdigital regions of the limb (Vokes et al. 2008). Consequently, mutations in TFs have been 
described to cause distinct limb malformations that affect only specific limb structures. For 
example, limb malformations of Ulnar-mammary syndrome and Holt-Oram syndrome are 
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dysplasias of the stylo- and zeugopod and are caused by mutations in the TFs TBX3 and TBX5, 
respectively (Bamshad et al. 1997; Li et al. 1997) (Figure 1.6B). Townes-Brocks syndrome 
includes a autopod-restricted polydactyly phenotype and is caused by mutations in the SALL1 
TF (Kohlhase et al. 1998) (Figure 1.6B). Similarly, mutations in the TFs HOXD13 and HOXA13 
lead to malformations of only the hands and feet (Muragaki et al. 1996; Mortlock and Innis 
1997) (Figure 1.6C). 
Even though TF expression patterns and knockout models attest to the role of TFs in limb 
development, the gene regulatory network that underlies limb patterning remains elusive. To 
highlight the fundamental influence TFs exert on limb development, two of the best-described 
examples are presented: forelimb-hindlimb specification through PITX1 and TBX4/5, and 
anterior-posterior and proximo-distal patterning by the HOXA and HOXD genes.  
Determination of Hindlimb Identity by PITX1 
The vertebrate fore- and hindlimbs develop as serially homologous structures and share the 
same general anatomy. Correspondingly, expression patterns of most genes are identical 
between both limb types (Shou et al. 2005; Duboc and Logan 2011). Still, the final shapes of 
fore- and hindlimbs are strikingly different from one another, if one considers bats, mice, birds, 
or humans, for example. 
Only few genes are known to be differentially expressed between fore- and hindlimbs (Logan et 
al. 1998). One of those is the homeodomain transcription factor PITX1. In the developing 
embryo, PITX1 is expressed throughout the hindlimb bud, but not in the forelimb (Figure 1.6D) 
(Logan and Tabin 1999; Szeto et al. 1999). Loss of Pitx1 in murine hindlimb buds causes the 
hindlimb to develop forelimb-like characteristics (Lanctot et al. 1999). Conversely, gain-of-
function experiments that misexpress PITX1/Pitx1 in the developing forelimb in chicken or 
mouse embryos cause the forelimb to develop hindlimb-like characteristics, such as the 
formation of knee-like joints instead of elbows (Logan and Tabin 1999; Szeto et al. 1999). The 
dramatic change in limb morphology results from misexpression of only one TF. Yet, the 
targets through which Pitx1 mediates these effects remain largely unknown. It is believed that 
regulatory genes, such as other TFs, signaling molecules, or their receptors are among the most 
crucial target genes. However, identification of key target genes for Pitx1 has so far not been 
very successful. Only one hindlimb-specific target has been validated unequivocally, the TF 
Tbx4 (Logan and Tabin 1999; Menke et al. 2008; Infante et al. 2012). In an attempt to further 
elucidate gene regulation by Pitx1, a recent study reported the genome-wide binding of PITX1 
in murine hindlimbs using ChIP-seq (Infante et al. 2012). The outcome of this study 
demonstrates the challenges that are a consequence of genome-wide binding profiles. Around 
10,000 binding sites for PITX1 were reported, partly overlapping with hindlimb-specific CREs. 
Reaffirmingly, PITX1 was shown to bind to a number of CREs that control Tbx4 expression. 
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However, just one novel target gene was reported, Tbx2, which is expressed in fore- and 
hindlimbs and does not seem to be directly related to limb identity. This example demonstrates 
that mere in vivo profiling of PITX1 binding sites did not improve the molecular understanding 
of PITX1 function in determining hindlimb identity. 
HOX Genes in Limb Development 
Throughout the animal kingdom, HOX genes pattern the anterior-posterior axis of the embryo 
(Lewis 1978; Akam 1989). The most striking feature of this gene family is the interrelation of 
the genes’ genomic organization with their respective expression domains along the main body 
 
Figure 1.6 Transcription Factors and Limb Development 
(A) The two main signaling centers in the limb bud, AER and ZPA. Shh and FGF signalling molecules create a positive 
feedback loop that drives limb bud outgrowth (modified after Zeller et al 2009). (B) expression pattern of three TFs that 
cause limb malformations in patients (C) HoxD TFs and their overlapping expression patterns in early and late limb 
buds. Colinear expression of the genes patterns the limb along the proximodistal and anterioposterior axis (modified 
after Zakany and Duboule 2007, Woltering and Duboule 2010) (D) Pitx1 determines limb identity in all vertebrates. The 
Tbx4/5 genes are downstream of Pitx1. 
 
 
1. Introduction 
 13 
axis, a mode of expression termed collinearity (Dolle et al. 1989; Graham et al. 1989; Tarchini 
and Duboule 2006). HOX genes are organized in clusters, and the position of a gene within the 
cluster correlates with its expression domain along the main body axis; the most 3’ gene of the 
cluster has the most anterior and the most 5’ the most posterior expression domain (Carroll 
1995).  
In tetrapods, there are four HOX-clusters, HOXA to HOXD, comprised of 39 genes in 13 paralog 
groups2 (Gehring et al. 2009). The HOXA and HOXD genes not only pattern the main body axis 
but also are critical for pattering the limb. Intriguingly, the collinear mode of expression has 
also been adopted in the limb. The HOX genes 3’ in the cluster are expressed in the proximal 
parts of the limb, while the more 5’ HOX genes have increasingly distal expression domains 
(Figure 1.6C) (Tschopp et al. 2009; Woltering and Duboule 2010). Analysis of a series of mice 
carrying targeted deletion of some of the HOX genes uncovered their regional influence on limb 
development. For example, mice missing Hoxa9/Hoxd9 lack the humerus and femur, whereas 
targeted deletion of Hoxa10/Hoxd10 affects tibia and fibula, and deletion of Hoxa11/Hoxd11 
leads to a strong reduction of radius and ulna. Furthermore, similar mouse models deleting 
Hoxd11-13 and/or Hoxa13 demonstrated that these genes control digit development (reviewed 
in Zakany and Duboule 2007). In addition to regional pattering, the mutations also affect the 
size and shape of the particular bones (Woltering and Duboule 2010).  
In early stage limb buds, the posterior HOX genes act redundantly to activate Shh expression in 
the ZPA (Zakany et al. 2004; Kmita et al. 2005). At a later stage, when the digits form, Hoxd13 
has been shown to mediate retinoic acid induced interdigital cell death (Kuss et al. 2009). 
Moreover, Hoxd13 and Hoxa13 both influence skeletal development (Salsi et al. 2008; Kuss et 
al. 2009; Perez et al. 2010; Villavicencio-Lorini et al. 2010).  
Despite major progress in understanding the regulation of the HOX gene clusters in limb 
development, only little is known about the targets of those TFs (Svingen and Tonissen 2006). 
Limb pattering and skeletal development suggest a complex mixture of HOX target genes that 
could on the one hand include genes of signaling pathways involved in patterning and on the 
other hand genes regulating specific skeletal cell differentiation processes. In line with these 
findings, human mutations in HOX genes are associated with digit malformations, which can 
affect both, limb pattering (i.e., digit number) and skeletal development. 
 
  
2  HOXA1-13, HOXB1-13, HOXC1-13, and HOXD1-13. Each cluster misses some of the paralogs (e.g. there is no HOXA12) 
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 Pathogenic Mutations in HOXD13 1.4
Mutations in HOXD13 were the first mutations identified in a human HOX gene (Muragaki et 
al. 1996). The phenotype most frequently associated with HOXD13 mutations is synpolydactyly 
(SPD, MIM *186000). SPD is characterized by a syndactyly of the third and fourth fingers and 
the fourth and fifth toes, with a partial or complete digit forming in the syndactylous web. 
However, the phenotypic spectrum of HOXD13 mutations encompasses various other 
phenotypes, some of which are described below.  
More than 20 distinct mutations HOXD13 have been reported (Figure 1.7A) (for a recent 
review, see Brison et al. 2013). The mutations are distributed along the whole gene body, 
although there is an accumulation of mutations that alter either the N-terminal polyalanine 
stretch or the C-terminal homeodomain (Figure 1.7).  
 
Each mutation can be assigned to one of three classes: 
 
I) Null Mutations  
II) Polyalanine Tract Variations 
III) Missense Mutations 
 
Class I – Null Mutations 
Four nonsense (Furniss et al. 2009; Kurban et al. 2011; Brison et al. 2012b; Jamsheer et al. 
2012) and three frameshift (Goodman et al. 1998; Brison et al. 2012b) mutations have been 
reported, all associated with a SPD phenotype. In the heterozygous state the SPD has a weak 
penetrance (around 30%) and expressivity but is fully penetrant in the homozygous state 
(Goodman et al. 1998; Kan et al. 2003). All alleles are thought to be null alleles due to nonsense 
mediated mRNA decay, although no experimental validation has been reported. Thus, the 
heterozygous phenotype would result from functional haploinsufficiency. Similar to the mild 
effects of haploinsufficiency in humans, a Hoxd13 mouse knockout model shows no obvious 
limb phenotype in heterozygous state but a strong phenotype when both copies of Hoxd13 are 
missing (Dollé et al. 1993). 
 
Class II – Polyalanine Tract Variations 
Near the N-terminus, HOXD13 harbors a trinucleotide repeat encoding a stretch of 15 alanines 
in the protein (Figure 1.7). Expansions of the polyalanine tract were the first described HOXD13 
mutations and expansions of seven to 14 alanines have been reported in over 40 families with a 
SPD phenotype (Brison et al. 2013). Strikingly, SPD penetrance and expressivity increase with 
the length of the alanine expansion (Goodman et al. 1997). Further, homozygous individuals are 
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more severely affected than heterozygous and show an additional phenotype characterized by 
malformation of the metacarpal bones, which has been interpreted as a metacarpal-to-carpal 
homeotic transformation (Kuss et al. 2009).  
Functional analysis of HOXD13polyAla proteins demonstrated that the expanded polyalanine tract 
of HOXD13 causes aggregation of the protein, its retention in the cytoplasm, and finally its 
degradation (Albrecht et al. 2004). In addition, the mutant copy of HOXD13 acts dominant-
negatively by entrapping some of the wildtype proteins, which then also leads to partial 
retention and degradation of wildtype HOXD13 protein. Thereby the polyalanine expansion 
does not only affect the mutant protein, but also renders some of the remaining functional 
HOXD13 inert. Finally, the mutant proteins’ cytoplasmatic retention becomes more pronounced 
the longer the extension of the polyalanine-repeat is, and thus provides a molecular basis for the 
phenotypic observation described above (Albrecht et al. 2004; Villavicencio-Lorini et al. 2010). 
Finally, three cases of polyalanine-contractions have been reported in patients with a 
brachydactyly phenotype in the hands and a SPD-like phenotype in their feet (Nakano et al. 
2007; Zhao et al. 2007; Garcia-Barceló et al. 2008), but there is currently no functional 
explanation for the underlying pathomechanism. 
 
 
Figure 1.7 Pathogenic mutations in HOXD13 are associated with several phenotypes (next page). 
(A) Scheme of the HOXD13 gene locus and annotation of published human mutations in HOXD13. The missense 
mutations are indicated by yellow arrowheads, polyalanine tract variations in blue and putative null mutations in 
gray. The numbers refer to photographs in (B). The three classes of HOXD13 mutations are associated with distinct 
dysmorphologies, i.e. synpolydactylies and different types of brachydactylies. 
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Class III – Missense Mutations 
To date, twelve missense mutations in HOXD13 have been reported, six of which are mutations 
in the DNA-binding homeodomain. Three missense mutations outside the homeodomain (G3A, 
G220A, and G220V) cause a SPD phenotype and additional clinodactyly of the 5th finger with 
varying degrees of expressivity and penetrance, not unlike class I mutations (Fantini et al. 2009; 
Brison et al. 2012a; Zhou et al. 2013)3. In contrast, missense mutations in the homeodomain 
cause multiple phenotypes that can include SPD-like dysplasias but can also appear completely 
unrelated.  
A R298W substitution with reduced penetrance is reported in a Belgian family with 17 mutation 
carriers; 13/17 heterozygous mutation carriers display bilateral clinodactyly of the 5th finger but 
a stronger effect is seen in three patients, which display a unilateral SPD phenotype (Debeer et 
al. 2002). A second dominantly inherited missense mutation affecting the same residue, R298Q, 
is reported in a Chinese family (Wang et al. 2012a). The mutation causes a fully penetrant SPD. 
Additionally, 3/6 individuals show a brachydactyly A2 phenotype (BDA2) that has not been 
reported for any other HOXD13 mutation. This study adds two new cases with an identical de 
novo mutation, leading to a R298Q substitution. Bot patients, like in the previously reported 
family show bilateral SPD and BDA2. 
The remaining three missense mutations in the HOXD13 homeodomain do not cause a SPD 
phenotype. Two mutations, S308C and I314L, are associated with phenotypes overlapping with 
brachydactylies type E and D. The phenotype has been reported to overlap marginally with the 
features of SPD, because isolated patients display a partial polydactyly of the 4th finger (Johnson 
et al. 2003). Molecularly, the I314L mutation has been shown subtly alter the DNA-binding 
specificity by preferably binding to only one of two possible HOXD13 recognition sequences 
(Caronia et al. 2003). Yet another phenotype is caused by a Q317R substitution in a Chinese 
family with dominantly inherited syndactyly type V (Zhao et al. 2007). The affected Q317 
corresponds to position 50 in the homeodomain that, like the I314 (I47), is one of the amino 
acids in the homeodomain known to directly contact the DNA basepairs and is therefore 
required for sequence specificity. The mutation is reported to act as a partial loss-of-function. 
However, this finding relies on a single functional assay that shows reduced activation of a 
reporter construct by the mutant. Finally, this work describes a de novo missense mutation in 
HOXD13 that was discovered in a patient with a complex brachydactyly/oligodactyly 
phenotype that has not been reported with any other HOXD13 mutation or with other mutations. 
The mutation converts Q317 to a lysine (Q317K) and although it affects the same residue as the 
Q317R substitution the phenotypes do not resemble each other. 
3  The remaining three missense mutations outside the homeodomain (P15T, R33G and R48Q) were identified in a patient screen by 
Nakano K, Sakai N, Yamazaki Y, Watanabe H, Yamada N, Sezaki K, Susami T, Tokunaga K, Takato T, Uchinuma E. 2007. 
Novel mutations of the HOXD13 gene in hand and foot malformations. International surgery 92(5): 287. and are reported to 
cause Wassel type IV polydactyly of the thumbs and SPD in the feet. However, the publication does not show patient photographs 
to assess the severity of the phenotype. 
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Given the preliminary evidence, each missense mutation inside the HOXD13 homeodomain 
seems to lead to individual alterations of protein function, thereby changing affinity and/or 
specificity of the TF. In turn such specific effects would help to explain the wide phenotypic 
spectrum of HOXD13 mutations. 
 
 
 Aims and Objectives 1.5
This thesis aims to further our understanding of the molecular mechanisms underlying missense 
mutations in TFs. Therefore, two novel pathogenic mutations in HOXD13 – Q317K and R298Q 
– were investigated. Both missense mutations affect the DNA-binding homeodomain of 
HOXD13, but cause very different patient phenotypes. The Q317K mutation is associated with 
a severe form of oligodactyly combined with brachydactyly, whereas the R298Q mutation is 
associated with SPD and BDA2.  
Current techniques, such as testing the nuclear localization, activation of reporter constructs, or 
in vitro DNA-binding assays provide only limited insights into the molecular changes induced 
by TF mutations. Given the diverse aspects to TF function, these methodologies are not 
sufficient to examine differences between different mutations and new experimental approaches 
are required.  
In this study, a new cell-culture based ChIP-seq approach was used to compare wildtype and 
mutant HOXD13 proteins. Central to this thesis is the application of the ChIP-seq technique, 
which allows versatile analysis of the results with regard to different aspects of TF function. 
Genome-wide binding profiles of wildtype and mutant HOXD13 were produced and, following 
initial data analysis, mutation-specific hypotheses were generated. Subsequently, the hypotheses 
regarding the molecular pathomechanism were tested using appropriate functional experiments 
for the Q317K and R298Q mutation. 
In combination, the functional analysis of the two HOXD13 mutations based on the ChIP-seq 
system revealed clearly distinct pathomechanisms for the Q317K and the R298Q missense 
mutations, and thereby point to different molecular requirements for correct HOXD13 function. 
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 Materials and Methods 2
 Materials 2.1
 Chemicals 2.1.1
Unless stated otherwise, chemicals were obtained from Merck (Darmstadt), Roth (Karlsruhe) or 
Sigma-Aldrich (Hamburg, Seelze, Schnelldorf and Steinheim) in analytical grade quality. 
 
 Buffers 2.1.2
Common buffers and solutions were prepared according to Sambrook et al. 2001. 
 
Buffers for Chromatin-Immunoprecipitation 
Lysis Buffer 1:  50mM HEPES-KOH, pH7.5; 140mM NaCl; 1mM EDTA; 10% Glycerol; 0,5% 
NP-40; 0,25% Triton X-100; Protease Inhibitors (Roche complete, add fresh) 
Lysis Buffer 2:  10mM Tris-HCl, pH 8.0; 200mM NaCl; 1mM EDTA; 0.5mM EGTA; Protease 
Inhibitors (Roche complete, add fresh) 
Lysis Buffer 3:  10mM Tris-HCl, pH 8.0; 100mM NaCl; 1mM EDTA; 0.5mM EGTA; 0,1% Na-
Deoxycholate; 0,5% N-Laurylsarcosine; Protease Inhibitors (Roche complete, add 
fresh) 
RIPA (Wash Buffer):  50mM HEPES-KOH, pKa 7.55; 500mM LiCl; 1mM EDTA; 1,0% NP-40; 0,7% 
Na-Deoxycholate; Protease Inhibitors (Roche complete, add fresh) 
TE-NaCl:  10mM Tris-HCl, pH 8.0; 1mM EDTA; 50mM NaCl, Protease Inhibitors (Roche 
complete, add fresh) 
ChIP-Elution Buffer:  50 mM Tris-HCl, pH8.0; 10mM EDTA, 1.0% SDS 
 
Buffers for Electromobility Shift Assays 
Binding Buffer:  100 mM NaCl; 2 mM MgCl2; 0,1 mg/ml BSA; 4 mM spermidine; 25 mM HEPES, 
pH7.5; Protease Inhibitors (Roche complete) 
Loading Buffer: (40% Glycerol + 0.01% Bromphenol blue)  
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 Antibodies 2.1.3
Table 2.1 Antibodies and Immuncytochemistry Working Dilutions  
Target Concentration/Dilution Catalog # / Lot # Supplier 
αFLAG-M2 1mg/ml 1:200-300 F1804-5MG / 035K6196 Sigma-Aldrich, DE 
gtαm-ALEXA546  2mg/ml 1:200 A11003 / 34779A Molecular Probes, NL 
 
Protein G magnetic beads were obtained from Invitrogen (Dynabeads, Cat.-No. #100.04D)  
 Kits 2.1.4
Standard procedures, such as DNA or RNA purification, cDNA-synthesis, DNA-sequencing, 
protein concentration measurement were conducted following manufacturer’s instructions using 
listed kits. 
Table 2.2 Molecular Biology Kits 
Task Kit Supplier 
Plasmid DNA-purification NucleoSpin Plasmid Macherey-Nagel, Düren 
Plasmid DNA-purification Nucleobond PC100 Macherey-Nagel, Düren 
Plasmid DNA-purification Nucleobond PC100 EF Macherey-Nagel, Düren 
DNA-purification ZymoClean Gel DNA Recovery Kit Zymo Research, Irvine, USA 
RNA-purification RNeasy Mini Kit Qiagen, Hilden 
cDNA-synthesis 
TaqMan Reverse Transcription 
Reagents 
Applied Biosystems, Foster City, 
USA 
Sanger-Sequencing 
BigDye Terminator v3.1 Sequencing 
Kit 
Applied Biosystems, Foster City, 
USA 
Protein concentration 
measurement 
BCA Protein Assay Kit 
Pierce/Thermo Fisher Scientific, 
Bonn 
 
 Enzymes 2.1.5
Restriction enzymes were obtained from NEB (Frankfurt) or MBI-Fermentas (St. Leon-Roth). 
Taq- and Pfu-DNA-polymerases were produced in house (A.C. Stiege). Phusion DNA-
Polymerase was obtained from NEB, T4-ligase and Polymerase from MBI- Fermentas, and 
RNase A (Cat.-No. R4875) and Proteinase K (Cat.-No. P2308) from Sigma-Aldrich. 
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 Bacterial Strains 2.1.6
General cloning steps were performed in the E. coli Top10 (Invitrogen) strain. The expression 
strain used for production of Hoxd13 homeodomains was E. coli Rosetta2 (DE3) pLysS 
(Novagen). 
 Expression Constructs and Vectors 2.1.7
Table 2.3 Plasmid Vectors used in this study 
Plasmid Task Supplier 
pSLAX13-5’FLAG Modified RCAS-Shuttle Vector Dr. Jochen Hecht (Berlin) 
RCASBP(A)-5’ Modified RCASBP-Vector Dr. Jochen Hecht (Berlin) 
RCASBP(B)-5’ Modified RCASBP-Vector Dr. Jochen Hecht (Berlin) 
pTA-GFP Cloning of in situ probes Dr. Jochen Hecht (Berlin) 
pVAX1 Expression vector for luciferase assays Invitrogen 
pCMV-mPitx1 
Transient expression vector 
Kind gift of Dr. J. Drouin and 
Dr. J. Johnston 
pET-41c Bacterial expression vector for 
expression of HOXD13 homeodomains 
Millipore 
 
 
 Primer 2.1.8
All primers were synthesized by MWG Biotech AG (Ebersberg) and HPSF purified.  
Table 2.4 Primers for absolute quantification of RCAS-derived constructs 
Oligoname Sequence (5’  3’)  
D13splice_F GAGCTGAGCTGACTCTGCTGGTGG Cloning RCAS 
standard plasmid D13splice_R CTTAATGACGGCTTCCATGCTTGATC 
D13qRT-F1 TCATCCTTTCCAGGAGATGTGG measuring all viral 
RNA D13qRT-R1 AGGCACCCTTTTCTTGCTTCC 
RCAS-spl-F1 AACTCAGAGGGTCGTCGGAAG measuring Hoxd13-
spliced RNA RCAS-spl-R2 TCACCGTCATCGTCTTTGTAGTC 
cPITX1_RT_F AACCGCTACCCCGATATGAG  
cPITX1_RT_R ACAGGTCCATCTGCTGGTTC  
cHOXD13_RT_F AGCTCGCACTTCTGGAAATC  
 
 
2. Materials and Methods 
 22 
cHOXD13_RT_R TAAGCTGGAGCTTGGTGTAGG  
cGAPDH_RT_F CCATTCCTCCACCTTTGATG  
cGAPDH_RT_R CACGGTTGCTGTATCCAAAC  
cHOXD13_RT_F AGCTCGCACTTCTGGAAATC  
cHOXD13_RT_R TAAGCTGGAGCTTGGTGTAGG  
 
Table 2.5 Primers used for quantitative Realtime-PCR 
Oligoname Sequence (5’  3’) 
cGAPDH_RT_F CCATTCCTCCACCTTTGATG 
cGAPDH_RT_R CACGGTTGCTGTATCCAAAC 
cBMP4_RT_F TGGGAGACCTTTGATGTGAG 
cBMP4_RT_R TTTGCCCTGATGAGTCTGTG 
cFRAS1_RT_F ATGGCCGACTGGTTATTGAG 
cFRAS1_RT_R TGACTTCACATCTGGCAAGC 
cMSX2_RT_F CGAGAGAGACTTCCTGGTGG 
cMSX2_RT_R CGGTTGGGTACTGCATTCTT  
 
Table 2.6 Primers used in Electromobility-Shift-Assays (EMSA) 
Oligoname Sequence (5’  3’) 
Cy-D13-f-5’ CY3-ggatcCCAATAAAAtcggc (labeled oligo) 
Cy-D13-f-3’ CY3-ccgaTTTTATTGGgatcc  (labeled oligo) 
D13-f-5’     ggatcCCAATAAAAtcggc (unlabeled competitor) 
D13-f-3’     ccgaTTTTATTGGgatcc  (unlabeled competitor) 
D13mut-f-5’     ggatcCCcAgcAcAtcgg  (mutant unlabeled competitor) 
D13mut-f-3’     ccgaTgTgcTgGGgatcc  (mutant unlabeled competitor) 
Cy-PITX-f-5’ CY3-ggatcAGGGATTAACtcgg (labeled oligo) 
Cy-PITX-f-3’ CY3-ccgaGTTAATCCCTgatcc (labeled oligo) 
PITX-f-5’     ggatcAGGGATTAACtcgg (unlabeled oligo) 
PITX-f-3’     ccgaGTTAATCCCTgatcc (unlabeled oligo) 
PITXmut-f-5’     ggatcAGGGcggAACtcgg (mutant unlabeled competitor) 
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Table 2.7 Primer used for cloning of expression and luciferase vectors 
Oligoname Sequence (5’  3’) 
Gg_PITX1_NcoI_F GCCCCCGCCATGGATTCC 
Gg_PITX1_SpeI_R ACTAGTCCGTCAACTGTTGTACTGAC 
Mm_Pitx1_NcoI_F CACCTCCATGGACGCCTTCAAGGGAGG 
Mm_Pitx1_RI_R AAAGAATTCGGTCAGCTGTTGTACTGGCAAGCGT 
Gg_SOX9_F3_Nhe1 AAAGCTAGCAAGAGAAGCGCAACGGC 
Gg_SOX9_R1_Xho1 AAAACTCGAGAGTAAAGCCGGCAGAGACG 
 
 Cultured Cell Lines 2.1.9
Table 2.8 Cell culture lines 
Cell Line Origin Supplier 
DF-1 Chicken fibroblast ATCC 
NIH3T3 Murine embryonic fibroblasts ATCC 
 
 Animals 2.1.10
Fertilized eggs (Clean Eggs quality) for chicken micromass cultures were obtained from VALO 
BioMedia GmbH (Osterholz-Scharmbeck). 
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 Instruments 2.1.11
Table 2.9 Centrifuges 
Instrument Model No. / Type Supplier 
Table Top centrifuge 5414D Eppendorf, Hamburg 
Chilling centrifuge 5417R Eppendorf, Hamburg 
Microtiterplate centrifuge 5416 Eppendorf, Hamburg 
Chilling centrifuge Avanti J-E Beckman-Coulter, Palo Alto, USA 
Rotor JLA16250 Beckman-Coulter, Palo Alto, USA 
Very cool refrigerating centrifuge Megafuge 1.0 Thermo Fisher 
Ultracentrifuge L7-55 Beckman, Palo Alto, USA 
Ultracentrifuge Rotor SW 32-Ti Beckman, Palo Alto, USA 
 
Table 2.10 Thermocycler 
Instrument Model No. / Type Supplier 
Thermocycler GeneAmp PCR System  
2700, 2720 and 9700 
Applied Biosystems, Foster City, 
USA 
Real-time Cycler ABIPrism 7900 HT Applied Biosystems, Foster City, 
USA 
 
Table 2.11 Microscopes 
Instrument Model No. / Type Supplier 
Stereomicroscope MZ7-5 Leica, Bensheim 
Camera Axiocam MRc5 Zeiss, Göttingen 
Light source KL1500 LCD Leica, Bensheim 
Software Axiovision 4.x Zeiss, Göttingen 
 
Table 2.12 Next-Generation Sequencing and other 
Instrument Model No. / Type Supplier 
Sequencer Genome Analyzer IIX Illumina, USA 
Cluster Station  Illumina, USA 
Sonicator BioRuptor NextGen UCD-300 Diagenode, Belgium 
Photometer NanoDrop 2000 Thermo Scientific, Wilmington, USA 
Microplate Reader Spectra Max 250 Molecular Devices, Biberach 
Fluorescent imaging system FLA-5000 Fuji, Tokyo, Japan 
Biochemical Analysis Bioanalyzer 2100 Agilent Technologies, Böblingen 
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 Software 2.1.12
General Software 
Digital pictures were edited using Carl Zeiss Axiovision 4.8.2 and Adobe Photoshop CS4. 
Figures were composed using Inkscape 0.48. The bibliography was managed using Thomson 
Reuters Endnote. 
 
Bioinformatics Software 
Table 2.13 lists the bioinformatics software used to perform all ChIP-seq analyses. 
Table 2.13 Specialized bioinformatics software 
Software Task Reference 
FastQC Quality Control fastq-sequencing 
files 
http://www.bioinformatics.babraham.ac.uk/proj
ects/fastqc/ 
BWA Aligner Aligning NGS-sequenced reads 
to reference genome 
(Li and Durbin 2009) 
SAM-Tools Handling of SAM-files (Li et al. 2009) 
MEME-suite Various motif analysis tools (Bailey et al. 2009) 
SPP Quality Control of ChIP-
enrichment 
(Kharchenko et al. 2008) 
BED-Tools Handling of BED-files (Quinlan and Hall 2010) 
MACS2 Detection of ChIP-enriched 
regions 
(Zhang et al. 2008) 
DREME Motif-analysis (Bailey 2011) 
IDR Reproducibility of ChIP-seq 
experiments 
(Li et al. 2011; Landt et al. 2012) 
seqMINER Read distribution analysis of 
ChIP-seq datasets 
(Ye et al. 2011) 
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 Methods 2.2
  General Molecular Biological Methods 2.2.1
All standard molecular biological procedures were performed according to Sambrook et al 
2001. 
 
DNA Isolation 
Isolation of plasmid-DNA from E. coli was performed according to manufacturer’s instructions 
using the Nucleospin or Nucleobond PC100 kits (Macherey-Nagel), depending on amount 
needed. Isolation of plasmid DNA for transfection of eukaryotic cells (for virus production or 
transient transfection) was always performed with the Nucleobond PC100 EF kit 
 
RNA Isolation 
All RNA-preparations for qRT-PCR were performed with the RNA-easy Mini Kit (Qiagen) 
according to manufacturer’s instructions. Usually, four chMM cultures were washed with PBS 
and subsequently lysed in 300 to 550µl RLT buffer. RNA that was not purified immediately 
was frozen in liquid nitrogen after cell lysis in RLT buffer and stored at -80°C until further 
processing.  
For RNA-seq, total RNA from chMM cultures was isolated using peqGOLD TriFast Reagent 
(peqLAB, Erlangen) and subsequently purified with the RNeasy Mini Kit (Qiagen). Extraction 
of mRNA from total RNA was performed using the Oligotex mRNA Mini Kit (Qiagen) and 6 
µg of total RNA.  
cDNA Synthesis 
cDNA synthesis for qRT-PCR was performed with the TaqMan Reverse Transcription Reagents 
Kit (Applied Biosystems) using 1µg of total RNA as template and random hexamer primers. 
The reaction was performed in 100µl volume. 
Polymerase Chain Reaction (PCR) 
PCR was generally performed using in-house produced Taq and Pfu polymerases (A.C. Stiege) 
or Phusion DNA-polymerase (NEB) when amplifying protein-coding expression constructs.  
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Quantitative Realtime-PCR (qRT-PCR) 
qRT-PCR enables quantification of template DNA in samples using the SYBR Green I 
chemistry (Applied Biosystems) and was run on an ABIPrism 7900 HT thermocycler. Primers 
were designed by Primer3Plus (Untergasser et al. 2007) or by hand and double-checked with the 
program OligoCalc (Kibbe 2007). 
 
Relative quantification of transcript levels 
To compare RNA abundance between various samples, cDNA was generated as described 
above. The qRT-PCR was set up in 18µl reaction volume (3µl Primer Mix (4.5pmol per 
primer); 6µl cDNA template; 9µl SYBR Green PCR Master Mix) on a 384-well plate. Each 
reaction was performed as a triplicate.  
The standard curve was generated from a cDNA-pool of all samples that were measured in an 
experiment and was diluted in 1:2 steps (1 – 0.5 – 0.25 – 0. 125 – 0.0625). Relative values were 
measured for each unknown reaction and then normalized to the housekeeping gene GAPDH in 
each experiment, allowing relative quantification of changes in transcript abundance. 
 
Absolute quantification 
While relative quantification measures transcript levels relative to a housekeeping gene 
(GAPDH), absolute quantification aims at measuring the number of molecules in a sample. For 
this, “standard plasmids” carrying the amplicons of interest were cloned (see below). This 
allows calculation of the number of molecules given a known concentration of plasmid DNA. 
The standard curve was generated with the “standard plasmids” starting from a known 
concentration of 1 ng/µl and diluted 1:10 steps. The 10-2 to 10-6 dilutions were used as creation 
standards. In the highest concentration (10-2) a PCR contained 0.06 ng plasmid DNA, the lowest 
concentration had 6 attograms plasmid DNA per PCR. To avoid loss of DNA at these low 
concentrations, all reactions were performed in nuclease-free H2O to which 0.01% Tween20 
was added. This greatly reduced initial inconsistency in PCR amplification. 
Sanger Sequencing 
The sequencing-PCR was performed with the BigDye v3.1 kit (Applied Biosystems), and 100ng 
plasmid-DNA as template. The product was cleaned by ethanol precipitation before transfer to 
the Charité sequencing facility for capillary electrophoresis, which was performed by Mohsen 
Karbasiyan on an ABI3700 capillary sequencer. 
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  Cloning 2.2.2
RCASBP Expression Constructs 
All wildtype and mutant Hoxd13 RCASBP vectors used in this study were cloned by Asita 
Stiege in collaboration with Dr. Jochen Hecht. The constructs are based on the murine Hoxd13 
gene (NM008275.2   NP032301.2) and carry a 3xFLAG tag at the N-terminal end of the 
protein. The RCASBP(A)-empty vectors were also available in the group. 
In the course of the project four new RCASBP-vectors were created, carrying the chicken and 
murine version of the PITX1/Pitx1 gene (NM_001167684.1 and NM_011097.2 respectively), 
preceded by a 3xFLAG-tag. Constructs for the RCASBP(A) and RCASBP(B) vectors were 
constructed in parallel, following identical cloning strategies, only differing by vector backbone 
(RCASBP(A) and RCASBP(B) respectively) in the final subcloning step. 
The cPITX1 CDS was amplified from chicken limb bud (HH25) cDNA with primers 
Gg_Pitx1_NcoI_F and Gg_Pitx1_SpeI_R and subsequently NcoI digested. The pSLAX13-
5’3xFLAG vector was EcoRI digested, and blunted by T4-Polymerase, followed by an NcoI 
digestion step. This enabled a directional ligation of the cPITX1 insert into the vector and 
creating a 3xFLAG tag using the NcoI site. This pSLAX13-3xFLAGcPITX1 shuttle vector was 
then digested with SpeI/ClaI to cut out the cPITX1 construct, that was then ligated into the also 
SpeI/ClaI cut RCASBP(A) and (B) vectors respectively.  
The mPitx1 CDS was amplified from murine brain (E11.5) cDNA with primers 
Mm_Pitx1_NcoI_F and Mm_Pitx1_RI_F and was cloned into RCASBP(A) and RCASBP(B) 
following an almost identical cloning strategy. The only difference was that for the initial 
cloning step into pSLAX13-5’3XFLAG. Here PCR-product and vector were SpeI/NcoI digested 
before ligation. 
 
Cloning of Standard Plasmids for Absolute Quantification 
To generate standard plasmids for absolute quantification a PCR using the adequate primers was 
run on appropriate cDNA with Taq DNA polymerase. The PCR product was then purified after 
size selection through an agarose gel and ligated into a pTA-GFP vector using standard 
procedures. 
 
Cloning of pGL3 Reporter Vectors 
For luciferase assays, the cSOX9 promoter sequence was cloned into the pGL3-basic vector 
(Invitrogen) using the XhoI/NheI restriction sites. The genomic sequences were amplified with 
primers ( 
Table 2.7) that had according restriction sites attached.  
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 Biochemical Methods 2.2.3
Determination of Protein Concentration 
Measurements of protein concentrations were performed using the BCA Protein Assay Reagent 
Kit (Pierce) according to manufacturer instructions. The absorption at 592nm wavelength was 
measured on a ELISA plate reader and quantified relative to a dilution series set up with BSA 
 
SDS-PAGE 
Gel electrophoresis for proteins (SDS-PAGE) was performed on 12.5% polyacrylamide gels as 
described in Sambrook et al 2001.  
 
Western Blot 
 
Protein Transfer 
Western Blots were performed following standard procedures using a tank transfer system onto 
a PVDF membrane (Millipore Immobilon P, 0.45µm pore size). Transfer conditions included 
pre-cooled transfer buffer (25mM Tris-Base; 200mM Glycine, 20% Methanol) and a run time of 
60-70 minutes at 100V in an ice-filled water bath or at 4°C. 
 
Protein Detection 
Immunodetection of antigens was performed as follows; 30 minutes blocking of the membrane 
in 5% milk powder in TBS-T (0.1% Tween-20); primary antibody incubation 1h at room 
temperature or 16h at 4°C; three TBS-T wash steps, 10 minutes each; secondary antibody 
incubation 1h at room temperature or 16h at 4°C; 3-5 wash TBS-T steps; Signal was detected 
using Western Lightning Plus ECL (Perkin-Elmer) and various X-Ray films, developed on the 
AGFA Curix 60. 
 
Electromobility-Shift Assay (EMSA) 
All EMSAs were performed by Asita C. Stiege and Dr. Jochen Hecht, who also produced and 
purified the recombinant HOXD13 homeodomains. 
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 Cell Culture Methods 2.2.4
Transient Transfection and Luciferase Assays 
NIH3T3 cells were grown in medium (DMEM 4.5% Glucose, 1% Penicillin, 1% L-Glutamine, 
10% Fetal Bovine Serum) and seeded in 24-well plates with 2 x 104 cells per well. The 
following day cells were transfected using Polyfect transfection reagent (Qiagen) with 100 ng of 
pGL3-reporter vector and 200 ng of pTL10 expression vector. After 24 h of incubation cells 
were lysed with 5x Passive Lysis Buffer (Promega) and reporter activity was measured with 
DualGlo luciferase reagent (Promega) on a Trilux MicroBeta1450 scintillation counter. Each 
experiment was performed in triplicate and in three biological replicates. 
 
Virus Production 
Production of highly concentrated virus followed a protocol described in detail by Seemann 
(2006) . A modification to the described protocol was the initial used of Turbofect (Thermo 
Scientific) to transfect the DF1-cells with RCAS-plasmids instead of Lipofectamine. 
 
Chicken Micromass Culture 
The protocol used for preparation of chicken micromass (chMM) cultures has been adapted 
from (Lise et al. 2000) and modified by Petra Seemann (2006).  
Eggs were incubated at 37.5°C and >60% humidity for 4.5days. Limb buds of fore- and 
hindlimbs from stage HH24-25 were dissected collected in room temperature PBS. Following 3-
5 washes in prewarmed HBSS (Hanks’ Balanced Salt Solution, Cambrex, Cat.-No.: BE10-
547F) the limb buds were digested for 15min at 37°C in Dispase solution (Gibco, CatNo:17105-
041, 3 mg/ml in HBSS) to detach the ectodermal from the mesenchymal layer and subsequently 
washed in prewarmed HBSS until the detached ectoderm was largely removed. The 
mesenchymal limb buds were then incubated in 1ml prewarmed digestion solution (0.1% (w/v) 
Collagenase type Ia (Sigma-Aldrich, Cat.-No. C9891), 0,1% (w/v) trypsin (Gibco), 5% FBS in 
PBS) for 30min at 37°C and gently pipetted up and down to create a single cell suspension. To 
these cells, 9ml of prewarmed chMM medium was added the suspension was filtered through a 
cell strainer (45µm, BD Bioscience) to ensure a single cell suspension. The cell strainer was 
washed with another 10ml of prewarmed chMM-medium.  
The cells were counted (using a Neubauer cell counting chamber), pelleted and adjusted to a 
2x107 cells/ml cell suspension (in chMM medium). Of this suspension a droplet of 10µl was 
seeded per well in a 24-well cell culture plate and incubated for 2h at 37°C to let the cells 
attach. Finally, 1ml of chMM medium was carefully added to each culture and medium was 
renewed every 2 days. 
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To exogenously express the TF of choice, chMM cultures were infected with the appropriate 
RCASBP(A) virus at the time of seeding. Approximately 0.5µl of concentrated virus was added 
per 10µl of 2x107 cells/ml suspension before seeding (i.e. for a 24-well plate 12µl virus/240µl 
cell suspension). Of this virus/cell mixture 10µl droplets were seeded. 
 
To generally assess the differentiation of the chMM culture, the individual cultures were stained 
with Eosin or Alcian Blue.  
For eosin staining, cultures were fixed in 4%PFA in PBS at 4°C over night and subsequently 
washed in PBS. The cultures were stained with eosin solution for 40-90 seconds and after that 
briefly washed in PBS. Photographs were taken immediately afterwards without liquid inside 
the well, to prevent destaining. 
For Alcian Blue staining, cultures were fixed for 1h room temperature or overnight  at 4°C in 
Kahles Fixativ (30%EtOH, 0.4%PFA, 4% acetic acid) and subsequently incubated in After 
Eight Blue stain (0.05% Alcian Blue in 0.1M HCl-solution) over night at room temperature. The 
chMM cultures were washed with PBS or freshly drafted tab water to remove excess Alcian 
Blue stain and, as for eosin staining, photographed without liquid inside the well. 
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 Chromatin-Immunoprecipitation (ChIP) 2.3
Chromatin Immunoprecipitation comprises a multistep protocol that enables detection of 
protein-DNA interactions. In brief, cells or tissues are fixed with formaldehyde to crosslink the 
protein DNA-complexes of the chromatin. The nuclear chromatin is then purified and fractioned 
by sonication. The sonicated chromatin is subjected to immunoprecipitation with antibodies 
against transcription factors, modified histones or other nuclear antigens. Subsequently, the co-
precipitated DNA can be analyzed in various ways. Analysis by qRT-PCR for example, allows 
testing the enrichment of specific DNA fragments, compared to control regions. In this work, 
ChIP-purified DNA was used for massively parallel sequencing.  
 
 Cell Fixation 2.3.1
To harvest chMM cultures for ChIP, medium was aspirated and 200-400µl of collagenase-
solution (0.1% (w/v) Collagenase type Ia (Sigma-Aldrich, Cat.-No. C9891) in chMM-medium) 
added. chMM cultures were incubated in collagenase-solution for 30 to 90 minutes and then 
disrupted by pipetting up and down. This creates smaller structures and allows a more 
homogenous fixation. Usually cells from 48 chMM cultures (two 24-well plates) were pooled 
for one biological replicate. All cultures were collected in a 50ml Falcon, pelleted and 
resuspended in 10ml cold chMM-medium.  
To crosslink, 273.5µl 37% formaldehyde (Roth) was added to the cell suspension (1% final 
concentration), which was briefly inverted and incubated for 10 minutes on ice. After 10 
minutes 555µl of 2.5M glycine (0.125M final concentration) was added to quench the 
formaldehyde fixation. Subsequently, cells were washed twice in cold PBS and, if not directly 
subjected to cell lysis, shock frozen in liquid nitrogen. 
 
 Nuclear Extraction 2.3.2
This protocol is a modified version of the ChIP-protocol published by Lee et al (2006). Cross-
linked chMM cells were thawed (if appropriate), resuspended in 10ml cold Lysis Buffer 1 and 
incubated with gentle rocking for 10 minutes at 4°C. Cells were spun down (5min at 2700xg), 
the supernatant discarded, resuspended in 10ml Lysis Buffer 2, and incubated with gentle 
rocking for 10 minutes at room temperature. Cells/nuclei were spun down (5min at 2700xg), the 
supernatant discarded and resuspended in 1.5ml Lysis Buffer 3. 
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 Sonication 2.3.3
The samples were sonicated with a Bioruptor NextGen for 35 to 45 cycles (40 cycles for most 
experiments) 30 seconds pulse, 30 seconds pause). During sonication, the tubes were immersed 
in a cooled water bath (4°C). 
To remove cell debris, 150µl 10% TritonX100 (1/10th of the volume) were added to the samples 
and they were centrifuged for 15 min at 16,000xg and 4°C. The supernatant contained the 
sonicated chromatin, which was transferred to a fresh reaction tube.  
 Quality Control of Sonicated Chromatin 2.3.4
Before proceeding to ChIP, the quality control of each chromatin sample was performed. For 
this, 50 to 100µl of sonicated chromatin were transferred to a fresh reaction tube and mixed with 
1/10th of the volume 5M NaCl. Reversal of formaldehyde crosslinks took place by overnight 
incubation at 65°C. Subsequently, RNA was digested by adding 2µl RNase and incubating at 
37°C for 30 minutes, followed by a proteinase K digest (2µl and 30 minute digestion at 55°C). 
The DNA was purified by ethanol precipitation and dissolved in 20µl nuclease free H2O. Then, 
the concentration in the sample was measured and used to infer the chromatin concentration in 
the original sample.  
 
                                                              = µg Chromatin in 1.6ml original sample 
 
Efficiency of sonication was checked on a 1% agarose gel where, in case of successful 
fragmentation, the majority of the DNA was expected to be sheared to fragments of 200-500bp 
length. 
 
 Immunoprecipitation 2.3.5
Prior to immunoprecipitation, protein G beads were blocked by washing two to three times with 
1ml of Blocking Solution (0.5% BSA in PBS), and finally resuspended in 100 to 400µl 
Blocking Solution. Then, antibody was added to the protein G beads and incubated with gentle 
rocking at 4°C for at least 3 hours. After this the antibody-bead complexes were washed twice 
with Blocking Solution. 10µg of anti-FLAG antibody and 40µl of protein G beads were used for 
a standard ChIP experiment. 
If the sample of sonicated chromatin was of sufficient quality, a volume equivalent to 35µg of 
chromatin was used as sample for ChIP. In parallel, 100 µl of sonicated chromatin were taken as 
input chromatin sample and stored at -20°C until crosslink reversal (see below). 
To each 40µl of antibody-coated beads, a volume equivalent to 35µg of sonicated chromatin 
was added and incubated over night at 4°C with constant gentle rocking.  
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Afterwards beads were captured using a magnet and the supernatant was discarded and beads 
were washed six times with RIPA Buffer followed by one washing step with TE-NaCl buffer. 
All supernatants were discarded. Following the final wash step, the beads were centrifuged for 
three minutes at 1000 rpm and 4°C and the remaining few µl of supernatant were carefully 
aspirated. To elute the protein-DNA complexes from the beads, 210µl of Elution Buffer was 
added to the beads and incubated for 30 minutes at 65°C and 1200rpm on a thermomixer. 
Afterwards the beads were spun down (1 minute at 16,000 rpm), and 200µl supernatant, 
containing the immunoprecipitated protein-DNA complexes were transferred to a fresh reaction 
tube. At this point the 100µl input chromatin samples were thawed and processed in parallel to 
the ChIP samples.  
Crosslink-reversal was performed by adding 1/10th of the volume (20µl for ChIP, 10µl for 
input) 5M NaCl, and overnight incubation at 65°C. Following RNase A (4µl, 30min, 37°C) and 
proteinase K (4µl, 30min, 45°C) digestions, the DNA was purified by ethanol precipitation 
using 4µl of Glycogen (Ambion 5mg/ml, Cat.-No. AM9510) as a carrier. 
The precipitated sample was sent to the BCRT sequencing facility for further processing. ChIP 
and input DNA samples were sequenced on an Illumina GAIIX sequencer in 36bp single-end 
reads. 
 
 Initial Processing of ChIP-seq Data 2.3.6
As mentioned earlier, ChIP–seq allows genome-wide detection of TF binding sites. Through 
massively parallel sequencing millions of short sequences, called reads, are generated from 
which one needs to extract the binding information. This requires multiple processing steps of 
the initial reads.  
Briefly, the initially sequenced reads are quality filtered and subsequently aligned (mapped) to a 
template genome. Due to sonication, co-precipitation of protein-DNA complexes enriches for 
short (200 – 500bp) DNA-fragments encompassing the location where the protein has bound. 
Since only the 5’ ends of these fragments are sequenced from one of either end, one expects an 
enrichment of reads in the genome surrounding a TF binding site. This enrichment can be 
detected after mapping the reads to the genome. It usually follows a very characteristic bimodal 
distribution of reads surrounding a binding site, where an enrichment of reads on the positive 
strand is followed by a similar enrichment on the negative strand (see Figure 1.5). When 
displaying the coverage of reads along the genome in a graph, the shape can resemble a 
mountain or mountain range, which is why an individual binding site has been termed peak. 
After mapping the reads to the genome, computer programs, aptly termed peak-callers, are used 
to automatically detect the characteristically enriched locations in the genome. 
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Each ChIP-seq experiment is performed in biological replicates (independently prepared chMM 
cultures and so forth). A crucial step is to validate the reproducibility of identified peaks. Only 
after validation of replicate reproducibility, a list of high-confidence binding sites is generated 
from the replicate experiments, which then can be further analyzed. The processing steps used 
in this study are based on the guidelines for ChIP-seq experiments published as part of the 
ENCODE publications (Landt et al. 2012).  
All bioinformatics analysis was run on a server at the Charité and operated by using a locally 
installed version of the GALAXY platform (Blankenberg et al. 2010; Goecks et al. 2010). The 
infrastructure for bioinformatics processing at the Charité was set up and is maintained by Peter 
Hansen, who also installed all additional programs that were not part of the standard GALAXY 
tools.  
 
Initial Quality Control and Read Mapping 
Initial quality of sequences was assessed using the FastQC program and all reads discarded that 
had an average Phred-score < 28 using the Filter-by-Quality function from the FASTX-toolkit. 
The remaining reads were mapped to the chicken genome (WUGSC2.1/galGal3) with the BWA 
aligner and following parameters (aln -n=0, aln -o=1, aln -e=1, aln -d=16, aln -i=5, aln -l=-1, aln -k=2, 
aln -M=3, aln -O=11, aln -E=4, aln -R=FALSE,  aln –N=FALSE, samse/sampe –n=3, sampe=–N10, 
sampe –a=500, sampe –o=100000, samse/sampe –r=NO). This created a .sam file of aligned reads. 
Next, all reads that aligned to more than one location were removed by selecting lines in the 
.sam file matching XT:A:U, @SQ, or @PG (XT:A:U is a tag in the .sam file that indicates a 
uniquely mapped read. @SG and @PG are comment lines). Next, the rmdup function from the 
SAMtools package was used to remove PCR artifacts from library preparation after the .sam file 
had been converted to a .bam format. Finally, the enrichment of the ChIP was assessed using the 
cross-correlation analysis of the spp 1.11 package (get-binding characteristics function, 
parameters: -srange=0,1000; -bin=5; -cluster=2; -debug=F; -MinTagCount=1000; -
Acceptance_Z_Score=3; -RemoveTagAnomalies=T; -Anomalies_Z=5; -AcceptAllTags=F). 
After performing this initial processing, the overall quality of the enrichment through ChIP was 
evaluated. The ChIP-seq guidelines suggested a number of quality thresholds, although not all 
thresholds need to be met by each experiment. The most meaningful metrics are the RSC and 
NSC values that can be calculated from the cross-correlation analysis and give an 
approximation of the enrichment from the immunoprecipitation step.  
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Reproducibility Testing 
For each ChIP-seq experiment two biological replicates were created. Initial quality control was 
performed independently for each experiment. Next, reproducibility of the genome-wide 
enrichment needed to be tested. For this, a protocol taking advantage of a statistical metric 
called Irreproducible Discovery Rate (IDR) (Li et al. 2011) was followed, which was developed 
in the ENCODE consortium to compare ChIP-seq replicates. 
The IDR aims at comparing the similarity of two ChIP-seq peak lists with making as little 
assumptions as possible. It compares two ranked lists of peaks (strongest to weakest) making 
only one assumption: The higher the significance of a peak in one replicate, the more likely it is 
to be a highly significant peak in the other replicate. If the peak is a false positive, it is less 
likely to be detected in the other replicate. The IDR algorithm uses signal peaks (true positives) 
and noise peaks (false positives) to distinguish between the two categories. Subsequently, the 
IDR is used to determine a threshold for the number of peaks above a certain irreproducible 
discovery rate (IDR). These peaks are likely to represent a reproducible “true positive”. 
Thereby, the method can be used to assess the reproducibility of two ChIP-seq experiments and 
to determine a threshold for significant peaks that is adjusted depending on data quality. 
 
Table 2.14 Quality thresholds and metrics used for assessing ChIP-seq quality 
Metric Origin Suggested threshold Meaning 
Sequencing 
depth 
Number of uniquely mapped, non-
redundant reads per experiment 
>10 million reads 
Sufficient 
number of reads 
to expect most 
binding sites 
recovered 
NRF  
(non-
redundancy 
fraction) 
 ≥ 0.8 for 10million 
reads 
low NRF indicates 
that only little DNA 
was recovered 
after ChIP (low 
library complexity) 
NSC  
(normalized 
strand 
coefficient) 
 ≥ 1.05 Both metrics 
measure the 
signal-to-noise 
ratio of a given 
experiment. 
RSC  
(relative strand 
correlation 
 
< 0.8 
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Figure 2.1 Quality Control steps and basic bioinformatics analysis of ChIP-seq data to validate enrichment 
and reproducibility of experiments. See text for Details 
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Peak Calling 
All peaks were called against pooled input controls of both biological replicates with low 
stringency using the MACS2 program (parameters: -g 1.0e9, –p 1e-1, --too-large, --bw (as 
determined by spp in the quality control step)). The low-stringency peak calling generated lists 
of up to 500,000 peaks, consisting predominantly of false-positives. For subsequent IDR 
analysis, these lists were sorted by p-value and the 120,000 most significant peaks selected 
(even here, most peaks represent false-positives). 
For IDR analysis, peak lists for each biological replicate were created, and additionally peak-
lists for pseudo replicates4 of each individual biological replicate and the pooled biological 
replicates. This comprises the eight peak-lists required for IDR analysis: 
 
i) biological replicate 1 (Rep1)  v)  biological replicate 2 pseudorep. 1 (Rep2.1) 
ii) biological replicate 2 (Rep2) vi) biological replicate 2 pseudorep. 2 (Rep2.2) 
iii) biological replicate 1 pseudorep. 1 (Rep1.1) vii) pooled replicates pseudorep. 1 (Rep0.1) 
iv) biological replicate 1 pseudorep. 2 (Rep1.2)  viii) pooled replicates pseudorep. 2 (Rep0.2) 
 
IDR-Analysis 
To test reproducibility, IDR analysis is performed for the biological replicates (replicate 
consistency), the pseudo replicates of each biological replicate (self-consistency), and the 
pseudo replicates of the pooled replicates (pooled-consistency).  
Each IDR analysis gives the number of peaks above a certain IDR threshold. This is, for a 0.01 
(1%) threshold, the number of peaks that have a 99% probability to be reproducible between the 
replicates. For replicate consistency and self-consistency IDR thresholds of 0.01 were used, for 
pooled- consistency 0.0025.  
Reproducibility of two datasets is ensured if the numbers of peaks above the threshold for the 
self-consistency sets are within the factor of two. Also, the number of peaks above threshold for 
replicate-consistency and pooled_consistency should be within a factor of two. More details on 
this method can be found in (Li et al. 2011; Kundaje 2012; Landt et al. 2012) 
 
Determination of the Final Peak Set 
The final peak-set was compiled by calling low-stringency peaks on the pooled reads from both 
replicates, which were then sorted by p-value. Of this list, the top number of peaks as given by 
the pooled-consistency analysis (peaks above IDR 0.0025) was selected and make up the high-
confidence peaks for a given ChIP-seq experiment. 
4  Pseudo replicates are used to test the self-consistency of a dataset. Reads from a ChIP-seq experiment are randomly 
distributed onto two „pseudo replicates“ and peaks are called for each set independently. IDR analysis of the 
pseudo replicates is expected to be very good, since it effectively measures the same dataset twice. More 
importantly, it also shows how good the signal-to-noise ratio for an individual dataset is by comparing the 
reproducible peaks called with half of the input reads. 
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 Bioinformatic Analyses 2.4
Motif analysis 
DREME 
Motif analysis was conducted using DREME (MEME package, version 4.7.0) (Bailey 2011). 
Sequences of 150bp surrounding the summits of the 1000 most significant peaks (sorted by p-
value) were used as input (non-default parameters: -mink 3, -maxk 10). 
RSAT 
Motif analysis with RSAT was performed using the identical input sequences as for DREME. 
(non-default parameters: -disco oligos, positions -nmotifs 5 -minol 6 -maxol 7) 
 
Peak overlap 
To calculate peaks the peaks were set to peak summits +/-150bp, creating a list of uniform 
peaks with 300bp width. Two peaks were considered overlapping when the overlap would be at 
least 200bp in length. This meant, that the peak summits were not further than 100bp apart and 
that if three peaks overlap, each pair of peaks would also overlap. 
 
seqMINER Analysis 
The seqMINER release 1.3.3 (April 2012) (Ye et al. 2011) was used. The peak summits were 
taken as reference coordinates. Subsequently, mean read densities relative to these locations 
were calculated for pooled reads from the two biological replicates for each factor. The graph 
displays is the distribution of mean read densities (tags/50bp) centered on the peaks summits 
(+/- 3000bp). 
Motif Tools 
For further analysis of motif distribution in ChIP-seq peaks the FIMO and CENTRIMO 
algorithms of the MEME suite (Bailey et al. 2009) were used, unless otherwise stated with 
default parameters. The motif matrices used as input correspond to the motifs shown in the 
according figures. Initial motifs detected by RSAT or DREME were manually shortened, so that 
only the core motifs with high information content bases were represented. 
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RNA-seq 
Dr. Marten Jäger and Peter Hansen at the Computational Biology Group of Prof. Dr. Peter 
Robinson at the Charité performed most processing and data analysis steps of RNA-seq data. 
 
Primary RNA-seq processing steps (Dr. Marten Jäger) 
The reference transcriptome for G. gallus was downloaded from Ensembl release 64 database 
(WASHUC2/GALGAL3 genome assembly) and contains 23,392 transcripts (exon models) for 
17,934 genes. Reads for each dataset were separately mapped to the reference transcriptome 
using bowtie (release 0.12.7) mostly using default parameters (exceptions: seed length (l=40), 
the number of allowed mismatches in the seed region (m=3)). A preceding quality filtering of 
the reads was skipped due to bowtie’s ability to use Phred quality scores of reads during the 
alignment step. Reads mapping to multiple transcripts were randomly assigned to one of them. 
To quantify the transcript expression and normalize between the datasets the reads per kilobase 
of exon model per million mapped reads (RPKM) values for all exon models were calculated 
(Mortazavi et al. 2008) and used for further analysis. 
 
Hierarchical Clustering and Principle Component Analysis of Expression Data 
(Dr. Marten Jäger and Peter Hansen) 
The analysis of expression data was performed for the five RNA-seq datasets with RPKM 
values for 3118 transcripts showing a minimum RPKM value of 2 in at least one of the 
experiments with the additional criterion of a fold change of at least two compared to the 
RPKM values obtained for the control RCASBP vector. Principle Component Analysis (PCA) 
and hierarchical clustering were applied to the base-2 logarithms of the RPKM fold change 
values. The PCA was performed using the R function prcomp (retx=TRUE, center=TRUE, 
scale=TRUE). The hierarchical clustering and dendrogram calculation was done using the 
Matlab 2011 function clustergram with the Euclidean metric for pairwise comparison and 
unweighted average distance for the linkage.  
 
Gene Ontology Analysis (Daniel Ibrahim) 
GO-analysis was performed using DAVID (Huang et al. 2008; Huang et al. 2009). Input lists 
were ENSGALG numbers found after expression filtering. 
 
Co-Binding of TF to Differentially Co-regulated Genes (Peter Hansen) 
 
The 3118 differentially regulated transcripts the RPKM values were summed up for each gene 
and condition. RPKM fold changes relative to control cultures were calculated as for transcripts. 
Genes with a twofold up-regulation for HOXD13Q317K and PITX1 or a twofold down-regulation 
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for HOXD13Q317K and PITX1 were defined as HOXD13Q317K/PITX1 co-regulated genes. 
HOXD13Q317R/PITX1 co-regulated genes were defined accordingly. 
Shared peaks for HOXD13Q317K and PITX1 and accordingly HOXD13Q317R and PITX1 were 
assigned to genes if they fall in the promoter (-5kb to +2kb of TSS), the gene body or gene 
flanking regions (-25kb to +25kb) of annotated ENSEMBL genes. Genes with at least one 
shared peak for HOYD13Q317K and PITX1 were defined as HOYD13Q317K-PITX1 cobound 
genes. Hoxd13Q317R-PITX1 cobound genes were defined accordingly. 
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 Results 3
 
 Two Novel HOXD13 Mutations Cause Distinct Human Phenotypes 3.1
 Two HOXD13 Missense Mutations, p.Q317K and p.R298Q, are 3.1.1
Associated with Distinct Limb Malformations 
Patients carrying two missense mutations in HOXD13 causing distinct limb malformations were 
identified and initially described in the Institute for Medical and Human Genetics, Charité 
Berlin. 
One case concerned a girl with a complex brachydactyly/oligodactyly phenotype. The girl was 
born in a family with no history of congenital malformations and with otherwise normal 
measurements and psychomotor development. On both hands the girl had only four, severely 
shortened fingers. The terminal phalanges as well as the nails of the thumbs were missing 
(Figure 3.1A, left). Radiograms of the right hand, performed at the age of five months showed 
only four metacarpals and only the proximal phalanges of the thumb and the two following 
digits were present (Figure 3.1A, right). In the little fingers, which also showed clinodactyly, the 
proximal phalanges and a hypoplastic middle phalanx could be identified. All other phalanges 
were missing (Figure 3.1). 
 The left and right foot had three and four toes, respectively, and the nails of both big toes were 
absent. As for the hand, the feet showed three and four metatarsals and only rudimentary 
proximal phalanges, all distal ones missing. Finally, the right foot displayed a syndactyly 
between the two central toes.  
 
Figure 3.1 Two HOXD13 missense mutations cause distinct phenotypes. 
Photo- and radiographs of HOXD13 mutant patients. (A) Hand and foot phenotype of the HOXD13Q317K patient. 
Missing digits and absent distal phalanges and nails are apparent. Radiographs show missing and deformed 
metacarpals. (B) Left hands of the two HOXD13R298Q patients. Note the BDA2 of the first digit with the notched 
terminal phalange. The SPD with an additional phalangeal anlage as seen in patient B was surgically removed in 
patient A. 
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The mutation underlying this severe phenotype was found to be a heterozygous c.949C>A 
mutation in exon 2 of the HOXD13 gene (NM_000523.2). The mutation has not been reported 
in the dbSNP database or elsewhere and was not present in either of the parents and had thus 
occurred de novo. On protein level, the mutation converts the glutamine at position 317 to a 
lysine (p.Q317K) (Figure 3.2A). Notably, the affected residue corresponds to position 50 of the 
DNA binding homeodomain, which is crucial for binding site specificity (Figure 3.2B). 
Interestingly, a different point mutation (p. Q317R) has been reported previously at this position 
in a family with a very different phenotype consisting of a form of brachysyndactyly type V 
(Zhao et al. 2007).  
The second mutation was also found as a de novo mutation in two non-related patients, both 
displaying a similar phenotype consisting of a combination of central polydactyly with 3-4 
finger syndactyly (SPD) and brachydactyly type A2 (BDA2) (Figure 3.1B). The patients were 
bilaterally affected by the SPD and the BDA2. Patient A’s SPD had been treated surgically and 
there is no information regarding a possible polydactyly. Radiographs of patient B’s right hand 
showed an additional phalangeal anlage between the third and fourth finger, while the 
syndactyly in the left hand showed no polydactyly (Figure 3.2B).  All patients displayed 
bilaterally affected index fingers with hypoplastic middle phalanges leading to a radial deviation 
of the terminal phalanges of the index fingers (Figure 3.1B). Moreover, the terminal phalanges 
of the index fingers display a very mild form of polydactyly, which can be seen as notched 
terminal phalanx on radiographs. The BDA2 phenotype was also noted for the 2nd toes of patient 
A while no syndactylies of the toes were reported. No foot malformations were reported for 
 
Figure 3.2 Location of the two HOXD13 missense mutations. 
(A) Schematic representation of human HOXD13 indicating the known protein domains and position of the 
described missense mutations. (B) Three-dimensional structure of a homeodomain binding to DNA (Drosophila 
Engrailed (Fraenkel et al. 1998)). The arginine and glutamine mutated in the patients are highlighted in red and the 
atoms of the side chains are shown as spheres. 
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patient B. 
Although novel at the beginning of this work, the same mutation causing an identical phenotype 
was reported by Wang and colleagues (2012a) in a two-generation Chinese family.  In all three 
cases, the mutation responsible for the disease is a c.893G>A exchange in exon 2 of HOXD13. 
It converts the arginine at position 298 to a glutamine (p.R298Q) (Figure 3.2A). The affected 
residue, R298, is conserved in most homeodomains and has been described to mediate non-
specific protein-DNA contexts through ionic bonds between the polar NH2 groups of the side 
chain and the DNA phosphate backbone (Gehring et al. 1994; Berger et al. 2008) (Figure 3.2B). 
Another missense mutation also altering R298 was reported by Debeer et al. (2002). This 
R298W mutation causes a mild form of SPD with reduced penetrance. Affected patients, 
however, do not display the BDA2 phenotype seen in HOXD13R298Q patients.  
 
 
 Functional Analysis Using Standard Biochemical Assays 3.1.2
First, I used standard biochemical and molecular biology assays to analyze the effects of the 
missense mutations on HOXD13 function. 
 
I. Nuclear localization of HOXD13 mutants 
To test whether the mutations affect nuclear localization of the HOXD13 proteins, as has been 
described for the poly-Alanine extensions in HOXD13, DF1 cells were infected with 
RCASBP(A) viruses expressing 3xFLAG-tagged versions of murine Hoxd13, that coded for 
wildtype, R298Q, and Q317K mutant proteins respectively. Figure 3.3A shows 
immunohistological staining of the cells with anti-FLAG antibody three days after infection. All 
variant HOXD13 proteins localize to the nucleus, indicating that the mutations do not affect the 
subcellular localization of the protein. 
 
II. Binding of mutant homeodomains to the HOXD13 motif (EMSA) 
Since both mutations affect the DNA-binding domain, the binding of the homeodomain to the 
known HOXD13 recognition sequence was tested. Wildtype and mutant HOXD13 
homeodomains were recombinantly expressed in E. coli and subsequently purified. These were 
then used for electromobility shift assays (EMSA) using equal amounts (400 ng) of purified 
homeodomains and labeled DNA-oligos containing the HOXD13 recognition sequence 
published by Berger et al. (2008). Adding either unlabeled wildtype competitor oligos, which 
also carried the HOXD13 binding site, or mutant competitor oligos, which contained a modified 
HOXD13 binding site, tested sequence specificity of the DNA-binding. 
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Figure 3.3 Standard functional analysis of HOXD13R298Q and HOXD13Q317K mutations. 
(A) Immunocytochemical detection of virally infected DF1 cells shows the nuclear localization of wildtype and mutant 
HOXD13 proteins. DAPI (blue) stains the nuclei while an anti-FLAG antibody (red) detects the nuclear localization of 
the proteins. (B) In vitro binding properties of wildtype and mutant HOXD13 homeodomains. EMSAs were performed 
using fluorescent dye labeled double-stranded oligonucleotides containing a binding site (CCAATAAAA) for HOXD13. 
The oligos were incubated with purified wildtype and mutant homeodomains. Unlabeled competitor reduced binding to 
the labeled oligos whereas a mutant competitor did not, indicating sequence-specific binding. The HOXD13 recognition 
sequence is bound by HOXD13wt and HOXD13R298Q homeodomains but not by HOXD13Q317K. (C) Schematic view of the 
promoter region used in luciferase reporter assays. (D) Transcriptional activation of the chicken SOX9-promoter by 
HOXD13 wildtype and mutants. NIH3T3 cells were transfected with 250 ng of reporter construct and 200 ng of Hoxd13 
cloned into expression vector pTL10. Bars represent the relative luciferase activity of at least three independent 
experiments. Co-transfection of Hoxd13wt leads to approximately 5-fold activation of the reporter vector. Hoxd13R298Q 
still achieves a 4-fold activation while Hoxd13Q317K only shows a weak 1.6-fold stronger activation than with co-
transfection of an empty pTL10 vector.  
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The wildtype HOXD13 homeodomain binds specifically to the labeled DNA-oligo carrying the 
HOXD13 binding site (band shift lane 1, Figure 3.3B). Adding excess unlabeled wildtype 
competitor removed the shifted band (lane 2). This was not the case when adding a mutant 
competitor oligo (lane 3), indicating sequence specificity of the protein-DNA interaction. The 
R298Q-mutant homeodomain showed an unchanged binding behavior and also specifically 
recognized the HOXD13 binding site (lane 4 – 6). In stark contrast, the HOXD13Q317K mutation 
virtually abolished binding to the HOXD13 binding site (lane 7 – 9). 
 
 
III. Activation of a luciferase reporter gene 
Previous experiments in the group had indicated a regulation of the chondrocyte specific TF 
SOX9 through HOXD13. To test the direct regulation of SOX9 by HOXD13, the chicken SOX9 
promoter was cloned into a luciferase reporter vector (Figure 3.3C). Reporter assays carried out 
in NIH3T3 cells showed a 5-fold activation of the reporter construct when cotransfected with 
Hoxd13wt (Figure 3.3D).  
This cSOX9 reporter vector was then used to compare the regulatory capacity of the 
HOXD13R298Q and HOXD13Q317K mutants to HOXD13wt (Figure 3.3D). The HOXD13R298Q-
mutant activated the cSOX9-promoter although less effective than HOXD13wt (approximately 
20% reduction). The HOXD13Q317K mutant fully lost its activating capacity and did not activate 
the reporter construct.  
 
Taken together, standard approaches to analyze the effects of the missense mutations on 
HOXD13 function found the HOXD13R298Q mutation to act as a hypomorphic allele with 
considerable amounts of residual wildtype activity, whereas the HOXD13Q317K allele appears to 
act as a strong loss-of-function allele.  
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 A Method to Functionally Characterize TF Mutations Using ChIP-seq 3.2
Using the standard approaches described above, varying loss of wildtype function could be 
observed, but – regarding genotype-phenotype correlation – led to presumably incomplete and 
inconsistent results. Therefore, ChIP-seq was chosen to allow a more comprehensive analysis of 
the HOXD13 mutations.  
Since no specific antibodies that could differentiate between wildtype and mutant HOXD13 
were available, chMM-ChIP-seq, a cell culture based system using mesenchymal limb bud cells 
and retroviral overexpression, was developed to overcome this hurdles. To be able to perform 
comparative ChIP-seq, murine sequences for Hoxd13wt, Hoxd13Q317K, and Hoxd13R298Q were 
cloned into a retroviral vector, RCASBP(A), adding a 3xFLAG-tag to the N-terminus of the 
protein (Figure 3.4). 
 
 Validation of the Method 3.2.1
The system is based on chicken limb bud micromass cultures (chMM), which are generated 
from limb bud mesenchyme in which HOXD13 is expressed physiologically. In culture, the 
cells spontaneously undergo a chondrogenic differentiation process that can be influenced by 
virally expressing a protein of interest using the avian-specific RCAS-system. Furthermore, 
previous studies in the group demonstrated that viral expression of Hoxd13 inhibits 
chondrogenic differentiation in this context (Kuss et al. 2009). 
To exclude that the 3xFLAG-tag affects HOXD13 protein function, the effect of tagged 
 
Figure 3.4 A system to stdy binding profiles of transcription factors 
In vitro investigation o genome-wide TF binding using chicken mesenchymal cells and RCASBP retrovirus. The 
coding sequence of a gene of interest (g.o.i.) is introduced into the pSLAX vector in frame with a 3xFLAG tag 
sequence. This is transferred into an RCASBP virus using standard procedures. Single cell suspensions are 
isolated from the limb buds of chicken embryos at stage HH24 and are infected with the virus, leading to moderate 
overexpression of the protein of interest. After the desired culture time, cells are harvested and ChIP-seq is 
performed using an antibody against the FLAG-tag sequence. 
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HOXD13 was compared to an RCAS-virus expressing an untagged version (Albrecht et al. 
2004). Chicken micromass cultures infected with the 3xFLAG-tagged version of HOXD13 had 
the same inhibitory effect on chondrogenic differentiation as untagged version (Figure 3.5A). 
For further molecular validation, expression analysis of selected Hoxd13 target genes was 
performed comparing chMM cultures infected with untagged or 3xFLAG-tagged Hoxd13 
viruses. In line with the gross morphological effect, qRT-PCR analysis showed nearly identical 
up-regulation of BMP4, FRAS1 and MSX2 in both chMM cultures (Figure 3.5B). 
Next, the degree of virally produced Hoxd13-transcript was compared to the endogenous 
transcript levels in posterior HH25 chicken limb buds, since viral overexpression can pose a 
problem by leading to excess amounts of TF protein,  
All virally produced transcripts and all Hoxd13-coding transcripts were measured in chMM 
cultures using absolute quantification by qRT-PCR and set into relation to absolute GAPDH 
transcripts numbers, which were measured in parallel. Correspondingly, endogenous HOXD13 
transcripts were measured from HH25 posterior chicken limb buds and set into relation with 
GAPDH (Figure 3.6).  
As shown in Figure 3.6, only 20% of all viral RNAs are spliced in such a way that a HOXD13 
protein is translated, which is consistent with the published literature (Morgan and Fekete 
1996)5. When comparing viral Hoxd13 levels in chMM to HH25 posterior forelimb buds, 
chMM cultures showed moderate 3-fold higher expression of Hoxd13 in chMM than HOXD13 
expression in limb buds (Figure 3.6).  
 
 
 
 
5 This number was the same for Hoxd13wt virus and all tested Hoxd13 mutant viruses. Also, Hoxd13wt and mutant infected chMM 
cultures produced comparable protein levels and showed no indication of protein degradation. 
 
Figure 3.5 The 3xFLAG-tag does not affect HOXD13 function 
(A) chMM cultures infected with virus carrying no insert, 3xFLAG-tagged Hoxd13 or untagged Hoxd13. Inhibition of 
chondrogenic differentiation is indistinguishable between the two Hoxd13 constructs. (B) qRT-PCR analysis of three 
genes, which are specifically up-regulated by Hoxd13. The bars indicated the relative expression of BMP4, FRAS1 
and MSX2 in infected chMM cultures relative to expression in mock-infected cultures. Both Hoxd13 constructs 
increase the gene expression to the same degree. 
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Figure 3.6 RCASBP-mediated expression induces only moderate overexpression 
(A) Schematic overview of the approach to measure Hoxd13 expression levels. Using absolute quantification of 
transcripts, the number of all RCAS-transcripts, Hoxd13-coding transcripts and GAPDH transcripts is measured in 
chMM cultures. For comparison, HOXD13 and GAPDH transcript levels are measured in HH25 posterior chicken 
forelimb buds. Then, transcript levels are normalized to the number of GAPDH transcripts. (B) Schematic view of 
RCASBP viral RNA. Alternative splicing of the polycistronic RNA causes only a fraction of all viral RNA to code for 
the gene of interest. Position of the primer pairs that distinguish between gene of interest-specific and all viral RNA 
are indicated. (SD: splice donor site, SA: splice acceptor site, LTR: long terminal repeats) (C) Quantification of all 
viral RNA (black bar) and Hoxd13-coding RNA (gray bar) in chMM cultures. Only one in five viral transcripts codes 
for Hoxd13. Comparison to HH25 posterior forelimb buds shows that the RCASBP-induced overexpression 
accounts to approximately 3 to 5-fold overexpression. Error bars indicated the S.D. of three biological replicates (for 
chMM) and the S.D. of three technical replicates for HH25 forelimb buds.  
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 HOXD13-Binding in chMM 3.2.2
To study the genome-wide binding of HOXD13, chMM cultures infected with RCASBP(A) 
viruses expressing 3xFLAG-Hoxd13 were prepared in two independent replicates from which 
replicate ChIP-seq experiments were performed. Since the primary result of each ChIP-seq 
experiment are millions of short sequence reads, validation of reproducibility is no trivial task. 
To assess the reproducibility of ChIP-seq replicates, we6 used the IDR method developed within 
the ENCODE consortium (Li et al. 2011; Landt et al. 2012), which specifically addresses 
reproducibility of ChIP-seq experiments (for details, see Section 2.3.6 and Figure 2.1). The two 
biological replicates for HOXD13wt demonstrated good reproducibility in IDR-analysis, passing 
all criteria for consistent ChIP-seq experiments (Figure 3.7 and Section 5). In addition to 
evaluating the reproducibility of ChIP-seq experiments, the IDR method also suggests a 
threshold for the number of reproducibly detectable binding sites that can be identified from the 
given data. Using these criteria, 34,267 binding sites for HOXD13wt were identified in chMM 
(Figure 3.7B).  
To date, no ChIP-seq dataset for HOXD13 has been published. To validate the specificity of the 
identified binding sites, de novo motif analysis using sequences from the 1000 most significant 
peaks was performed with two different motif analysis tools (DREME and RSAT). 
Both tools identified similar primary motifs for HOXD13wt that contain a AT[A/T]AAA core 
sequence characteristic for HOX proteins, preceded 5’ by a somewhat more loosely defined 
[C/T][A/C] ( 
6  After several unsuccessful attempts to prove the reproducibility of our ChIP-seq experiments, Peter Hansen, in collaboration with 
whom much of the bioinformatic analyses were performed, suggested implementing the ENCODE data reproducibility criteria for 
our data. He was critical for progressing from successfully conducted wet-lab experiments to proper bioinformatic analysis of the 
ChIP-seq results. 
 
Figure 3.7 HOXD13wt ChIP-seq reproducibility by the irreproducible discovery rate (IDR) framework.  
(A) Scatterplots of signal scores for peaks that overlap in both replicates. Black circles represent peak pairs that 
pass an IDR threshold of 1%. Red circles represent peak pairs that do not pass the IDR threshold of 1%. (B) The 
estimated IDR as a function of different rank thresholds. The HOXD13wt replicates show high reproducibility with 
34,267 peaks passing an IDR threshold of 1%. See also Figure 2.1. 
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Figure 3.8). Moreover, the ChIP-seq identified motifs were highly similar to the in vitro 
detected HOXD13 motifs (Berger et al. 2008; Jolma et al. 2013) and appeared more frequently 
in the Top 1000 peaks than the published motifs (Figure 3.8). This confirmed that using the 
chMM-based ChIP-seq approach allows reproducible detection of HOXD13 binding sites 
reflecting the proteins DNA-binding specificity and that it thus can be adapted to identify 
differences between wildtype and mutant HOXD13 proteins.  
 
 
 
 
Figure 3.8 De novo motif analysis from ChIP-seq peaks identifies the canonical HOXD13 motif. 
De novo motif analysis using sequences for the 1000 most significant HOXD13wt peaks (summit +/- 75bp) as 
inferred by RSAT and DREME. Sig and e-values indicate the significance of the motif. The numbers refer to the 
number of motifs found in the Top 1000 peaks (FIMO p <0.0001). (FIMO p<0.0001). Comparison to motifs 
determined by Protein Binding Microarrays (PBM) (Berger et al. 2008) and high-throughput SELEX-seq (Jolma et al. 
2013). Motifs were drawn using the MEME suite (Bailey et al. 2009). 
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 Functional Characterization of the HOXD13Q317K and HOXD13Q317R 3.3
Mutations 
 Binding Specificity 3.3.1
Initial experiments showed that the HOXD13Q317K mutant localizes to the nucleus, but EMSA 
and reporter assays found the variant to act as a severe loss-of-function mutation. These results 
did not allow conclusions as to why the patient phenotype differs from other missense mutations 
in the homeodomain that also act as a loss-of-function in similar reporter assays.  
To gain insight into the molecular pathomechanism underlying the HOXD13Q317K mutation, the 
chMM-ChIP-seq approach was used to compare the binding properties of the HOXD13Q317K 
mutant to HOXD13wt, using the HOXD13Q317R mutant as a control to further distinguish 
between specific amino acid changes at the Q317 residue. 
Cross-linked chromatin from chMM cultures expressing tagged murine HOXD13wt, 
HOXD13Q317K, or HOXD13Q317R were used for ChIP-seq and, after quality control and 
reproducibility testing, 34,267 binding sites for HOXD13wt, 25,036 sites for HOXD13Q317K, and 
21,396 for HOXD13Q317R were identified (see Section 5). To initially explore differences in 
binding specificity, de novo motif analysis was performed. Strikingly, primary motifs for both 
mutants revealed a changed 5’ terminus of the motif (Figure 3.9). The primary motif for 
HOXD13Q317K inferred by RSAT begins with a [G/A]G dinucleotide at the 5’ end, followed by a 
variable base. The DREME motif is very similar but starts with single G a instead of a [G/A]G 
 
Figure 3.9 The HOXD13Q317 mutations alter the recognition site at the 5’ terminus 
De novo motif analysis using sequences for the 1000 most significant mutant HOXD13 peaks (summit +/- 75bp), as inferred by 
RSAT and DREME. The HOXD13Q317K mutation recognizes a GGN trinucleotide at the 5’ terminus.  Selected secondary motifs 
(RSAT) show variations of the primary motif. The HOXD13Q317R mutation recognizes a [G/A][C/G]TA at the 5’ terminus. 
Selected secondary motifs (RSAT) for HOXD13Q317R show a refined version of the primary motif or a CT[C/A]A 5’ end, which is 
included in a subset of HOXD13wt recognition sequences. Sig and e-values indicate the significance of the motif. Numbers are 
given for motifs found in the Top1000 peaks (FIMO p<0.0001). Motifs were drawn using the MEME suite (Bailey et al. 2009). 
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dinucleotide. The HOXD13Q317R motif (RSAT) also starts with a [G/A][C/G], but is then 
followed by a thymine residue (Figure 3.9B). As for HOXD13Q317K, the primary HOXD13Q317R 
motif from DREME is similar but shortened at the 5’ end, which starts with a single G followed 
by the thymidine residue.  
Analysis of the secondary motifs identified by RSAT and DREME revealed further differences 
between HOXD13Q317K and HOXD13Q317R. The HOXD13Q317K secondary motifs are comprised 
of a variety of motifs similar to the primary motif identified and strikingly feature a GG 
dinucleotide at the start. The HOXD13Q317R secondary motifs, on the other hand, also resemble 
the primary motif with the characteristic GT dinucleotide in the beginning. In addition, both 
motif tools identified a secondary motif that is similar to the HOXD13wt motif. This motif does 
not start with a GT dinucleotide but with a CT[C/A] followed by the AT[A/T]AAA core (Figure 
3.9). 
Taken together, primary and secondary motifs in both mutants clearly show an altered 5’ 
terminus, whereas the AT[A/T]AAA core remains largely unchanged. This observation strongly 
suggests that Q317 mutations alter only the 5’ terminus of the DNA recognition sequence of 
HOXD13 and do not affect the AT[A/T]AAA core of the recognition sequence. 
The characteristic change in sequence specificity confirmed the reported role of the mutated 
residue (position 50 of the homeodomain, Q50) in sequence recognition. In order to identify 
other TFs with related recognition sequences, the HOXD13 homeodomain sequence was 
compared to all other human homeodomains in the Uniprot database carrying an arginine (R) or 
a lysine (K) at position 50. Eight R50 and 20 K50 homeodomain proteins are annotated in the 
human genome. The eight R50 matches are unusual for homeodomain-proteins in general, and 
none of the eight R50 homeodomain proteins is a developmental TF. Five R50-proteins are 
ceramide synthases (CERS2-6); enzymes bound to the endoplasmatic reticulum membrane 
(Levy and Futerman 2010). Another, ARGFX is a very weakly expressed transcript, and likely a 
pseudogene (Li and Holland 2010) and the two remaining, ZFHX3 and ZFHX4, are tumor 
suppressor genes with multiple zinc-fingers and three full homeodomains, only one of harbors 
an R50 (Sun et al. 2005).  
In contrast, the 20 K50 homeodomain proteins belong to various TF-families involved in 
different developmental processes (Figure 3.10A) and sequence alignment between these 
homeodomains and the mutant HOXD13 homeodomain revealed the greatest similarity to the 
PITX-family (Figure 3.10A). Furthermore, PITX1 is the only homeodomain protein carrying a 
K or R at position 50 known to be involved in limb patterning. PITX1 is a TF that determines 
hindlimb identity (Logan and Tabin 1999; Szeto et al. 1999) and has been shown to specifically 
bind to GGATTA (Tremblay et al. 1998)(Berger et al. 2008).  
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Taken together, the altered binding specificity of the HOXD13Q317 mutants in combination with 
the importance of PITX1 in limb development raised the possibility, that the pathogenicity of 
the HOXD13Q317K mutation might at least partially be due to aberrant transactivation of genes 
that are regulated by PITX1.  
 
 
 In vitro Binding Specificities of HOXD13Q317-mutant Homeodomains 3.3.2
To regulate putative PITX1 target genes, HOXD13Q317K needs to be able to bind to the PITX1 
recognition sequence. Since de novo motif analysis revealed a very similar, but not identical 
motif to the known PITX1 recognition sequence, the binding activity of wildtype and Q317 
mutant homeodomains in respect to the PITX1 recognition sequence was tested.  
For this, EMSAs with oligonucleotides carrying PITX1 and HOXD13 binding sites were 
conducted. HOXD13wt specifically bound the oligo containing a HOXD13 binding site, but 
HOXD13Q317K did not show appreciable binding activity (Figure 3.3B and Figure 3.11A). In 
contrast, the HOXD13Q317R showed considerable residual binding to the wildtype HOXD13 site, 
reflective of the de novo motif analysis, where a HOXD13wt-like motif was detected as 
secondary motif for HOXD13Q317R but not for HOXD13Q317K.  
 
Figure 3.10 The Q317K mutation changes the HOXD13 homeodomain to a bicoid-type homeodomain. 
(A) Localization of the Q317K mutation in the HOXD13 protein. Alignment between the human HOXD13 homeodomain 
sequence and all bicoid-type homeodomains in mouse (Uniprot). All identical positions are highlighted in red. (B) 
Expression of Pitx1 transcript in E11.5 mouse embryos visualized by in situ hybridization (with kind permission from M. 
Spielmann and D. Lupiañez) (C) De novo motif analysis using sequences for the 1000 most significant PITX1 peaks 
(summit +/- 75bp) as inferred by RSAT. 
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When testing the PITX1 binding site, wildtype and Q317-mutant homeodomains showed a 
directly opposite effect. Only the Q317K mutant homeodomain was able to efficiently bind the 
oligo harboring a PITX1 binding site, whereas the wildtype and Q317R homeodomains were 
not (Figure 3.11B).  
 Comparison of In Vivo Binding to PITX1 3.3.3
Motif analyses and EMSAs for HOXD13Q317K and HOXD13Q317R raise the question to which 
extent the genomic binding of the HOXD13 mutants reflected the genomic binding of either 
HOXD13 or PITX1.  
To identify PITX1 binding sites in the chicken genome, ChIP-seq from chMM-cultures infected 
with PITX1-expressing RCASBP-virus was performed and identified 40,881 binding sites for 
PITX1. De novo motif analysis of ChIP-seq peaks readily identified the known PITX1 motif 
(Figure 3.11B), indicating functionality of the protein. Next, with the genomic data generated 
for HOXD13wt, HOXD13Q317R, HOXD13Q317K, and PITX1 at hand, the genome-wide binding of 
the four factors was compared using three separate methods. 
 
I. Principle Component Analysis (PCA) 
ChIP-seq experiments produced genome-wide coverage profiles that were characteristic and 
reproducible for each factor. To compare the genome-wide binding in an as unbiased way as 
possible, Principle Component Analysis (PCA) was selected to assess the similarity of the 
coverage profiles.  The read count distribution across the genome in 500bp windows for the 
 
Figure 3.11 HOXD13Q317K , but not HOXD13Q317R binds the PITX1 bindng site in vitro 
In vitro binding of wildtype and mutant HOXD13 homeodomains to HOXD13 and PITX1 binding sites, respectively. 
EMSAs were performed as in Figure 3.3 using oligonucleotides containing a HOXD13 (CCAATAAAA) or PITX1 
recognition sequences (GGATTA). (A) HOXD13wt and HOXD13Q317R recognize the HOXD13 binding site, whereas 
HOXD13Q317K does not. (B) Conversely, only the HOXD13Q317K homeodomain binds to the PITX1 binding site, 
whereas it is not bound by HOXD13wt or HOXD13Q317R homeodomains.  
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eight datasets, representing the replicates for HOXD13wt, HOXD13Q317K, HOXD13Q317R and 
PITX1, were used as input. The PCA result, when presented in a biplot as shown in Figure 
3.12A, clusters data points the closer together the more similar the datasets are. As expected, the 
biological replicates for each condition clustered closely together. The data points for 
HOXD13Q317K were located at an intermediate position between those of HOXD13wt and PITX1 
(Figure 3.12A), indicating a shift in the genomic binding of HOXD13Q317K towards that of 
PITX1. In contrast, the data points for HOXD13Q317R remained closer to those of HOXD13wt. 
 
II. Peak Overlap 
As mentioned above, HOXD13wt bound 34,267 sites, HOXD13Q317K 25,036, HOXD13Q317R 
21,396, and PITX1 40,881. Based on a restrictive definition of shared binding events (the 
summits of overlapping peaks must be within 100bp of on another), most peaks were found to 
be TF specific and only 45 sites were bound by all four factors. However, HOXD13Q317K and 
HOXD13Q317R showed striking differences when comparing the overlap with HOXD13wt or 
PITX1 peaks. HOXD13Q317R shared 27.5% (5887) of its binding sites with HOXD13wt, whereas 
HOXD13Q317K shared only 6.0% (1492) (Figure 3.12B). In contrast, HOXD13Q317R shared just 
2.9% (633) of its binding sites with PITX1 but HOXD13Q317K 6.6% (1671). The wildtype 
HOXD13 also shared only 1.1% (383) of its binding sites with PITX1 (Figure 3.12B). 
Additionally, HOXD13Q317K and HOXD13Q317R shared a large set of target sites (3094) that were 
bound by neither HOXD13wt nor PITX1. 
 
III. Read Count Distribution 
Weak binding events are signified by weak read enrichments and are not always detected as 
peaks. In turn, this might lead to an underrepresentation of shared binding events based on the 
sole observation of overlapping peaks. To take this into account, the mean read density from 
HOXD13wt, HOXD13Q317K, HOXD13Q317R, and PITX1 ChIP-seq experiments surrounding the 
identified binding sites for each factor was determined using seqMINER (Figure 3.12C). As 
expected, a strong read enrichment for each factor was detected surrounding its peaks. There 
was no read enrichment in HOXD13wt or HOXD13Q317R ChIP-seq experiments at the position of 
PITX1 peaks. In contrast to HOXD13wt and HOXD13Q317R, there was a moderate read 
enrichment at the PITX1 peaks in the HOXD13Q317K ChIP-seq, indicating HOXD13Q317K binding 
at PITX1 peaks. HOXD13Q317K reads also displayed a moderate enrichment at HOXD13wt peaks 
and somewhat stronger around HOXD13Q317R peaks. Conversely, read enrichment in the PITX1 
ChIP-seq was observed at HOXD13Q317K peaks, but not at HOXD13wt or HOXD13Q317R peaks. 
Again, the genomic binding of the HOXD13Q317K mutant specifically shifted towards PITX1 
sites to an extent that was not observed for HOXD13Q317R or HOXD13wt. 
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Taken together, all three analyses identified an altered genomic binding of the HOXD13Q317K 
mutant that shifts to adopt a more PITX1-like binding profile, which is not observed for the 
HOXD13Q317R mutant. 
 
 
 
 
Figure 3.12 The genomic binding of HOXD13Q317K shifts towards PITX1 
(A) Principle component analysis for the coverage profiles of the uniquely mapped reads for all eight datasets (two 
biological replicates each for HOXD13wt, HOXD13Q317K, HOXD13Q317R, and PITX1. (B) Peak overlap with respect to 
HOXD13wt and PITX1 peaks. (left) PITX1 shares 1.0% (383/40,881) of its peaks with HOXD13wt, HOXD13Q317R 27.5% 
(5,887/21,396) and HOXD13Q317K 6.0% (1,492/25,036). (right) HOXD13wt shares 1.1% (383/24,267) of its binding sites 
with PITX1, HOXD13Q317R 3.0% (633/21,296) and HOXD13Q317K 6.7% (1,671/25,036). (C) HOXD13Q317K shares binding 
properties with both HOXD13wt and PITX1. Mean read densities centred (+/- 3kb) around the peak summits for 
HOXD13wt, HOXD13Q317R, HOXD13Q317K, and PITX1 (left to right). HOXD13wt (164.1 tags/50bp; 93.5 tags/50bp; 43.2 
tags/50bp; 23.6 tags/50bp), HOXD13Q317R (49.7 tags/50bp; 101.2 tags/50bp; 49.8 tags/50bp; 19.5 tags/50bp), 
HOXD13Q317K (24.9 tags/50bp; 51.9 tags/50bp; 109.1 tags/50bp; 25.6 tags/50bp) and PITX1 (15.1 tags/50bp; 24.2 
tags/50bp; 38.9 tags/50bp; 191.2 tags/50bp). 
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 Gene Regulation: HOXD13Q317K and PITX1 Induce Similar Gene 3.3.4
Expression  
To analyze whether the shift in genomic binding profiles was also reflected in gene regulation, 
RNA-seq expression analysis for chMM cultures infected with Hoxd13wt, Hoxd13Q317K, 
Hoxd13Q317R, or PITX1 was performed. First, differentially expressed genes were identified by 
filtering expression levels according to a minimal expression of 2 RPKM in at least one 
experiment and an at least two-fold differential expression in any of the cultures as compared to 
mock infected cultures. This resulted in 3118 transcripts belonging to 2506 genes that were 
differentially expressed in at least one of the chMM cultures. Next, to assess general similarities 
and differences in the induced expression changes, PCA analysis and hierarchical clustering of 
the expression values for all differentially expressed transcripts were conducted. For the PCA, 
the resulting biplot demonstrated a similar distribution as seen for ChIP-seq with the 
HOXD13Q317K data point being close to PITX1 and HOXD13Q317R close to HOXD13wt (Figure 
3.13A). Similarly, hierarchical clustering of transcript levels clustered HOXD13Q317K with 
PITX1 infected cultures, and HOXD13Q317R with HOXD13wt (Figure 3.13B), indicating that the 
gene expression changes induced by HOXD13Q317K were more similar to those induced by 
 
Figure 3.13 Regulation by HOXD13Q317K is more similar to PITX1 than to HOXD13wt or HOXD13Q317R.  
Global expression analysis of genes regulated by HOXD13wt, HOXD13Q317R, HOXD13Q317K, or PITX1 in chMM 
cultures. RNA-seq expression analysis found 3118 transcripts (2506 genes) to be at least two-fold differentially 
regulated in Hoxd13wt, Hoxd13Q317R, Hoxd13Q317K or PITX1 chMM compared to mock infected cultures (RPKM cut-off 
2). (A) Principle component analysis (PCA) of the expression values (normalized to expression values in mock 
infected cultures) of these genes shows a similar clustering as seen in the ChIP-seq PCA. (B) Hierarchical 
Clustering of the expression values (RPKM) clusters Hoxd13Q317K with PITX1 and Hoxd13Q317R with Hoxd13wt. Red 
colors indicate up-regulation, green colors down-regulation as compared to mock-infected cultures. 
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PITX1 than to HOXD13wt or HOXD13Q317R. 
For each factor, a comparable number of genes were differentially expressed (HOXD13wt 1006 
genes, HOXD13Q317R 845, HOXD13Q317K 1102, PITX1 1014). Interestingly, when comparing 
the genes regulated by mutant or wildtype HOXD13 with PITX1 regulated genes, 436 genes 
were co-regulated by HOXD13Q317K and PITX1, whereas only 262 genes were co-regulated by 
HOXD13wt and PITX1 and 237 genes by HOXD13Q317R and PITX1 (Figure 3.14A).  
 
Figure 3.14 HOXD13Q317K and PITX1 activate genes involved in muscle and vasculature development 
(A) HOXD13Q317K co-regulates nearly twice as many genes with PITX1 than HOXD13wt or HOXD13Q317R. The number 
of genes co-up-regulated (left) or co-down-regulated (right) with PITX1 for HOXD13 wildtype and mutants. (B-D) GO 
analysis of genes differentially regulated by the four factors individually and genes co-regulated by HOXD13Q317K and 
PITX1. For each factor, a list of differentially regulated genes, compared to mock-infected cultures was generated and 
used for GO-analysis with DAVID . The bars represent the negative log10 of the p-values of the selected GO terms. 
(B) Genes associated with limb morphogenesis, cartilage development, and cartilage condensation, were enriched in 
the set of genes down-regulated by HOXD13Q317K and PITX1 (top). Genes associated with GO terms related to muscle 
development and vasculature development, were enriched in the set of genes up-regulated by HOXD13Q317K and 
PITX1 (bottom). (C) Genes associated with GO terms limb morphogenesis, bone development and cartilage 
development were enriched in the set of down-regulated genes for all four factors (except chondrocyte differentiation 
for HOXD13Q317R). The colored bars represent the negative log10 of the p-value found for selected GO terms found in 
each of the sets of down-regulated genes (D) In the set of up-regulated genes, genes associated with GO terms 
related to muscle differentiation and vasculature development were strongly enriched among the up-regulated genes 
in HOXD13Q317K and PITX1 chMM cultures, but not for HOXD13wt and HOXD13Q317R. The colored bars represent the 
negative log10 of the p-value for selected GO terms found in each of the sets of up-regulated genes. 
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Next, to identify those among the 436 HOXD13Q317K/PITX1 co-regulated genes that might 
contribute to the similarity found in PCA and hierarchical clustering analysis, a Gene Ontology 
(GO) analysis on the 305 co-down-regulated and 131 co-up-regulated genes was performed. GO 
terms related to cartilage differentiation and limb development were overrepresented in the set 
of co-down-regulated genes, which were also found to be overrepresented in the sets of down-
regulated genes for each individual factor (Figure 3.14B,C). In contrast, genes annotated to 
several GO categories related to muscle development as well as blood vessel development were 
overrepresented among the HOXD13Q317K/PITX1 co-up-regulated genes and, intriguingly, these 
and related GO terms were also enriched among HOXD13Q317K and PITX1 up-regulated genes 
and were not similarly enriched in the HOXD13wt or HOXD13Q317R up- or down-regulated 
genes (Figure 3.14).  
 
 
 Differential Binding in the Vicinity of Co-Regulated Genes 3.3.5
Genome-wide comparison of TF-binding demonstrated that HOXD13Q317K specifically binds to 
many PITX1 binding sites and that a group of target genes is co-regulated by only 
HOXD13Q317K and PITX1 as compared to HOXD13wt and HOXD13Q317R. The next analysis 
attempted to identify whether co-regulation and cobinding are associated. 
An intriguing example for this hypothesis is depicted in Figure 3.15A, which shows the binding 
profiles of the four TFs at the genomic region surrounding the Matrix-Gla protein (MGP) gene. 
MGP encodes the Matrix-Gla protein, which inhibits calcification in proliferating chondrocytes 
 
Figure 3.15 Binding profiles at the gene locus of the differentially regulated MGP gene 
(A) Coverage profiles for HOXD13wt, HOXD13Q317R, HOXD13Q317K and PITX1 in a 20 kb region covering the MGP gene 
show the similarity in binding between HOXD13Q317K and PITX1. (B) MGP is 3-fold up-regulated in PITX1 and 
Hoxd13Q317K infected chMM cultures and 3-f^^old down-regulated by Hoxd13wt cultures (Log2 fold changes compared 
to mock-infected cultures). 
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and blood vessels (Luo et al. 1997; Yao et al. 2011). HOXD13wt, HOXD13Q317K and PITX1 bind 
to different sites in the upstream region of MGP, whereas HOXD13Q317R shows only weak 
binding in this region. HOXD13wt binds a unique site, while HOXD13Q317K and PITX1 share 
three binding sites with additional unique binding sites for HOXD13Q317K and PITX1 each. The 
MGP gene is also among the set of co-regulated genes, as it is 3-fold up-regulated in 
Hoxd13Q317K and PITX1 infected cultures, but 3-fold down-regulated in Hoxd13wt infected 
cultures and not regulated in Hoxd13Q317R cultures (Figure 3.15B). 
In order to systematically test whether HOXD13Q317K/PITX1 co-regulated genes are also 
cobound by the factors, the genes had to be identified as cobound or not cobound. For this, all 
genes were classified as cobound when a HOXD13Q317K/PITX1 shared peak was found in the 
gene body or within 25kb up- or downstream of the gene. Using this classification, 13.1% (57) 
of the 436 co-regulated genes were also cobound by HOXD13Q317K/PITX1, significantly more 
than expected by chance (Fisher's exact p=1.295x10-3) (Figure 3.16). As a control, an equivalent 
analysis performed for the HOXD13Q317R mutant and PITX1 and found a non-significant 5.06% 
(12 out of 237) of co-regulated genes cobound (p=0.1335) (Figure 3.16).  
 
 
 
 Hoxd13Q317K and PITX1 Induce Similar Phenotypic Effects  3.3.6
Chicken micromass cultures are derived from limb bud mesenchymal cells. Cultured at high 
density, they spontaneously differentiate into various cell lineages including chondrocytes 
which form cartilage nodules that undergo differentiation, mineralization and finally bone 
 
Figure 3.16 HOXD13Q317K and PITX1 share binding sites in the vicinity of co-regulated genes 
More HOXD13Q317K/PITX1 co-regulated genes were significantly more co-bound (13.1% (57 of 436); red line) than 
expected by chance  (Fishers exact p=1.295x10-3). The histogram shows the distribution of co-bound genes when 
randomly selecting 346 genes (100,000 iterations). 5.1% (12 of 237) of HOXD13Q317R/PITX1 co-regulated genes 
were also co-bound (red line), not significant (Fishers exact p=0.1335). The histogram shows the distribution of co-
bound gene numbers when randomly selecting 237 genes (100,000 iterations). 
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formation (Ahrens et al. 1979). Viral expression of wildtype Hoxd13 strongly inhibits 
chondrogenic differentiation. Instead, cells in every part of the culture except the very center do 
not assemble into organized structures (Figure 3.17). In contrast, chMM cultures overexpressing 
Hoxd13Q317R, although a little smaller in size, appear to undergo the same chondrogenic 
differentiation process as mock infected chMM (Figure 3.17). ChMM infection with 
Hoxd13Q317K resulted in a completely different phenotype. The inhibition of chondrogenic 
differentiation was even stronger, but in contrast to Hoxd13wt, the cells formed a multi-layered 
fibrotic tissue, radially extending from the center of the culture (Figure 3.17). This very 
characteristic growth of the culture was also observed in PITX1-expressing chMM cultures.  
So far, the experiments demonstrated that binding specificity, gene expression and morphology 
of Hoxd13Q317K infected chMM cultures shift from Hoxd13 to PITX1 characteristics. To test 
whether this shift in specificity can also be observed in vivo, Hoxd13wt, Hoxd13Q317R, 
Hoxd13Q317K, and PITX1 were expressed in chicken limb buds using the same 3xFLAG-tagged 
constructs as used for ChIP-seq experiments. The effects of Hoxd13wt and PITX1 in this 
experiment have been described and are clearly distinguishable. On the one hand, expression of 
PITX1 in the developing chick wing bud led to a partial fore-to-hindlimb transformation of the 
infected wing (Logan and Tabin 1999; Szeto et al. 1999). The infected wings showed an 
absence of the patagium (the skin that will form the surface of the wing), demonstrated 
straightening of the posterior wrist flexure, and developed an additional digit (Figure 3.17). On 
the other hand, ectopic expression of Hoxd13wt led to an overall reduction in wing size but had 
no effect on limb patterning (Figure 3.17) (Goff and Tabin 1997).  
Like Hoxd13wt, viral infection of wing buds with Hoxd13Q317R mainly led to an overall reduction 
of the limb structures (Figure 3.17). In a minority of cases, however, reduced interdigital cell 
death at the first and between the first and second digit, as well as mispositioning of the wrist 
could be observed.  
 
Figure 3.17 Some effects on cell differentiation and development are shared between Hoxd13Q317K and PITX1. 
(Upper row) Eosin-stained chMM cultures for Hoxd13wt, Hoxd13Q317R, Hoxd13Q317K, and PITX1. Both Hoxd13Q317K and 
PITX1 induced differentiation into thick, fibrotic tissue (day 9). (Lower row) Viral overexpression of Hoxd13wt, 
Hoxd13Q317R, Hoxd13Q317K and PITX1 in chicken wing buds (HH36). Hoxd13wt and Hoxd13Q317R overexpression leads 
to an overall shortening of skeletal elements. Hoxd13Q317K infected wing buds lack or have a reduced forelimb-specific 
patagium, have a straightened wrist and develop a fourth digit (arrowheads). PITX1 overexpression leads to a partial 
hind- to forelimb transformation. 
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In strong contrast, Hoxd13Q317K infected wing buds repeatedly lacked or had a reduced patagium, 
and exhibited a straightening of the posterior flexure of the wrist. Moreover, a fourth digit 
developed; however, the position of this digit was different from that observed in PITX1 
infected wings. This additional digit extended from the first phalanx of digit 1, whereas with 
PITX1 overexpression, the additional digit was located completely apart from digit 1 (Figure 
3.17 (arrowheads)).  
Collectively, the analyses of Hoxd13Q317K expression in chMM cultures as well as the effects 
induced in limb bud injections clearly demonstrate that HOXD13Q317K causes distinct effects 
from those induced by HOXD13wt or HOXD13Q317R and displays a partial overlap with the 
effects of wildtype PITX1.  
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 Functional Characterization of the HOXD13R298Q Mutation 3.4
 
Standard biochemical approaches (see Section 3.2) demonstrated a moderate loss-of-function 
effect for the HOXD13R298Q mutation. The mutant protein was still able to bind the HOXD13 
recognition sequence in vitro and had a 20% reduced activation capacity in reporter assay 
(Figure 3.3). In contrast, the mutation causes a fully penetrant SPD phenotype and a not fully 
penetrant BDA2 phenotype in patients, whereas HOXD13 haploinsufficiency only leads to SPD 
with low penetrance (Goodman et al. 1998; Goodman and Scambler 2001).  
Therefore, the chMM-ChIP-seq system was applied to further elucidate the binding behavior of 
HOXD13R298Q. First, the chondrogenic differentiation of 3xFLAGHoxd13R298Q and 
3xFLAGHoxd13R298W infected chMM cultures was compared to 3xFLAG-Hoxd13wt and to mock 
infected chMM cultures. As expected, Hoxd13wt strongly inhibited chondrogenic differentiation. 
Alcian Blue staining of the Hoxd13R298Q infected cultures, however, showed a reduced inhibition 
of chondrogenic differentiation, whereas the Hoxd13R298Q infected cultures showed no effect on 
differentiation at all (Figure 3.18). 
 
 
 
 
 
 
 
 
 
 
 Binding Specificity 3.4.1
Next, chromatin from Hoxd13R298Q-infected chMM cultures was used for ChIP-seq. Two 
biological replicate experiments were subjected to quality control, tested for reproducibility 
(IDR), and 21,347 reproducible HOXD13R298Q binding sites were identified (for details, see 
Section 5).  
Analogous to the initial analysis of Q317 mutants, the 1000 most significant binding sites were 
used for de novo motif analysis using DREME and RSAT. The primary HOXD13R298Q motif 
closely resembled the HOXD13wt motif (Figure 3.19), however, a small difference, an A-to-G 
substitution at position 5 that is not present in the wildtype (asterisk in Figure 3.19), was 
observed. Notably, both motif-analysis tools identified a composition of secondary motifs that 
was unlike HOXD13wt, HOXD13Q317K, or HOXD13Q317R, where the majority of secondary 
motifs resembled the primary motif.  
 
Figure 3.18 HOXD13R298Q inhibits the chondrogenesis less than HOXD13wt 
Alcian Blue stained chMM cultures (day 9) infected with the same amount empty, 3xFLAG-
Hoxd13wt, 3xFLAG-Hoxd13R298Q, and 3xFLAG-Hoxd13R298W expressing RCASBP(A) virus.  
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RSAT detected the non-HOX motif (TGA[G/C]TCA) (Figure 3.19B) among the secondary 
motifs and DREME found the unrelated GGAAA and [A/T/C][A/G]TAAA at 2nd and 3rd 
position, respectively. However, to a lower extent secondary motifs resembling the primary 
were also detected for HOXD13R298Q, as can be seen for the refined primary motif at 2nd position 
(RSAT, Figure 3.19B). Intriguingly, although motif analyses for all factors were performed on 
the 1000 most significant peaks for each factor, the significance for the primary motif for 
HOXD13R298Q was the lowest of all HOXD13 variants (compare e-values and sig-values of 
Figure 3.19 to Figure 3.8 and Figure 3.9). In line with this observation, when using FIMO to 
identify individual motif occurrences, HOXD13R298Q also was the HOXD13 variant with the 
least primary motifs in its Top 1000 peaks (DREME: 206/RSAT: 240).  
Taken together, initial analysis of the HOXD13R298Q ChIP-seq data demonstrates that the mutant 
locates to the nucleus and binds DNA-sequences that are highly similar to the wildtype 
recognition sequences, although they are present in fewer HOXD13R298Q binding sites. 
Furthermore, the data also indicate that the composition of binding sites seems to be more 
diverse than for HOXD13wt or the HOXD13Q317 mutants 
 
 Binding Intensity 3.4.2
The results of the initial motif analysis indicated that the molecular effect of the R298Q 
substitution might be more subtle than the switch in sequence specificity seen for the Q317 
mutations. Moreover, there are several pathogenic mutations in homeodomain proteins that alter 
the arginine affected by the R298Q mutation (R31, within the homeodomain), most importantly 
a HOXD13R298W mutation associated with a mild form of SPD (Debeer et al. 2002). In that case, 
the authors proposed loss of DNA-binding as underlying pathomechanism, because a R31H 
 
Figure 3.19 HOXD13R298Q binds a site similar to HOXD13wt  
De novo motif analysis using sequences for the 1000 most significant HOXD13R298Q peaks (summit +/- 75bp) as 
inferred by RSAT and DREME. (A) The HOXD13R298Q mutation (top) recognizes motif similar to HOXD13wt (Figure 
3.8). The major difference is at position 5, where HOXD13R298Q prefers a G (DREME) or an A or a G (RSAT). Sig 
and e-values indicate the significance of the motif. The numbers refer to the number of motifs found in the Top1000 
peaks (FIMO p <0.0001). (B) Selected secondary motifs from RSAT (left) show (top) a refined version of the 
primary motif that shows an unusual G at position 1 and (bottom) a HOX-unrelated motif. Secondary motifs found 
with DREME (right) for HOXD13R298Q show a HOX-unrelated GGAAA and the an [A/G]TAAA motif that resembles 
the HOX9-13 core motif. Motifs were drawn using the MEME suite (Bailey et al. 2009). 
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substitution in MSX2 (MSX2R31H) did not change the sequence specificity, but rather reduced 
the binding affinity of a mutant MSX2 homeodomain (Wilkie et al. 2000). 
Therefore, to assess the DNA-binding affinity of wildtype and R298-mutant homeodomains, 
quantitative EMSAs were performed. Different concentrations (5, 10, 15, and 20ng) of purified 
HOXD13wt, HOXD13R298Q, and HOXD13R298W homeodomains were mixed with labeled 
oligonucleotides harboring the HOXD13 recognition sequence. At comparable protein 
concentrations, DNA-binding by HOXD13wt homeodomains was strongest, that of 
HOXD13R298Q homeodomains clearly weaker and that of HOXD13R298W mutant homeodomain 
was very strongly reduced (Figure 3.20). 
  
 
 
 
 
Figure 3.20 DNA-binding affinity in HOXD13R298 mutants is reduced 
In vitro binding affinity of wildtype and R298-mutant HOXD13 homeodomains were measured in gel-shift assays 
(EMSA). Fluorescent dye labeled double-stranded oligonucleotides containing a binding site (CCAATAAAA) for 
HOXD13 were incubated with different concentrations (5, 10, 15, and 20ng) of purified wildtype and mutant 
homeodomains. The wildtype HOXD13 displayed stronger retention of oligonucleotides at lower concentrations 
indicating higher binding affinity. HOXD13R298Q bound slightly lower, HOXD13R298W with weak affinity. 
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 Differential Motif Analysis 3.4.3
Motif analysis and gel shift assays found only minor differences between HOXD13wt and 
HOXD13R298Q. Therefore, the ChIP-seq data was then analyzed to see whether the genomic 
binding of HOXD13R298Q is similar or distinct from HOXD13w 
First, the overlap between the binding sites was calculated. Strikingly, despite similar sequence 
specificity of HOXD13wt and HOXD13R298Q, only 5488 peaks (25.7% of all HOXD13R298Q 
peaks) were bound by both factors. Consequently, this leaves 28,779 HOXD13wt-unique and 
15,949 HOXD13R298Q-unique peaks (Figure 3.21).  
To further profile the genomic binding surrounding the HOXD13wt-unique, shared, and 
HOXD13R298Q-unique peaks, seqMINER was used to display the read distribution both ChIP-
seq experiments. As expected, the mean read density (enrichment) surrounding the HOXD13wt-
unique peaks was higher for HOXD13wt than for HOXD13R298Q and the same was true vice 
versa. Also, reads were strongly enriched at the shared peaks in both datasets (Figure 3.21B).  
However, there was a notable difference in enrichment at the HOXD13wt and HOXD13R298Q-
unique peaks. At the HOXD13wt-unique peaks, the mean enrichment by HOXD13wt was 3.5-
 
Figure 3.21 HOXD13wt and HOXD13R298Q weakly bind each others unique peaks 
(A) Overlap of HOXD13wt and HOXD13R298Q binding sites found in ChIP-seq. Calculation of the overlapping 
peaks is described in Materials and Methods. (B) Mean read enrichment in HOXD13wt and HOXD13R298Q ChIP-
seq surrounding (+/-2500bp) the HOXD13wt-unique, shared and HOXD13R298Q-unique peaks. Residual 
enrichment of HOXD13R298Q at HOXD13wt-unique peaks is weaker than HOXD13wt enrichment at 
HOXD13R298Q-unique peaks. 
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fold stronger than the HOXD13R298Q-enrichment. On the other hand, at the HOXD13R298Q-
unique peaks, the mean enrichment of the mutant was only 2-fold stronger than HOXD13wt-
enrichment (Figure 3.21).  
 
In addition to displaying the mean read density surrounding provided peak lists, the seqMINER 
program also groups the peaksets into subclusters of peaks that are bound in a similar manner or 
intensity. The program clustered HOXD13wt-unique, shared, and HOXD13R298Q-unique peaks 
into ten subclusters with similar binding modes. Then, the ten subclusters were grouped by hand 
into three clusters with similar binding intensities (Figure 3.22). Strikingly, this clustering 
revealed that the read enrichment at subclusters is more variable than suggested by the mean 
read density presented in Figure 3.21 (compare to Figure 3.22A).  
For example, one subcluster of HOXD13wt-unique peaks (HOXD13wt very strong) was very 
strongly enriched in the HOXD13wt-ChIP-seq but only very weakly in the HOXD13R298Q-ChIP-
seq (4- to 5-fold difference) (Figure 3.22A, top). Another group of HOXD13wt -unique peaks 
(HOXD13wt-moderate) was moderately enriched by HOXD13wt and weakly by HOXD13R298Q 
(3.3-fold difference). Conversely, the HOXD13R298Q-unique peaks did also form a number of 
subclusters. However, these HOXD13R298Q-unique subclusters all showed stronger 
HOXD13R298Q enrichment by but did not differ as starkly in residual HOXD13wt enrichment 
(Figure 3.22A, bottom). The ratio between HOXD13wt-enrichment and HOXD13R298Q-
enrichment was similar (2.1- to 2.4-fold difference) between all groups, indicating uniformly 
stronger HOXD13R298Q binding. Again, the residual HOXD13wt enrichment at each group of 
HOXD13R298Q-unique peaks was higher than it was for HOXD13R298Q at HOXD13wt-unique 
peaks7. 
The most dramatic differences between subclusters were observed for the 
HOXD13wt/HOXD13R298Q shared peaks (Figure 3.22A, middle). The shared peaks –
independently detected as bound in both ChIP-seq experiments – consist of three different 
subclusters; HOXD13wt-stronger (505), equally bound (4027) and HOXD13R298Q stronger (956) 
peaks.  
 
Next, to identify differences between the various subclusters, sequences from each set were 
subjected to de novo motif analysis using RSAT. The primary and two secondary motifs 
detected for each peakset of Figure 3.22A are depicted in Figure 3.22B. Intriguingly, a 
systematic difference in sequence composition between predominantly HOXD13wt-bound and 
predominantly HOXD13R298Q-bound peaks was revealed when investigating the peak 
subclusters independently (Figure 3.22B).  
7  There was one subcluster of HOXD13R298Q-unique peaks that showed an equally strong enrichment in HOXD13wt and 
HOXD13R298Q ChIP-seq experiments .This is possibly due to HOXD13R298Q peaks that were not detected by peak calling or were 
filtered out in the overlap-process. 
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On the one hand, a bona fide HOXD13 motif was identified in all subclusters that showed 
stronger read enrichment by HOXD13wt. On the other hand, the motifs identified for 
predominantly HOXD13R298Q-bound peaks revealed two striking changes. First, similar to the 
HOXD13R298Q primary motif, the HOXD13-like motif was changed at the 1st and 6th position 
(Figure 3.22B, asterisks). Second, two HOX-unrelated motifs were identified as overrepresented 
 
Figure 3.22 Differential motif analysis of HOXD13wt-unique, HOXD13R298Q-unique and shared peaks  
(A) Read count distribution (+/- 2500bp) surrounding the peak sets. (left) heatmap demonstrating the different 
clustered as detected by seqMINER. (right) mean read distribution of the indicated subclusters of peaks. (B) De novo 
motif analysis (RSAT) using the sequences of indicated subclusters as input. Asterisks indicate changes to the 
HOXD13wt motif, red boxes motifs unique to predominantly HOXD13R298Q bound sites, blue boxes indicate de novo 
detection of HOXA13-like motifs. 
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in several subclusters (Figure 3.22B, red boxes). Further, among the motifs identified for the 
two subclusters of the shared peaks was another HOX-like motif (Figure 3.22, blue boxes). 
Comparison of these three motifs to the JASPAR database showed their similarity to known 
motifs. The sTGAsTCAs detected in predominantly HOXD13R298Q-bound peaks is a bona fide 
motif of AP1-transcription factors (Figure 3.23). The other motif detected as secondary motif 
only in HOXD13R298Q-unique peaks and not in HOXD13wt-unique or shared peaks was 
GGAAAA that closely resembles the motif of the NFATc2 TF (Figure 3.23). Finally, the HOX-
like motif overrepresented in the shared peaks is highly similar to the known HOXA13-motif 
(Figure 3.23). 
 
The differential motif analysis of HOXD13wt and HOXD13R298Q peaks subclusters highlighted 
three differences between wildtype and mutant. First, predominantly HOXD13R298Q-bound 
motifs differ slightly but reproducibly from the HOXD13wt-motif. Second, two HOX-unrelated 
motifs of potential co-factors are enriched in the predominantly HOXD13R298Q-bound peaks. 
Finally, the HOXA13 motif appears among the shared peaks that are predominantly bound by 
HOXD13wt 
 
  
 
Figure 3.23 Motifs discoverd in differential motif analysis resemble motifs described for other TFs 
Motifs found in ChIP-seq (left) compared to highly similar published (JASPAR) motifs (right). Motifs were drawn using 
the MEME suite (Bailey et al. 2009). 
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 The Distribution of AP1-Motifs in HOXD13wt and HOXD13R298Q Peaks  3.4.4
The de novo motif analyses for the HOXD13R298Q peaks found an enrichment of AP1 
recognition sites, which suggested that HOXD13R298Q might directly or indirectly interact with 
AP1 TFs. 
Therefore, AP1 binding site containing peaks were identified using FIMO; 5% (1500) and 
13.7% (3111) of HOXD13wt and HOXD13R298Q peaks, respectively, harbored an AP1 binding 
site (Figure 3.24A). Next, Centrimo analysis was used to profile the distribution of AP1 sites in 
AP1-containing peaks (Figure 3.24B). There was no central enrichment of AP1-sites in 
HOXD13wt peaks, but a slight central enrichment of AP1-sites in HOXD13R298Q peaks (Figure 
3.24B). 
To further profile the distribution of AP1-sites, the peaks were divided into peaks where FIMO 
identified both HOXD13 and AP1 binding sites (HOXD13/AP1-both) and into peaks that only 
had an AP1 binding site (AP1-only). For the 1500 AP1-containing HOXD13wt peaks, half were 
HOXD13/AP1-both and half were AP1-only peaks. Of the 3111 HOXD13R298Q peaks, only 20% 
were HOXD13/AP1-both, whereas 80% were AP1-only peaks (Figure 3.24A).  
The 80% HOXD13/AP1-both peaks for HOXD13R298Q indicated that the mutant might 
recognize these peaks via tethered binding to an AP1 TF. If this were the case, the AP1 binding 
sites in those peaks should be enriched centrally, surrounding the summit of the peaks. 
Therefore, Centrimo was used to determine the distribution of AP1 motifs in the 
HOXD13/AP1-both and in the AP1-only peaks (Figure 3.24C). For HOXD13wt, neither the 
HOXD13/AP1-both nor the AP1-only peaks showed central enrichment of the AP1 motif. In 
contrast, the HOXD13wt motif was centrally enriched in both peaksets (Figure 3.24C, left). For 
HOXD13R298Q, both motifs, AP1 and HOXD13, were not centrally enriched in HOXD13/AP1-
both peaks (Figure 3.24C, top right). In the AP1-only peaks, the graph describes a curve that 
might be interpreted as weak enrichment of AP1-like sites (Figure 3.24C, bottom right). 
Taken together, FIMO and Centrimo analysis did not reveal discernible central AP1 binding site 
enrichment in AP1-containing HOXD13R298Q peaks. 
 
Figure 3.24 (next page) Analysis of AP1 binding sites in HOXD13wt and HOXD13R298Q peaks. 
(A) Percentage of peaks containing an AP1 binding site (lighter shade are AP1-only, darker shaed HOXD13/AP1-
both peaks) as determined by FIMO (p<0.0001). (B, C) Centrimo analysis of the best sequence match to the AP1 
or HOXD13 motif of all HOXD13wt or HOXD13R298Q peaks (B), or of HOXD13/AP1-both or AP1-only peaksets (C). 
HOXD13wt peaksets show the best sequence match to a HOXD13 motif centrally, near the peak summit, whereas 
no positional enrichment of AP1 binding sites is detected. In HOXD13R298Q peaks sets, a minor central HOXD13 
site enrichment can be seen in the AP1-only peaks. However, there is just a minor central enrichment for AP1 
sites in AP1-only HOXD13R298Q peaks. 
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 The Distribution of NFATc2-Motifs in HOXD13wt and HOXD13R298Q 3.4.5
Peaks 
The second motif identified in predominantly HOXD13R298Q bound peaks was a GGAAAA that 
has been described as recognition sequence for the Nuclear Factor of Activated T-Cells 2 
(NFATc2) transcription factor, which is important in T-Cell development, but also expressed in 
the cartilage of murine E14.5 embryos (Ranger et al. 2000).  
As for AP1, FIMO was used to identify wildtype and mutant peaks containing NFATc2 binding 
sites. The stringency of the GGAAA motif (large letters mean little variability) prevented 
identification of putative NFATc2 binding sites at a p-value<0.0001. However, when the cutoff 
threshold was set to p<0.001 potential binding sites were found in HOXD13wt and 
HOXD13R298Q peaks (the worst sequence match detected as NFATc2 binding site with p<0.001 
was GGAAT). With this lowered cutoff, most HOXD13wt (57%) and even more HOXD13R298Q 
peaks (71%) were identified as NFATc2-site containing (Figure 3.25A). Then, Centrimo was 
used to assess the distribution of NFATc2 in HOXD13wt or HOXD13R298Q peaks, but neither 
HOXD13wt nor HOXD13R298Q peaks showed central enrichment (Figure 3.25B).  
Subsequently, peaks were separated into HOXD13/NFATc2-both and NFATc2-only peaks. For 
HOXD13wt, approximately equal numbers were NFATc2/HOXD13-both and NFATc2-only, 
whereas for HOXD13R298Q, 40% of peaks were HOXD13/NFATc2-both and 60% were 
NFATc2-only peaks (Figure 3.25A). Finally, Centrimo was used to test for the distribution of 
HOXD13 and NFATc2 binding sites in the HOXD13/NFATc2-both and NFATc2-only peaks 
(Figure 3.25C). As for the combined peakset, HOXD13wt peaks showed only central enrichment 
of HOXD13 binding sites and no central enrichment for NFATc2 binding sites. For 
HOXD13R298Q peaks a weak central enrichment of HOXD13 binding sites was detected (as seen 
for HOXD13R298Q peaks in general), but the NFATc2 binding sites did not show a central 
enrichment. 
Taken together, the results indicate that the identification of GGAAA sequences in the 
HOXD13R298Q peaksets might be an artifact and is not related to a gained or lost cofactor 
interaction of HOXD13R298Q. 
  
 
 
 
Figure 3.25 (next page) Analysis of NFATc2 binding sites in HOXD13wt and HOXD13R298Q peaks. 
(A) Percentage of peaks containing an NFATc2 binding site (lighter shade are NFATc2-only, darker shade 
HOXD13/NFATc2-both) as determined by FIMO (p < 0.001). (B, C) Centrimo analysis of the best sequence match to 
the NFATc2 or HOXD13 motif in all HOXD13wt or HOXD13R298Q peaks (B), or in HOXD13/NFATc2-both or NFATc2-
only peaks (C). All HOXD13wt peaksets show the best sequence match to a HOXD13 motif centrally, near the peak 
summit while there is no positional enrichment for an NFATc2 motif. In HOXD13R298Q peaksets, the HOXD13 motif 
shows a slight central enrichment but there is no positional enrichment for potential NFATc2 binding sites. 
 
 
 
3. Results 
 74   
 
 
 
3. Results 
 75 
 Distribution of HOXA13 Binding Sites in HOXD13wt and HOXD13R298Q 3.4.6
Peaks 
 
General distribution 
The differential motif analysis revealed an overrepresentation HOXA13 binding sites among 
predominantly HOXD13wt-bound peaks, which indicated that HOXD13 might share a 
significant subset of its binding sites with HOXA13. 
To further investigate the relationship between HOXD13 and HOXA13 binding sites, FIMO 
was used to identify all HOXD13 and HOXA13 binding sites in the HOXD13wt and 
HOXD13R298Q peaks. Of all HOXD13-peaks, 47.5% (16,279) contained a HOXD13 binding site 
and 22.5% (7709) contained a HOXA13 binding site (Figure 3.26A). In strong contrast, only 
26% of all HOXD13R298Q peaks contained a HOXD13 binding site (FIMO p<0.0001, Figure 
3.26A) and 11.2% a HOXA13 binding site. To ensure that the lower number of HOXD13 
binding sites in HOXD13R298Q peaks was not due to the slightly changed HOXD13R298Q motif, 
the number of typical HOXD13R298Q binding sites in HOXD13wt and HOXD13R29Q peaks was 
identified (the motif found in Figure 3.22B, HOXD13R298Q-strong peaks was used for this 
analysis). In HOXD13wt and HOXD13R298Q peaks, the HOXD13R298Q binding sites were present 
in only 19% and 22% of peaks, respectively. Collectively, the analysis shows that a large 
fraction of HOXD13wt peaks contain HOXA13 binding sites, and that HOXD13R298Q peaks 
generally contain fewer HOX-like binding site compared to HOXD13wt peaks. 
 
Figure 3.26 Identification of HOXA13 binding sites in HOXD13wt and HOXD13R298Q peaks 
(A) Identification of HOXD13wt and HOXD13R298Q peaks containing a HOXD13, HOXA13, and HOXD13R298Q binding 
sites as identified by FIMO (p<0.0001). (B) Distribution of the best sequence match to HOXD13 and HOXA13 motifs in 
all HOXD13wt (top) or all HOXD13R298Q (bottom) peaks as determined by Centrimo. The HOXD13 and HOXA13 motifs 
used for this and subsequent analyses are the primary motifs identified by Berger et al. (2008) which were shortened to 
the central 9bp. 
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Following this, the position of the best HOXD13 or HOXA13 recognition sequence within 
peaks was identified using Centrimo. Usually, for ChIP-seq data, an enrichment of the best 
sequence match to the motif is centered with a single maximum near the peak summit. Here, a 
striking distribution of HOXD13 and HOXA13 binding sites within the HOXD13wt peaks was 
observed. The best sequence match to the HOXD13 (blue) or HOXA13 (red) motif was located 
at the peak summit or 40 to 50bp downstream of the peak summit, resulting in a graph with two 
maxima (Figure 3.26B). When performing the corresponding analysis on the HOXD13R298Q 
peaks, only a weak enrichment of the best sequence matches surrounding the summit was 
found, and the characteristic profile with two maxima was not seen.  
In order to distinguish whether the appearance of HOXA13 binding sites in HOXD13 peaks 
originates from HOXD13 and HOXA13 binding to separate sequences in the same peak (co-
binding) or whether they originate from peaks that only carry a HOXA13 site, the HOXD13 
peaks containing a HOXA13 binding site were separated into HOXA13-only or 
HOXD13/HOXA13-both peaks. The 7709 HOXD13wt peaks containing a HOXA13 binding site 
split evenly into 3881 HOXA13-only peaks (50.4%) and 3829 HOXD13/HOXA13-both peaks 
(49.6%) (Figure 3.27). A different distribution was observed for the HOXD13R298Q peaks. Of the 
2420 HOXD13R298Q peaks with a HOXA13 binding site, only 545 (22.5%) were 
HOXD13/HOXA13-both peaks, whereas the large majority (1875/ 77.5%) were HOXA13-only; 
in other words, the detected HOXA13 binding site was the only HOX-like sequence in the peak. 
Notably, the majority (356/545) of HOXD13R298Q-peaks containing a HOXD13 and a HOXA13 
binding site were shared with HOXD13wt-peaks. 
 
Figure 3.27 HOXD13R298Q binds less frequently in sites that contain HOXD13 and HOXA13 binding sites 
(A) The absolute number of HOXD13wt and HOXD13R298Q peaks that carry a HOXD13 binding site only and those that 
carry in HOXA13 binding site. Lighter shaded colors indicate the peaks that contain HOXD13 and HOXA13 binding 
sites. (B) Tabular description of the data. All binding sites identified by FIMO (p < 0.0001). 
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Centrimo analysis for HOXA13-only and HOXD13/HOXA13-both peaks produced graphs in 
line with those in Figure 3.26. The characteristic “double-peak” for HOXD13wt was not 
observed for HOXD13R298Q (Figure 3.28) 
Collectively, comparison of HOXA13 binding sites in HOXD13wt and HOXD13R298Q peaks 
revealed three key observations. First, HOXD13R298Q peaks generally have fewer HOX-like 
motifs. Second, a surprisingly large number of HOXD13wt peaks contain HOXD13 and 
HOXA13 binding sites and third, the characteristic co-occurrence of HOXD13 and HOXA13 
binding sites is strongly reduced in HOXD13R298Q peaks. 
 
HOXD13/HOXA13 Motif Co-occurrences 
The large fraction of HOXD13/HOXA13-both peaks in addition with the intriguing distribution 
of HOXD13 and HOXA13 binding sites indicated that these peaks might be bound in parallel 
by HOXD13 and HOXA13 proteins. To see whether the co-occurrence of HOXD13 and 
HOXA13 binding sites followed any rules that indicate stereotypic binding of HOXD13 and 
HOXA13, the HOXD13/HOXA13-both peaks were further investigated. 
First, the positions of HOXD13 (4846) and HOXA13 (4198) binding sites (FIMO p<0.0001) in 
the 3829 HOXD13/HOXA13-both peaks were identified. Then, for each HOXD13 site, the 
location of the nearest non-overlapping HOXA13 binding site was determined. This 
automatically excluded all CTCATAAAA sequences, which are detected by both given 
HOXD13 and HOXA13 motifs.  In total, 3150 HOXD13 binding sites – 15.5% of all HOXD13 
 
Figure 3.28  Distribution of HOXD13 and HOXA13 motifs at HOXA13 containing peak sets 
Distribution of the best sequence match to HOXD13 and HOXA13 motifs in HOXD13wt (left) or HOXD13R298Q (right) 
peak sets that contain a HOXA13 binding site. Above are the peaks that contain non-overlapping HOXD13 and 
HOXA13 sites, below are the peaks that only contain a HOXA13 site. Graphs generated using Centrimo. 
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binding sites found in peaks – have a second HOXA13 binding site within 300bp radius (Figure 
3.29).  
Next, to identify preferred distances between the two binding sites, the distance between each 
binding site pair was calculated. Most HOXA13 binding sites occurred within 40bp of the 
HOXD13 site (median = 40bp), gradually declining with distance (Figure 3.30). Further, a 
similar distribution in site distances was observed when considering binding site pairs on the 
 
Figure 3.29 Frequent co-occurrence of HOXD13 and HOXA13 binding sites  
The great majority of HOXD13 and HOXA13 binding sites in HOXD13wt peaks that contain a HOXA13 binding site 
are non-overlapping. 3,150 HOXD13 binding sites have a second HOXA13 binding site within 300bp. This 
amounts to 15.5% of all HOXD13 binding sites found in peaks. There is no preferential orientation of the two 
binding sites towards one another. 
 
Figure 3.30 Distribution of HOXD13-HOXA13 binding site distances in HOXD13wt peaks 
Histogram of distances between HOXD13 and HOXA13 binding sites in 10 bp steps. Most binding sites are within 
40bp of one another. Binding sites separated by one or two basepairs are more frequently located on opposite 
strands than on the same strand (red bars). 
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same and on opposite strands separately, and there was also no preferred orientation of binding 
sites to one another (1629 same strand, 1521 opposite strand) (Figure 3.29 and Figure 3.30).  
 
However, a striking difference between both orientations could be observed when comparing 
co-occurring motifs in the same orientation with those of opposite orientation. If the two 
binding sites are directly adjacent they are counted as separated by 9bp and, if there is a one-
basepair gap, by 10bp. Only few HOXD13 sites were adjacent to a HOXA13 site when they 
were in the same orientation (30), whereas when located on opposite strands, there were 
approximately twice as many (60) (red bars in Figure 3.30 and Figure 3.31). This difference was 
even more obvious when looking at the distribution of HOXD13-HOXA13 motif pairs in 
basepair resolution (Figure 3.31A,C). 
 
Even more specific, if two non-palindromic binding sites are located on opposite strands they 
can be directed in two different orientations towards one another, convergent or divergent 
(Figure 3.31B,D). To test whether there are preferences for one orientation over another, the 
HOXA13-HOXD13 pairs were separated into convergent and divergent pairs. Of the 30 directly 
adjacent HOXA13-HOXD13 motif pairs in HOXD13wt peaks, 21 were divergently oriented and 
9 were convergently oriented, whereas the 30 pairs separated by one basepair were distributed 
evenly between divergent/convergent (15/14). Interestingly, at 19bp difference – one full 
 
Figure 3.31 Distribution of HOXD13 HOXA13 binding site distances in HOXD13wt peaks 
(A, C) Histogram of distances between HOXD13 and HOXA13 binding sites at basepair resolution. Binding sites 
separated by one or two basepairs are twice as frequently located on opposite strands compared to those located on 
the same strand (red bars). (B) Histogram of binding site distances (basepair resolution) located on the same strand 
split into HOXD13-HOXA13 or HOXA13-HOXD13 order. Both orders are equally common. (D) Histogram of binding 
site distances (basepair resolution) split into divergent and convergent orientation toward one another. When directly 
adjacent and at 19bp distance the majority of binding sites are oriented divergent to one another. 
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rotation of the DNA double helix – the distribution was again shifted (10 divergent, 4 
convergent). In comparison, the orientations for most other distances were distributed evenly, as 
were the orientations for motif pairs on the same strand (HOXD13-HOXA13 or HOXA13-
HOXD13; Figure 3.31). However, due to the low number of individual binding site pairs, these 
observations were not statistically significant.   
Taken together, closer inspection of HOXD13-HOXA13 binding site pairs revealed no preferred 
distance or orientation for the two binding sites; however, intriguing preferences for binding site 
orientation could be observed in those pairs, where the HOXA13 binding site lies adjacent to 
the HOXD13 site.  
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 Discussion 4
 
 Poor Genotype-Phenotype Correlation of HOXD13 Mutations is Due 4.1
to Mutation Specific Effects 
 
Transcription factors are crucial for the exact control of gene expression in the developing 
embryo. Most TF proteins specifically bind to DNA sequences via a DNA-binding domain, 
while different protein domains interact with other TFs or the transcriptional machinery to 
activate or inhibit the expression of target genes. TFs are frequently involved in the 
pathogenesis of disease, in particular congenital malformation syndromes (Boyadjiev and Jabs 
2000; Vaquerizas et al. 2009). In many instances this is due to haploinsufficiency, i.e. the 
functional loss of one allele caused by deletions, nonsense mutations, frameshifts or other 
inactivating variants. In contrast, missense mutations will not lead to haploinsufficiency, but 
rather alter TF function by affecting protein-protein or protein-DNA interactions and thereby 
challenge the interpretation of these mutations. 
More than 20 distinct mutations in HOXD13 have been described (reviewed in Brison et al. 
2013). The phenotypic spectrum of HOXD13 mutations, however, is variable and there is no 
good genotype-phenotype correlation for HOXD13 mutations, leading to the observation that, 
depending on the exact type of mutation, the hands and feet can be affected in very different 
ways. In general, HOXD13 mutations are associated with SPD. However, HOXD13 mutations 
have also been shown to cause brachydactylies (type A2, B, and E), syndactyly type V, 
clinodactyly of the fifth finger and to change the bone formation process (Debeer et al. 2002; 
Goodman 2002; Caronia et al. 2003; Zhao et al. 2007; Jamsheer et al. 2012; Wang et al. 2012a). 
More specifically, haploinsufficiencies and polyalanine expansions in HOXD13 are associated 
with synpolydactyly (Muragaki et al. 1996; Goodman et al. 1998), whereas amino acid 
substitutions in the homeodomain have mostly been described in cases with SPD-unrelated 
phenotypes affecting the distal thumb and the metacarpals (Caronia et al. 2003; Johnson et al. 
2003; Zhao et al. 2007; Wang et al. 2012a).  
The presence of several distinctive phenotypes suggests mutation specific disease mechanisms 
for each type of mutation. In the case of HOXD13 polyalanine expansions, the pathomechanism 
appears to be a combination of loss of function and gain of function caused by protein 
aggregation and the interaction with other alanine repeat containing TFs (Villavicencio-Lorini et 
al. 2010). Considering the drastic differences in phenotypic expression for missense mutations, 
a common pathomechanism for all mutations is a rather unlikely scenario and specific effects, 
such as alterations in binding capacity or cofactor interactions are more likely to explain this 
phenomenon.  
In this study, ChIP-seq was applied to characterize two missense mutations in HOXD13 that are 
associated with distinct phenotypes. The results of this approach provide direct evidence for the 
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mutation specific effect of missense mutations for HOXD13 protein function and elucidate the 
molecular pathomechanims underlying two distinct diseases caused by mutations in the same 
gene. 
 
 The chMM-ChIP-seq System 4.2
 Investigation of Mutant TFs 4.2.1
To interpret the effect of a mutation, the full spectrum of TF function needs to be taken into 
account. TFs are proteins of modular nature and mutations located in the DNA-binding domain 
will likely lead to a different protein dysfunction than a mutation affecting a protein-interaction 
domain or a nuclear localization sequence. Unlike enzymes, which stereotypically catalyze 
specific biochemical reactions, the nature of TFs is to positively or negatively influence the 
transcription of certain genes inside the nucleus. Current techniques to investigate TF mutations 
mostly test specific aspects of TF function that often provoke yes-or-no answers. For these 
approaches prior knowledge of individual TF function and a working hypothesis for the effect 
of the mutation are required.  
ChIP-seq has been used to characterize the genomic binding profiles of numerous TFs in many 
different experimental settings. However, it has not yet been systematically used to investigate 
the effects of mutations in TFs associated with hereditary diseases. The main roadblocks 
consisted in the difficulty in distinguishing between wildtype and mutant TFs with a primary 
antibody and in obtaining sufficient amounts of tissue of a relevant anatomical site and 
developmental stage for the analysis.  
The chMM-ChIP-seq method developed and applied in this thesis is designed to overcome these 
hurdles and characterize TF mutations as unbiased as possible and in parallel allowing a flexible 
setup. One advantage of the system is that it profiles wildtype and mutant TF binding in its 
environment, the nucleus. In addition, application of a primary cell culture system (chMM) 
generates comparable conditions for wildtype and mutant proteins on the one hand and avoids 
the artificial situation of immortalized cell culture lines on the other hand. Furthermore, the 
chMM system is well suited for investigation of HOXD13 mutations, as the cells originate from 
the developing limb bud, where the gene is physiologically expressed. Finally, chMM cultures, 
in contrast to other cell culture systems, undergo a differentiation process, and thus are well 
suited to investigate the factors that influence this process.  
To date, standard approaches used to elucidate the molecular underpinnings of TF mutations not 
only have more artificial nature than chMM-ChIP-seq, but also are also limited in the 
interpretation of the results. Common practices include transient expression of wildtype and 
mutant proteins followed by immunocytochemistry to test whether folding or nuclear 
localization of the protein is affected. More specifically, the “activating” ability of a mutant is 
 
 
4. Discussion 
 83 
assessed in luciferase reporter assays using known target promoters, ideally, but not always, in 
multiple cell lines. Another common method, if the recognition sequence is known, are EMSAs, 
which determine the binding affinity of the purified DNA-binding domains in vitro. More 
elaborate methods, such as yeast-2-hybrid or pull-down experiments, can be used to analyze 
normal or altered protein-protein interactions and are sometimes adapted to screen for potential 
binding partners (see De Folter and Immink 2011 for an overview). Finally, sophisticated in 
vitro techniques – SELEX, Protein Binding Microarrays (PBM) and Surface plasmon resonance 
(SPR/Biacore) – could be used to determine differences in DNA-binding specificity and affinity 
of wildtype and mutant TFs (e.g. Berger et al. 2008; Siggers et al. 2011; Jolma et al. 2013).  
To varying degrees, all of these approaches allow only limited insights and/or are artificial in 
nature. As could be seen for both HOXD13 mutations, correct nuclear localization does not 
answer whether the protein is functioning correctly inside the nucleus. Luciferase reporter 
assays, despite having the advantage of comparing sequence requirements for gene activation, 
are dependent on transient overexpression of TF proteins. The transient transfection leads to TF 
protein levels that can be much higher than physiological levels and test the activity on target 
sequences located on plasmid vectors detached from their nuclear environment. Moreover, these 
reporter assays often show high variability between cell lines, indicating a dependency on 
cofactors that are not present in all cell types (Whitfield et al. 2012). Regarding protein-protein 
interactions, the Yeast-2-hybrid and pulldown assays are artificial, as they test for interaction 
between isolated protein domains in yeast and are prone to identify false-positive interactions 
(Deane et al. 2002; Chen et al. 2010). PBM and SELEX-seq are less biased in their outcome and 
could be easily adapted to compare wildtype and mutant TFs. However, in contrast to ChIP-seq 
assays, these require purified proteins and test their in vitro binding. Commonly, only the DNA-
binding domain of the TF is used in these assays, since full-length TFs are frequently difficult to 
purify and despite precise characterization of DNA-binding preferences, in vitro assays lack 
important information of TF binding in the genomic context. 
The chMM-ChIP-seq method allows comparative analysis of wildtype and mutant TF binding 
throughout the genome. De novo motif analysis can be used to detect changed binding 
specificities, whereas the genomic location of binding sites can indicate putative regulatory 
effects. Additional bioinformatics analyses enable further investigations regarding altered 
cofactor binding sites or changed distribution of binding sites in relation to genomic landmarks. 
Moreover, the chMM-system allows analysis of the regulatory effects between wildtype and 
mutant TFs either by comparing the effect on chondrogenic differentiation in general or by 
measuring expression levels of individual target genes (see Section 3.2). Thus – performing a 
single experiment – chMM-ChIP-seq enables to address multiple aspects of TF function that 
would require separate in vitro experiments using common approaches. 
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However, the chMM-ChIP-seq method is not without limitations. The RCASBP system leads to 
overexpression of the transduced TF, which in turn might lead to false positive binding sites, 
although for the comparison of mutant to wildtype TF this is not likely to be relevant.  
Moreover, absolute quantification of transcript levels could show that the overexpression levels 
for Hoxd13 remain in the range of endogenous expression levels in the developing limb bud. In 
addition, although the chMM system is well suited for studying TFs that influence 
chondrogenesis, TFs not involved in this process should be tested adequate avian cell culture 
systems, such as models for muscle, neuronal, and neural crest cell differentiation (McCobb et 
al. 1990; Dorman and Johnson 1999; Etchevers 2011). Finally, the RCASBP-virus is limited in 
insert size, so that cDNA of TFs larger than 2kb will likely not be amenable to expression 
through RCASBP viruses. 
Taken together, the chMM-ChIP-seq system enables a relatively quick functional 
characterization by comparing wildtype and mutant proteins in the genomic context and reveals 
not only where the mutant TF fails to bind, but also if the protein changes its binding specificity. 
The ever-growing repertoire of bioinformatic analysis tools allows addressing specific questions 
regarding binding affinity and specificity, potential cofactor binding sites, or the location of 
binding sites near regulated genes. Thus, this initial screening of the mutant TF leads to the 
development of a mutation-specific hypothesis regarding the underlying pathomechanism, 
which can then be followed by testing the hypothesis in appropriate and custom-designed 
functional assays.  
 
 Possible Applications for the chMM-ChIP-seq Approach 4.2.2
The versatile experimental setup and the chondrogenic differentiation of the chMM cultures 
enable the adaption of the chMM-ChIP-seq method to address a range of other biological 
questions.  
Since chMM cultures mimic physiological chondrogenic differentiation, the system is well 
suited to investigate TFs that influence this process. The generation of ChIP-seq profiles for 
several key TFs in chondrogenic development such as SOX9, RUNX2, SOX5/6 etc. could be 
used to map common chondrogenic TF binding sites and characterize important cis-regulatory 
elements, as well as elucidating the regulatory relationship of the TFs among each other. Along 
these lines, coinfection of chMM cultures with adequate viruses the system would provide a 
good platform to experimentally address regulatory and protein-protein relationships between 
(chondrogenic) TFs. Finally, generating or integrating chromatin modifications over the 
developmental time course of chondrogenic differentiation would allow characterization of the 
changing genomic landscape from undifferentiated mesenchymal progenitor cells to fully 
differentiated chondrocytes and give insights how TFs influence this process.  
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 Analysis of two HOXD13Q317 Missense Mutations 4.3
 HOXD13Q317 Mutations Induce Distinct Genomic Binding Shifts 4.3.1
The HOXD13Q317K and HOXD13Q317R mutations lead to distinct and novel patient phenotypes, a 
complex combination of brachy- and oligodactyly, and syndactyly type V (Zhao et al. 2007), 
respectively, and thus provide a good opportunity to apply the chMM-ChIP-seq technique. 
Initial motif analysis demonstrated that the sequence-specificity, but not the general DNA-
binding ability was altered and that both mutations specifically changed the 5’ end of the 
recognition sequence albeit in slightly different ways.  
The result confirmed previous findings of homeodomain-DNA recognition, which showed that 
the affected glutamine residue is responsible for sequence specificity (Fraenkel et al. 1998). An 
identical Q to K substitution was introduced in the Drosophila fushi-tarazu (ftz) homeodomain 
(Percival-Smith et al. 1990a; Schier and Gehring 1992), changing the recognition motif in vitro 
from CCATTA to GGATTA, the motif of the homeodomain-protein bicoid (bcd) that 
endogenously carries a lysine at this position. The altered regulatory capacity ftzQ50K 
substitution was investigated in Drosophila using reporter constructs (Schier and Gehring 1992; 
Zhao et al. 2000). Flies transgenic for a ftzQ50K allele develop normally and do not show any 
malformations, although reporter constructs respond to the altered binding of ftzQ50K (Schier and 
Gehring 1992). Experiments using a Drosophila cell culture system were able to show the 
importance of other sequences inside the homeodomains and sequences outside the 
homeodomain, which are needed to confer the full regulatory capacity (Zhao et al. 2000). In 
these experiments, the ftzQ50K protein bound with high affinity to and activated constructs 
carrying consensus bcd binding sites while failing to activate natural enhancers harboring non-
consensus binding sites (Zhao et al. 2000).  
Motif analysis and EMSAs demonstrated that a similar switch in sequence specificity occurs in 
the HOXD13Q317K mutant, which recognized the PITX1 binding site in vitro. Of the 25 bicoid-
type (K50) homeodomain TFs in the mouse genome (20 in humans), only PITX1 is known to 
play a major role in limb development. Pitx1 is required for the formation of hindlimb-specific 
structures and produces hindlimb-like morphologies when misexpressed in forelimbs (Logan 
and Tabin 1999; Szeto et al. 1999).  
The change in sequence specificity introduced by the HOXD13Q317R mutation is similar, but 
distinct from HOXD13Q317K, as can be seen in the de novo motif analysis and EMSAs. 
Interestingly, although the preferred motif begins with GT, a HOXD13-like motif appears 
among the secondary motifs in motif analysis. This residual wildtype specificity is also reflected 
in EMSAs, where HOXD13Q317R still shows considerable binding to the HOXD13wt sequence, 
whereas this is completely abolished in HOXD13Q317K. 
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An advantage of this study over previous reports studying mutant homeodomains (Zhao et al. 
2000; Caronia et al. 2003; Zhao et al. 2007) is that ChIP-seq allowed to profile the genome-
wide binding of mutant HOXD13 proteins and could provide first direct evidence for a genome-
wide shift of the mutant towards a more PITX1-like binding pattern. In contrast to the 
observations for ftzQ50K, the shift in binding is accompanied by a regulatory switch. RNA-seq 
expression analysis demonstrated that in comparison with HOXD13wt and HOXD13Q317R, 
HOXD13Q317K leads to a clearly different regulation of target genes, many of which are also 
recognized and regulated by PITX1 (Figure 3.16). This is likely due to the fact that 
HOXD13Q317K is capable of binding to and regulating a substantially greater number of PITX1 
targets than is observed for ftzQ50K and bcd, which is further supported by the fact that only 
HOXD13Q317K recognized the PITX1 binding site in vitro, indicating that the recognition of 
PITX1 sites is specific to HOXD13Q317K.  In addition, shared binding sites for PITX1 and 
HOXD13Q317K are enriched in the vicinity of the co-regulated genes, also indicating shared 
properties of HOXD13Q317K and PITX1. 
 
 Regulatory Consequences of Genome-Wide Binding Shifts are Mutation-4.3.2
Specific 
An important aspect further influences the regulatory consequences of the HOXD13Q317 
mutations. The adoption of a novel set of target genes is only possible, if the new binding sites 
in the genome are meaningful in the regulatory context of the cell.  
In the case of the HOXD13Q317K mutation, the cells in the embryonic limb bud are responsive to 
Pitx1 expression, as indicated by Pitx1 overexpression and knockout experiments in transgenic 
models (Logan and Tabin 1999; Szeto et al. 1999). In the patient, the altered binding of 
HOXD13Q317K is therefore likely to disturb the regulatory balance during limb bud development 
by regulating PITX1 targets in the HOXD13 expression domain. Thus, a PITX1-like activity in 
the HOXD13 expression domain can be expected to result in a major degree of misexpression. 
The hypothesis that normal HOXD13 function is partially replaced by PITX1 activity is 
supported by the effects of overexpressing Hoxd13Q317K and PITX1 in chMM cultures and in 
infected chicken wing buds (see Section 0). The findings in chMM-cultures demonstrate that the 
mutant is able to bind and activate PITX1 target genes. The wing bud injections confirm that 
this effect is biologically relevant, as the mutant is able to induce PITX1-like morphological 
changes. The specificity of these effects is further corroborated by the investigation of the 
HOXD13Q317R mutant.  
The shift in genomic binding introduced by the HOXD13Q317R mutation is not as drastic as seen 
for the HOXD13Q317K mutation and the limb bud injections show the effects of HOXD13Q317R to 
mostly overlap with HOXD13wt. In addition to residual wildtype activity, the HOXD13Q317R 
recognition site does not correspond to known TF target sites and might therefore have only 
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minor effects. In comparison to previous analysis (Zhao et al. 2007), the new data highlights the 
potential insights and limitations of standard approaches. In light of the patient phenotype, the 
authors speculate about the possibility of a mixed LOF and GOF phenotype but cannot present 
any data supporting this. By using the chMM-ChIP-seq technique, a single experiment allowed 
not only to observe a genome-wide shift in binding, but also considerable residual wildtype 
HOXD13 activity, providing direct evidence for the hypothesis.  
 
The underlying biochemistry of the HOXD13Q317K and HOXD13Q317R mutations (and of 
HOXD13I314L (Caronia et al. 2003)) is the same. A change in amino acid composition in the 
recognition helix leads to an altered binding specificity of the TF. However, the resulting 
phenotypes differ drastically from one another. In comparison to a normal hand, the 
HOXD13I314L mutation introduces the weakest change, whereas the HOXD13Q317R phenotype is 
stronger and the HOXD13Q317K phenotype deviates the most from a normal hand. Why is this? 
Caronia and colleagues (2003) demonstrated that the HOXD13I314L recognizes a subset of 
HOXD13 motifs (a CTCGTAAAA sequence also typical for HOXA13) which in ChIP-seq 
would be expected to cause an even weaker shift in binding as compared to HOXD13Q317R and 
HOXD13Q317K. In context with the binding shifts observed for HOXD13Q317R and 
HOXD13Q317K, different degrees of remaining wildtype activity might partially explain the 
phenotype strength. 
Thus, the results presented here clearly show that a missense mutation in a TF can act as gain-
of-function mutation that shifts the binding profile of the relevant TF on a genome-wide scale. 
However, individual consequences of such a shift are dependent on the presence of compatible 
cis-regulatory elements/targets as well as the properties of protein domains involved in 
transactivation and protein-protein-interaction. 
 
 Despite low Overlap HOXD13Q317K and PITX1 Show High Regulatory 4.3.3
Similarity  
Several factors contribute to the observation that, despite sharing only 1600 binding sites, 
HOXD13Q317K and PITX1 induce highly similar chMM morphologies and global gene 
expression changes. 
Importantly, the reported binding site overlap is likely to be an underestimation, since very 
stringent criteria were used for its calculation. However, even a more relaxed calculation of 
overlapping binding sites would lead to a maximum of approximately 5000 binding sites (15% 
of HOXD13Q317K peaks). Likewise, despite the 25% overlap between HOXD13Q317R and 
HOXD13wt peaks, HOXD13Q317R induces an almost indistinguishable phenotype in limb bud 
injections.  
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Moreover, similar to the results presented here, ChIP-seq experiments across model systems and 
organisms have reported thousands of binding sites for TFs across the genome (e.g. Ouyang et 
al. 2009; Junion et al. 2012; Wang et al. 2012b). Importantly, two recent studies suggest that a 
substantial amount of TF binding might be non-functional (Paris et al. 2013; Stefflova et al. 
2013). These findings raise the question which fraction of the binding sites is functional and 
how to distinguish between non-functional and functional binding sites. Two promising 
approaches increase the likelihood of identifying functional binding sites. On the one hand, 
integration of multiple TF binding profiles in the same cells revealed that TFs tend to bind in 
clusters, generating highly occupied TF (HOT) regions (Ouyang et al. 2009; Gerstein et al. 
2012; Junion et al. 2012; Kvon et al. 2012). When tested in reporter assays, these regions were 
shown to be much better indicators of functional cis-regulatory elements than, for example, 
evolutionary conserved regions (Kvon et al. 2012). On the other hand, identification of TF 
binding to functional cis-regulatory elements can be achieved by profiling a set of histone 
modifications that faithfully identify cis-regulatory elements in the sample of interest 
(Heintzman et al. 2007; Ernst and Kellis 2010).  
Combining such methods with shared and differential binding of HOXD13Q317K and PITX1 
would help to identify those shared binding events that confer biological function. In principle, 
the chMM-ChIP-seq system is amenable to such kind of extension, which would provide further 
insights into the regulatory effects TF binding. However, additional experimental data would be 
required to further investigate the binding of and the regulation by wildtype and mutant 
HOXD13 proteins. 
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 Analysis of the HOXD13R298Q Mutation 4.4
 The HOXD13R298Q Phenotype in Relation to the Mild Loss-of-Function 4.4.1
Found in ChIP-seq and Biochemical Approaches 
 
The phenotype displayed by HOXD13R298Q patients encompasses classical features of both SPD 
and BDA2. Whereas SPD phenotype is associated with several HOXD13 mutations, BDA2 
symptoms have not yet been reported for HOXD13 mutations. A common effect of many 
HOXD13 mutations that cause SPD is the loss of functional HOXD13 protein through mRNA 
or protein degradation or loss of DNA-binding ability. The observed SPD in HOXD13R298Q 
patients suggests that loss of HOXD13 function is likely one aspect of the pathomechanism. 
However, the unique BDA2 in HOXD13R298Q patients strongly suggests that the protein function 
is altered in additional ways. 
Interestingly, the results of all biological and biochemical assays performed in this study find 
the mutant protein to act as a hypomorph allele, since the loss in functionality compared to 
HOXD13wt is only moderate. Contrary to the hypomorphic protein function, penetrance of 
HOXD13R298Q in patients is stronger than seen for other loss-of-function mutations. All eight 
affected individuals display SPD symptoms and the additional BDA2 features were observed in 
five out of eight cases across three different families. Frameshift or nonsense mutations in 
HOXD13, however, are also associated with SPD, but mutation carriers are affected in as little 
as 30% of the cases (Goodman et al. 1998). Further complicating the genotype-phenotype 
relation, the HOXD13R298W mutation modifies the same residue as in HOXD13R298Q, but shows 
reduced penetrance as in haploinsufficient cases (Debeer et al. 2002). In the large 
HOXD13R298W pedigree, only 3 in 17 mutation carriers show unilateral SPD and the remaining 
14 individuals only exhibit a mild phenotype, a 5th finger clinodactyly. In this case, functional 
HOXD13 protein is possibly completely lost due to a strong reduction in DNA-binding ability 
(see Section 3.4.1 and 3.4.2).  
In other words, whereas the HOXD13R298Q mutation displays only a moderate loss-of-function 
in biological and biochemical experiments, it causes a highly penetrant phenotype, contrasting 
the effect of mutations that reduce more of the proteins “measurable” function. It is thus highly 
likely that the HOXD13R298Q mutation exerts a deleterious, dominant-negative, effect on the 
wildtype allele in addition to the loss-of-function effects detected in experiments. 
 
 Possible Dominant-Negative Mechanisms of HOXD13R298Q are 4.4.2
Amenable to Experimental Investigation 
By definition, a dominant-negative allele disrupts the activity of the wildtype allele in addition 
to losing its own functionality (Herskowitz 1987). Prominent examples of dominant-negative 
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effects are polyalanine tract expansions in HOXD13. When exceeding a certain length, the 
mutant HOXD13 proteins aggregate in the cytoplasm, are degraded, and also incorporate 
wildtype HOXD13 proteins into the aggregates, thereby reducing the amount of functional 
HOXD13 in the nucleus (Albrecht et al. 2004). In patients, the degree of the biochemical effect 
correlates with penetrance of the SPD phenotype (Goodman et al. 1997). 
An experimental setup to test the dominant-negative potential of mutant HOXD13 was used by 
Caronia et al. (2003), who analyzed two homeodomain mutations. In that case, the authors 
showed that upon cotransfection of wildtype and mutant HOXD13, the mutant protein impaired 
the activation of a luciferase reporter construct by HOXD13wt. Similar future experiments 
should validate whether the HOXD13R298Q mutant can act in a dominant-negative way over 
HOXD13wt (see below).  
 
 Molecular Mechanism Underlying Dominant-Negative Mutations 4.4.3
There are several biochemical possibilities how the mutant protein exerts its dominant-negative 
effect on a molecular level. Importantly, the type of biochemical mechanism that might underlie 
a dominant-negative effect can be experimentally addressed. The ChIP-seq analysis of 
HOXD13R298Q revealed some intriguing aspects that support discussion of possible 
pathomechanims. 
 
AP1 and NFATc2 – Increased Cofactor Interaction? 
Cofactor interaction is crucial for TF function; therefore, a possible effect of HOXD13R298Q 
might involve cofactor interaction. One possibility could be that reduced DNA-binding of 
HOXD13R298Q supports indirect binding events through cofactors. Given that those cofactors are 
DNA-binding TFs, increased interaction would be reflected in the sequence composition of the 
mutant’s binding to sites when compared to the wildtype. Importantly, in such a situation the 
cofactor recognition sequences would be centrally enriched in those peaks.  
The de novo detection of AP1 and NFATc2 motifs in predominantly HOXD13R298Q-bound 
peaks suggested the possibility of indirect binding events mediated by AP1 or NFATc2 TFs. To 
further validate this hypothesis, Centrimo analysis was used to identify the distribution of AP1 
and NFATc2 recognition sequences in HOXD13R298Q peaks (pp. 71-73). However, no central 
enrichment of the recognition sequences was found, contraindicating indirect DNA-binding of 
HOXD13R298Q via AP1 or NFATc2. In addition, interpretation of AP1 and NFATc2 motifs is 
problematic. AP1 TFs bind as dimers consisting of two subunits belonging to one of four 
protein families, cJun, cFos, ATF and JDP (reviewed in Hess et al. 2004). However, most of the 
possible heterodimeric complexes bind a similar motif. Moreover, AP1 dimers are extremely 
variable in their composition and, depending on composition, have been demonstrated to 
regulate gene expression in many biological processes. Thus, the presence of an AP1 binding 
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site is very challenging to interpret. In addition, chMM-ChIP-seq experiments in the group 
performed for the TFs MSX2 and RUNX2 also detect the AP1 motif in their peaks (Hein 2013). 
Since AP1 – Activating Protein 1 – has been shown to be a cofactor for many TFs (see Turpaev 
2006 and references therein), one possible explanation might be, that AP1 motifs are present in 
a subset of peaks that is associated with (highly) transcribed genes, and therefore prone to be 
found in a broad range of ChIP-seq peaks. 
For NFATc2, an indirect explanation for the de novo motif detection is even more likely. First, 
the GGAAA motif is only a half-site of the normally dimeric binding sites (Jolma et al. 2013). 
Second, the motif was mainly found in weakly bound HOXD13R298Q binding sites. Finally, the 
sequence composition is unspecific, so that the detection threshold for FIMO analysis had to be 
lowered. However, a functional role for NFATc2 cannot fully be excluded, since the gene is 
strongly expressed in developing cartilage and can repress chondrogenesis (Ranger et al. 2000). 
Therefore, the NFATc2 motif possibly represents an unspecific signal that becomes visible in 
weakly enriched binding sites.  
Taken together, a closer analysis of both motifs detected in predominantly HOXD13R298Q bound 
peaks does not indicate altered (stronger) interaction of the mutant with AP1 or NFATc2 
proteins. 
 
HOXA13 – Decreased Cofactor Interaction? 
In contrast to AP1 and NFATc2, HOXA13 binding sites were reduced in HOXD13R298Q peaks. 
The large fraction of HOXD13wt peaks containing a HOXA13 binding site was a surprising and 
characteristic outcome of the HOXD13wt ChIP-seq (discussed below), and was not observed for 
HOXD13R298Q ChIP-seq. The fraction of HOXD13R298Q peaks containing a HOXA13 motif was 
lower in general and specifically the number of peaks containing motifs for both – HOXD13 
and HOXA13 – was strongly reduced. A possible explanation could be that the R298Q mutation 
hinders putative protein-protein interaction between HOXD13 and HOXA13 proteins. 
Homeodomains are known to form dimers, however, the interaction between homeodomains is 
usually mediated via the N-terminal arm or non-homeodomain sequences of the respective 
proteins (reviewed in Mann et al. 2009). Additionally, detailed analysis of dimeric 
homeodomain-complexes demonstrated that the recognition sequences of dimeric 
homeodomain complexes differ decisively from those of the monomers (Joshi et al. 2007; 
Slattery et al. 2011). Assuming that HOXD13-HOXA13-both peaks are more likely to represent 
functional biding sites, the reduction of those peaks could be due to an indirect effect, given that 
HOXD13R298Q fails to distinguish between functional and non-functional biding sites. 
However, some literature reports support a possible direct effect of the missense mutation on the 
observed reduction in HOXD13-HOXA13 both peaks. Saadi and colleagues (2003) described a 
dominant-negative acting mutation in the homeodomain TF PITX2 in patients with Axenfeld-
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Rieger syndrome. In carefully designed experiments, the authors demonstrated that the mutant 
protein hindered dimeric PITX2-complexes, composed of wildtype and mutant PITX2 proteins, 
from adequately binding to and activating reporter constructs. In another line of evidence, recent 
experiments demonstrated HOXA13 homeodomains binding to DNA as a dimer. Interestingly, 
interaction between both homeodomains was mediated via the second helix that harbors the 
mutated R298 (Zhang et al. 2011). Although the R298 is not involved in dimer formation and 
dimeric DNA-binding of HOXD13 has not been shown, a dominant-negative effect of 
HOXD13R298Q on this binding might be a possible pathomechanism and could be addressed 
experimentally using coimmunoprecipitation, EMSAs or similar biochemical experiments. 
However, contradictory evidence for this line of argumentation is provided by the 
HOXD13R298W mutation that does not act dominant-negatively. In this mutation, the identical 
residue is changed to a bulky tryptophan, which is why the R298W substitution might disturb 
protein-protein interaction even more than the R298Q substitution and should thereby provoke a 
similar dominant-negative effect. 
 
Collectively, the sequence composition of HOXD13R298Q peaks give some indications towards 
altered cofactor interaction; however, further studies are needed to assess whether the detected 
differences are in fact due to altered protein-protein interaction of the mutant or an indirect 
effect as a consequence failure to distinguish between functional and non-functional binding 
sites. 
 
 
Dominant-Negative Effects on HOXD13wt via Competitive Binding 
The sum of experimental evidence strongly suggests that HOXD13R298Q acts as a hypomorph 
allele in terms of DNA-binding and regulation, whereas it likely has a dominant-negative effect 
in the patients. HOXD13R298W, in contrast, shows no such discrepancy between experimental 
and medical evidence and is highly likely acting as an amorphic allele, retaining no regulatory 
function (Debeer et al. 2002). The question arises how a hypomorphic allele exerts a stronger 
phenotype than an amorphic one, and whether the mechanism could be independent of cofactor 
interactions? 
To answer the question, the mutated protein's biochemical function, in this case the TF 
HOXD13, must be taken into account. Aside from isolated reports (Zhang et al. 2011), 
overwhelming evidence suggests that HOX-proteins do not bind DNA as a homodimer 
(Gehring et al. 1994; Berger et al. 2008; Jolma et al. 2013). Therefore, mechanisms distinct 
from protein-protein interaction must be evaluated. Veitia (2007) described the seemingly 
paradoxical effect of hypomorph mutations based on the assumption of cooperative binding of 
TFs. Cooperative or synergistic binding is independent of dimer formation and thought to be a 
common mechanism through which TFs activate their target genes. This is strongly supported 
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by clustered occurrence of TF binding sites in regulatory elements that remain functional 
independent of orientation or distance of the binding sites to one another (Arnosti et al. 1996; 
Swanson et al. 2010). In a simulation of cooperative activation, a hypomorph mutation caused a 
much stronger reduction of transcriptional output than the haploinsufficient situation. The 
dominant-negatively acting missense mutations in PITX2 supported this simulation and also a 
dominant-negative mutation in KLF1 has been interpreted to act through such a mechanism 
(Saadi et al. 2003; Siatecka et al. 2010).  
Another aspect is that not only sequence specificity, but also residency at the bound DNA 
sequence is of importance to TF function. In an elegant ChIP-seq experiment Lickwar and 
colleagues (2012) recently demonstrated differences between TF binding sites that were very 
briefly bound and sites that were bound for longer time period. Strikingly, the sites that were 
bound for a long time were much more likely to be associated with genes that were 
transcriptionally regulated by the TF than the briefly bound sites.  
In fact, the large reduction of HOXD13-HOXA13 both peaks and the reduced DNA-binding 
affinity of HOXD13R298Q suggest that (1) HOXD13R298Q might specifically lose binding sites 
that require cooperative regulation and (2) the reduced binding strength itself hinders the 
regulatory potential of the mutant protein.  
Thus, a dominant-negative effect of the hypomorph HOXD13R298Q may result from a 
competition between the mutant and the wildtype HOXD13 at each individual binding site. If 
the HOXD13R298Q binds to a site, its reduced affinity would lead to a premature dissociation 
from the DNA preventing efficient regulation of target genes. Importantly, at the same time the 
binding event would prevent the wildtype protein from binding to DNA. In combination, the 
hypomorph HOXD13R298Q would bind long enough to disturb HOXD13wt function but not long 
enough to adequately regulate gene expression. Analogously, the DNA-binding of the 
HOXD13R298W would be so severely hampered, that the mutant does compete with HOXD13wt 
for DNA-binding, thereby acting as a haploinsufficient allele. 
However, it needs to be noted that the dominant-negative effects discussed above do not explain 
the BDA2 phenotype observed in the patients, which might result from additional effects of the 
HOXD13R298Q protein that would be independent of the putative dominant-negative mechanism 
discussed here. 
Taken together, the analysis and interpretation of the HOXD13R298Q mutation turns out to be 
more complicated than the effect introduced by altered sequence specificity in HOXD13Q317 
mutations. However, preliminary results point to highly interesting insights regarding HOXD13 
function and warrant further investigation. 
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 Outlook 4.4.4
Analysis of HOXD13R298Q binding sites especially in relation to the strong phenotype suggests a 
dominant-negative effect of the mutant protein. However, the experiments performed so far 
have not proven this hypothesis and future experiments need to validate the initial findings. 
This could be achieved by performing experiments similar to the luciferase experiments 
performed by Caronia et al. (2003). The chMM system provides a convenient experimental 
setup to test a possible dominant negative effect of HOXD13 mutations. Double infection of 
chMM cultures using RCASBP(A) and RCASBP(B) vectors leads to expression of both 
wildtype and mutant HOXD13 in the same cell. In an experimental setup, infection with 
RCASBP(B)-virus expressing a HOXD13wt will reduce chondrogenic differentiation of the 
chMM-culture to a measurable extent. Modulation of this effect could then be measured by 
coinfection of RCASBP(B)-HOXD13wt and RCASBP(A)-HOXD13R298Q viruses. If 
HOXD13R298Q acts dominant-negatively over HOXD13wt, the inhibition of chondrogenic 
differentiation by HOXD13wt would be reduced in this assay. Three possible control 
experiments should be performed to validate the result: coinfection with additional HOXD13wt, 
HOXD13+7Ala, or HOXD13R298W RCASBP(A)-viruses. HOXD13wt coinfection would further 
reduce chondrogenic differentiation, HOXD13+7Ala would also act dominant-negative, and 
HOXD13R298W should not modify the effect of HOXD13wt, since it is thought to act as a loss-of-
function allele with no dominant-negative effect. A further advantage of using the chMM-
system for this approach is that the measured effect on chondrogenic differentiation is systemic 
and independent of the regulatory requirements at individual reporter constructs used in 
luciferase assays. 
Investigation of HOXD13-HOXA13 both peaks showed an intriguing difference between 
HOXD13R298Q and HOXD13wt. Further experiments using EMSAs should investigate whether 
(1) HOXD13wt can bind DNA as a dimer, (2) the orientation of binding sites towards one 
another is influencing this binding and (3) whether HOXD13R298Q and/ HOXD13R298W variants 
show a different behavior in any of these experiments. The outcome of such experiments should 
allow important insights into the pathomechanism for both HOXD13R298 mutations. 
 
 
 Interpretation of Genome-wide TF Binding 4.5
Despite intensive studies, the molecular mechanism of TF function remains rather mysterious. 
The genome-wide binding data with thousands of binding sites presented in this study is in line 
with the findings of many other groups reporting on the binding of various TFs (e.g. Ouyang et 
al. 2009; Junion et al. 2012; Wang et al. 2012b). It remains difficult to assign ChIP-seq peaks to 
target genes as well as functionality to individual ChIP-seq peaks (reviewed in MacQuarrie et 
al. 2011; Spitz and Furlong 2012). As in our results, especially developmental TFs have been 
 
 
4. Discussion 
 95 
shown to bind to numerous sites throughout the genome. Further complicating the analysis, 
many peaks are found in intergenic regions that cannot be easily attributed to the regulation of a 
specific target (Cao et al. 2010). Therefore the absence of a nearby peak does not exclude direct 
regulation of a certain gene through a TF. However, neither does the presence of ChIP-seq 
peaks in promoters of differentially expressed genes prove direct regulation. Thus, although for 
example the enrichment of HOXD13Q317K-PITX1 shared peaks near co-regulated genes links 
binding to regulation, the list of candidate genes generated in this manner will neither be 
complete nor will all the genes be direct targets.  
In recent years, various approaches have been used to increase the probability of identifying 
functional binding sites by adding information to an initial ChIP-seq data set (see also Section 
4.3.3), such as restricting TF binding sites to those located in evolutionary conserved elements 
(Visel et al. 2008), combining binding data for multiple, functionally related TFs  (Junion et al. 
2012), or generating a chromatin profile of the ChIP sample (Heintzman et al. 2007; Ernst and 
Kellis 2010 and 2013). The results gained by these approaches show, that additional information 
is needed to interpret the genomic TF binding sites.  
In that respect, the design of the chMM-ChIP-seq experiments performed here limits the 
interpretation of functional TF binding in chMM cultures, because additional filters to interpret 
the ChIP-seq peaks are missing. However, the chMM-ChIP-seq system established in this study 
enables the design of experiments that could add missing datasets to address a wide range of 
biological questions. 
 
 
 General Implications for HOXD13 Binding and Function 4.6
This study provides the first report of a HOXD13 ChIP-seq dataset and finds HOXD13 to bind 
to thousands of sites throughout the genome and recognizes the same DNA-sequence as the 
homeodomain in vitro (CCAATAAAA). Strikingly, approximately 22% of HOXD13 peaks 
contain the reported HOXA13 recognition sequence (CTCGTAAAA) (Berger et al. 2008; 
Zhang et al. 2011; Jolma et al. 2013). These peaks either contain only a HOXA13 site 
(HOXA13-only) or a HOXA13 site in addition to a HOXD13 binding site (HOXD13-HOXA13 
both). This finding confirms previous observations by several groups that found the HOXD13 
homeodomain to bind to the HOXA13 recognition sequence and vice versa in in vitro assays  
(Caronia et al. 2003; Berger et al. 2008; Zhang et al. 2011; Jolma et al. 2013). An additional key 
observation is that one in five HOXD13 motifs found in HOXD13 peaks contained an 
additional HOXA13 binding site within 300 bp, which is also reflected in the characteristic 
distribution of the best HOXD13 sequence found in Centrimo analysis. Notably, the HOXA13 
motif used for the analysis is highly similar to the motif that HOXD12, HOXD11 and HOXA11 
bind in vitro (Berger et al. 2008; Jolma et al. 2013). The similarity of the motifs complicates the 
conclusions concerning cobinding of any two HOX proteins. Therefore, the results do not allow 
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to conclude that HOXD13 specifically binds with HOXA13 throughout the genome, but rather 
suggest a general cooperative regulation by all posterior HOX proteins.  
This observation is in line with the phenotype of Hoxd11-13 triple knockout mice, which exhibit 
a syndactyly that strongly resembles SPD (Zakany and Duboule 1996). Similarly, HOXD13 and 
HOXA13 redundantly activate the EphA7 promoter in reporter constructs and inhibit 
chondrogenic differentiation in chMM, respectively (Salsi and Zappavigna 2006; Kuss et al. 
2009). Detailed analysis of the HOXD13-HOXA13 motif pairs provided little evidence for 
dimeric binding of two HOX-proteins but rather suggest a cooperative binding. However, in a 
minority of cases, the HOXD13-HOXA13 recognition sites seem to exhibit a preferred 
orientation, possibly indicating steric limitations to the binding of two HOX proteins to directly 
adjacent binding sites.  
The analyses performed over the course of this study did not focus on the regulatory effect of 
HOXD13 but rather on its biochemical binding properties. Salsi et al. (2008) performed a ChIP-
chip study of endogenous and transiently expressed Hoxd13 in murine limb buds and human 
osteogenic cell lines, respectively, and demonstrated that HOXD13 binds and regulates genes 
involved in limb development and/or cartilage/bone formation. The chMM-ChIP-seq system 
offers an excellent opportunity to study skeletal development and future analyses using chMM-
ChIP-seq should provide insights into the mechanisms and regulatory pathways through which 
HOXD13 influences chondrogenesis. 
Collectively, analysis of the HOXD13 binding profile strongly suggests that posterior HOX 
proteins bind cooperatively throughout the genome and confirms biological evidence of 
posterior HOX proteins’ redundancy.  
 
 
 The End 4.7
Using chMM-ChIP-seq, distinct pathomechanisms underlying two HOXD13 mutations were 
uncovered. First, the HOXD13Q317K mutation was found to specifically change the sequence 
specificity, thereby inducing a genome-wide shift in binding. Interestingly, the regulatory 
effects of such a genomic shift in binding are connected to the presence or absence of other TF 
binding sites that make this shift meaningful. 
Second, the HOXD13R298Q mutation reduced the DNA-binding affinity of the mutant protein, 
possibly causing a loss of functional binding sites. A key observation regarding this loss is that 
the pathogenic potential of the mutant HOXD13 does not seem to be directly connected to the 
binding strength. However, the experimental data presented here are incomplete and warrant 
further investigation. 
Finally, a close analysis of HOXD13 binding sites revealed a high fraction of binding sites with 
several HOX-like recognition sequences, which points to a molecular basis for the functional 
redundancy of this TF family.  
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Figure 5.1 Data sheet for HOXD13wt ChIP-seq. 
Quality-filtering and read-mapping, cross-correlation analysis and IDR analysis for HOXD13wt replicates performed as 
described in Section 2.3.6. 
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Figure 5.2 Data sheet for HOXD13Q317K ChIP-seq. 
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Figure 5.3 Data sheet for HOXD13Q317R ChIP-seq. 
 
  
5. Appendix 
 101 
 
 
Figure 5.4 Data sheet for HOXD13R298Q ChIP-seq. 
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Figure 5.5 Data sheet for PITX1 ChIP-seq. 
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